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The 2-chloro-s-triazine family of herbicides,
widely used to control broad-leaved and
grassy weeds, includes the chemicals atrazine,
simazine, and propazine. Triazine herbicides
have been used increasingly since the 1960s,
particularly on maize crops, in North
America and Europe. The estimated use of
atrazine alone in the United States was
almost 35,000 tons in 1993 (1). As a result it
is found in relatively high concentrations in
surface waters in certain parts of the North
American continent (2). Triazine herbicides
are relatively persistent to abiotic and biotic
breakdown (2,3) producing detectable levels
in drinking water, foods, and ﬁsh (2).
Epidemiologic studies have associated
long-term exposures to triazine herbicides
with increased risk of ovarian cancer in
female farm workers in Italy (4) and of
breast cancer in the general population of
Kentucky in the United States (5). In experi-
ments with female F344 rats, atrazine
induced tumors of the mammary gland and
reproductive organs (6). In female Sprague-
Dawley rats, atrazine caused lengthening of
estrous cycle and a dose–dependent increase
in plasma levels of 17β-estradiol (7).
Atrazine also caused an earlier onset of the
incidence of mammary and pituitary tumors
in this rat strain (7), a response typical of
exposure to exogenously administered estro-
gens (8,9). Recently, atrazine exposure dur-
ing lactation has been shown to suppress
suckling-induced prolactin release in female
Wistar rats (10). Further, the lactationally
exposed male offspring of the atrazine-
exposed dams had an increased incidence of
prostatitis (10), an effect also induced by
exposure to exogenous 17β-estradiol (11). A
subsequent study in Long-Evans and
Sprague-Dawley rats has attributed the
effects of atrazine on serum prolactin levels
to alterations in the hypothalamic control of
the release of this hormone by the pituitary
(12).
Investigations into the mechanism of
these apparent estrogenic effects have not
been able to demonstrate any consistent
interactions of triazine herbicides with the
estrogen receptor or effects on receptor-
mediated responses (13–15). Effects on
enzymes involved in steroid synthesis or
metabolism have been limited to a study of
the inhibition of testosterone metabolism in
the anterior pituitary of rats exposed in vivo
or of whole anterior pituitaries exposed in
vitro to atrazine (16). Weak inhibitory
effects were observed on testosterone 5α-
reductase (20–37%) at an atrazine concen-
tration of 0.5 mM; a similar observation was
made for the deethylated metabolite
atrazine-desethyl (16). Taken together,
effects of atrazine and other triazine herbi-
cides on estrogen receptor function or
enzymes involved in sex hormone metabo-
lism have been inconsistent and occurred at
extremely high concentrations.
Triazine herbicides are known to be
metabolized in various mammals (17–19)
and chickens (3). In human liver micro-
somes, the major metabolites formed are the
mono-dealkylated forms of atrazine: atrazine-
desethyl and atrazine-desisopropyl; hydroxy-
lation of the isopropyl groups present in
atrazine and propazine also occurs, but to a
lesser extent (for structures see Figure 1).
Other metabolites formed in vivo and found
in human urine are the fully dealkylated
metabolite of the triazines (atrazine-desethyl-
desisopropyl) and several 2-hydroxylated
metabolites. Triazine metabolism is catalyzed
primarily by cytochrome P450 (CYP)
enzymes (19). The fully dealkylated metabo-
lite of atrazine, like atrazine, has been shown
to have little interaction with the estrogen
receptor (14). Other than this, little or no
toxicologic information is available for the
metabolites of triazine herbicides.
Recently, we reported the ability of
atrazine, simazine, and propazine to induce
aromatase activity in a human adrenocortical
carcinoma cell line (20). This response was
observed at concentrations in the submicro-
molar range. In the present study we have
continued to examine the effects of triazine
herbicides and several of their common
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Articles
We investigated a potential mechanism for the estrogenic properties of three chloro-s-triazine her-
bicides and six metabolites in vitro in several cell systems. We determined effects on human aro-
matase (CYP19), the enzyme that converts androgens to estrogens, in H295R (adrenocortical
carcinoma), JEG-3 (placental choriocarcinoma), and MCF-7 (breast cancer) cells; we determined
effects on estrogen receptor-mediated induction of vitellogenin in primary hepatocyte cultures of
adult male carp (Cyprinus carpio). In addition to atrazine, simazine, and propazine, two metabo-
lites—atrazine-desethyl and atrazine-desisopropyl—induced aromatase activity in H295R cells
concentration-dependently (0.3–30 µM) and with potencies similar to those of the parent tri-
azines. After a 24-hr exposure to 30 µM of the triazines, an apparent maximum induction of
about 2- to 2.5-fold was achieved. The induction responses were conﬁrmed by similar increases in
CYP19 mRNA levels, determined by reverse-transcriptase polymerase chain reaction. In JEG-3
cells, where basal aromatase expression is about 15-fold greater than in H295R cells, the induc-
tion responses were similar but less pronounced; aromatase expression in MCF-7 cells was neither
detectable nor inducible under our culture conditions. The fully dealkylated metabolite atrazine-
desethyl-desisopropyl and the three hydroxylated metabolites (2-OH-atrazine-desethyl, -desiso-
propyl, and -desethyl-desisopropyl) did not induce aromatase activity. None of the triazine
herbicides nor their metabolites induced vitellogenin production in male carp hepatocytes; nor
did they antagonize the induction of vitellogenin by 100 nM (EC50) 17β-estradiol. These ﬁndings
together with other reports indicate that the estrogenic effects associated with the triazine herbi-
cides in vivo are not estrogen receptor-mediated, but may be explained partly by their ability to
induce aromatase in vitro. Key words: antiestrogenic, aromatase, atrazine, carp, chloro-s-triazines,
CYP19, estrogenic, H295R, hepatocytes, herbicides, JEG-3, MCF-7, vitellogenin. Environ
Health Perspect 109:1027–1031 (2001). [Online 26 September 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1027-1031sanderson/abstract.htmlmetabolites on aromatase activity in several
human cell lines—the H295R adrenocorti-
cal, JEG-3 placental, and MCF-7 breast can-
cer cell line. The rationale for choosing
JEG-3 cells was to examine the inducibility
of aromatase in a system where the enzyme is
known to be expressed at relatively high lev-
els compared to the H295R cells; we chose
MCF-7 cells to test whether the triazines
could induce aromatase activity in a system
where the enzyme is normally expressed at
very low levels. In addition, we have exam-
ined the effects of the triazines and their
metabolites on estrogen receptor-mediated
vitellogenin expression in cultured primary
hepatocytes of male carp (21). Increased syn-
thesis of vitellogenin, a yolk-precursor pro-
tein in fish and birds, is a response highly
sensitive to estrogens and also occurs after
exposure to other compounds that are ago-
nists for the estrogen receptor.
Materials and Methods
Cell culture conditions. We obtained H295R,
JEG-3, and MCF-7 cells from the American
Type Culture Collection (ATCC No. CRL-
2128, HTB-36, and HTB-22, respectively).
H295R cells were grown in 1:1 (v/v)
Dulbecco’s modiﬁed Eagle medium/Ham’s F-
12 nutrient mix (DMEM/F12; GibcoBRL,
Breda, The Netherlands) containing 365
mg/mL L-glutamine and 15 mM HEPES
(GibcoBRL). The mix was further supple-
mented with 10 mg/L insulin, 6.7 µg/L
sodium selenite, and 5.5 mg/L transferrin
(ITS-G; GibcoBRL), 1.25 mg/L bovine serum
albumin (Sigma, St. Louis, MO, USA), 100
U/L penicillin/100 µg/L streptomycin
(GibcoBRL) and 2% steroid-free replacement
serum Ultroser SF (Soprachem, France).
JEG-3 cells and MCF-7 cells were cultured in
DMEM containing 4,500 mg/L D-glucose
and 110 mg/L sodium pyruvate (GibcoBRL),
10% heat-inactivated fetal calf serum (ICN,
Costa Mesa, CA, USA), and 100 U/L peni-
cillin/100 µg/L streptomycin (GibcoBRL).
MCF-7 cells were cultured in DMEM sup-
plemented with L-glutamine, 4,500 mg/L D-
glucose, and sodium pyruvate (GibcoBRL)
For the aromatase experiments, cells were
treated as described previously (20). In brief,
cells (about 1–2 × 105 cells/well) in 24-well
culture plates containing 1 mL medium per
well were exposed to various concentrations
(0, 0.3, 1.0, 3.0, 10.0, and 30 µM) of the
triazine herbicides or their metabolites
(Riedel-deHaen, Seelze, Germany) (see
structures in Figure 1) dissolved in 1 µL of
dimethyl sulfoxide (DMSO; Sigma).
Negative control cells received 1 µL of
DMSO. Positive control cells were exposed
to 100 µM of 8-bromo-cyclic adenosine
monophosphate (8Br-cAMP) dissolved in
medium containing 0.1% DMSO. We
included unexposed cells as further controls,
and we tested all treatments in quadruplicate. 
For the reverse-transcriptase polymerase
chain reaction (RT-PCR) experiments, we
exposed cells in 12-well plates to 2 µL
DMSO or the test chemicals in DMSO; a
positive control (100 µM 8Br-cAMP) was
included on each plate. We tested each treat-
ment in triplicate and reproduced each
experiment three times. DMSO at 0.1% had
no effect on CYP19 expression or catalytic
activity relative to unexposed cells. The test
chemicals did not cause cytotoxicity at con-
centrations of 30 µM and below, based on
visual inspection of the cells, cell attachment,
protein content of the wells, and the inabil-
ity of the triazines to decrease the mitochon-
drial activity of succinate dehydrogenase
determined by the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT)
test (22). We determined protein concentra-
tions by the fluorometric method of
Udenfriend et al. (23), using bovine serum
albumin (Sigma) as standard. We added tri-
azines to the cell culture medium at concen-
trations below their aqueous solubility limit
[e.g., 300 µM for atrazine; 50 µM for
simazine (24)]. All exposures were for 24 hr.
Isolation and ampliﬁcation of RNA. We
isolated RNA using the RNA Insta-Pure
System (Eurogentec,  Liège, Belgium)
according to the enclosed instructions and
stored it at –70°C. We performed RT-PCRs
using the Access RT-PCR System (Promega,
Madison, WI, USA) with various modiﬁca-
tions reported previously (20). We verified
the purity of the RNA preparations by dena-
turing agarose gel electrophoresis. We
obtained suitable primer pairs by entering the
human CYP19 cDNA sequence obtained
from the European Molecular Biology
Laboratories database (Heidelberg, Germany)
into the software program Geneworks (ver-
sion 2.4; IntelliGenetics, Mountain View,
CA, USA). The primer pair used for CYP19
mRNA amplification was 5´-TTA-TGA-
GAG-CAT-GCG-GTA-CC-3´ and 5´-
CTT-GCA-ATG-TCT-TCA-CGT-GG-3´,
producing an amplification product of 314
base pairs. As reference, RT-PCR was per-
formed on β-actin mRNA using the primer
pair 5´-AAA-CTA-CCT-TCA-ACT-CCA-
TC-3´ and 5´-ATG-ATC-TTG-ATC-TTC-
ATT-GT-3´, according to the instructions
of the Access RT-PCR kit, except using 1
mM MgSO4, an annealing temperature of
54°C, and 25 cycles. We found β-actin
mRNA unaffected by any of the treatments
(DMSO, triazines, metabolites or 8Br-cAMP)
and could be used reliably as a reference
amplification response. Detailed informa-
tion on PCR conditions and reproducibility
and ability of the method to be used
(semi)quantitatively was published previ-
ously (20). We detected ampliﬁcation prod-
ucts using agarose gel electrophoresis and
ethidium bromide staining. We quantified
intensity of the ethidium bromide stains
using a FluorImager (Molecular Dymanics,
Sunnyvale, CA, USA).
Aromatase assay. We determined the cat-
alytic activity of aromatase using the method
of Lephart and Simpson (25) with minor
modiﬁcations. Cells were exposed to 54 nM
1β-3H-androstenedione (New England
Nuclear Research Products, Boston, MA,
USA) dissolved in serum-free (Ultroser SF-
free) culture medium and incubated for 1.5
hr at 37°C in an atmosphere of 5% CO2
and 95% air. All further steps proceeded as
reported previously (20,26). Aromatase
activity was expressed in picomoles of
androstenedione converted per hour per mil-
ligram cellular protein. We verified the
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Figure 1. The various routes of metabolism of the 2-chloro-s-triazines herbicides atrazine, simazine, and
propazine to several common dealkylated metabolites. Each of the three dealkylated metabolites can be
further dechlorinated via 2-hydroxylation.
Simazine Atrazine Propazine
Atrazine-desisopropyl
(Atrz-DI)
Atrazine-desethyl-desisopropyl
(Atrz-DE-DI or DACT)
Atrazine-desethyl
(Atrz-DE)specificity of the aromatase assay based on
the release of tritiated water by measuring
the production of estrone (the aromatization
product of androstenedione), using a 125I-
labeled double-antibody radioimmunoassay
kit (ICN), and by using 4-hydroxyan-
drostenedione, an irreversible inhibitor of
the catalytic activity of aromatase, to block
the formation of tritiated water (27).
Carp hepatocyte/vitellogenin production
assay. Male carp (Cyprinus carpio) hepato-
cytes were freshly perfused by a two-step
retrograde technique, isolated and cultured
as described previously in 96-well plates
(21). Culture conditions included the use of
phenol red-free DMEM/F12 medium
(Sigma) supplements with 14.3 mM
NaHCO3, 20 mM HEPES, 50 µg/L gen-
tamycin, 1 uM insulin, 10 µM hydrocorti-
sone, 2% Ultroser SF and 2 mg/L of the
protease inhibitor aprotinin (Fluka, Buchs,
Switzerland). Cells were seeded in 96-well
plates at a density of 1 × 106 cells/mL (180
µL/well). For the estrogenicity studies, we
exposed cells to various concentrations of
17β-estradiol (0.06–6 µM) or the triazines
and their metabolites (0.3–30 µM), from
DMSO stocks. For the antiestrogenicity
studies, we used the same triazine concentra-
tions but added them in culture medium
containing 100 nM 17β-estradiol (approxi-
mate EC50). The final concentration of
DMSO did not exceed 0.2% (v/v). As posi-
tive controls we included on every plate
either a 100 nM 17β-estradiol (for estro-
genicity studies) or 0.1, 1.0, and 10 µM
tamoxifen, a known estrogen receptor
antagonist (for antiestrogenicity studies). All
treatments were in sextuplet; each concen-
tration–response experiment was repro-
duced three times. Exposures were for 6
days. We quantiﬁed vitellogenin production
by an indirect competitive ELISA, and we
determined cell viability as described in
detail previously (21).
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Figure 2. Concentration–response curves for induction of aromatase activity in
H295R human adrenocortical carcinoma cells after 24-hr exposure to atrazine
and six of its metabolites. Each concentration was tested in quadruplicate. 
Figure 3. Comparison of aromatase activity based on estrone production of triti-
ated water release in H295R human adrenocortical carcinoma cells treated for
24 hr with 30 µM atrazine, its metabolites atrazine-desethyl (Atrz-DE), atrazine-
desisopropyl (Atrz-DI), and atrazine-desethyl-desisopropyl (Atrz-DE-DI or DACT),
or 100 µM 8-bromo-cAMP. Each concentration was tested in quadruplicate.
*Signiﬁcantly different from control (DMSO)(two-tailed Student t-test, p < 0.05).
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Figure 5. Concentration–response curves for induction of aromatase activity in
JEG-3 human placental choriocarcinoma cells after 24 hr exposure to atrazine,
simazine, or propazine, and the effect of 24-hr exposure of JEG-3 cells to a sin-
gle concentration of 30 µM of six triazine metabolites, or 100 µM 8-bromo-
cAMP. Each concentration was tested in quadruplicate.
*Signiﬁcantly different from control (DMSO) (two-tailed Student t-test, p < 0.05). 
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Aromatase induction in H295R cells.
Atrazine, atrazine-desethyl (Atrz-DE), and
atrazine-desisopropyl (Atrz-DI) were able to
induce the catalytic activity of aromatase
concentration-dependently to an apparent
maximum of just over 2-fold (Figure 2).
Greater concentrations of these compounds
demonstrated slight cytotoxicity (about 20%
decrease in MTT reduction at 100 µM).
The fully dealkylated metabolite of
atrazine—atrazine-desethyl-desisopropyl
(Atrz-DE-DI or DACT)—and the metabo-
lites that were hydroxylated at the 2 position
of the triazine ring [and thus dechlorinated
(Figure 1)] had no effect on aromatase activ-
ity (Figure 2). We veriﬁed further the differ-
ential effects of the triazine compounds on
aromatase activity by measuring the ability
of the cells to convert androstenedione to
estrone. Tritiated water release and estrone
production were increased in a 1:1 ratio in
cells exposed to atrazine or Atrz-DE, Atrz-
DI, and 8Br-cAMP, whereas the metabolite
Atrz-DE-DI had no effect on either mea-
surement (Figure 3). The mechanism of
induction of aromatase activity appeared to
involve the induction of CYP19 mRNA,
because atrazine, Atrz-DE, Atrz-DI, and
8Br-cAMP were able to increase mRNA lev-
els for CYP19 relative to control, whereas
Atrz-DE-DI had no effect (Figure 4). None
of the triazine metabolites could inhibit or
enhance the activity of aromatase when
added directly to the medium used for the
aromatase assay (data not shown). The same
was true for the parent triazines (20).
Aromatase induction in JEG-3 and
MCF-7 cells. Several 2-chloro-s-triazine her-
bicides were able to induce aromatase activ-
ity in JEG-3 cells (Figure 5). Atrazine,
simazine, and propazine induced aromatase
activity concentration-dependently, produc-
ing statistically signiﬁcant increases in activ-
ity above control at concentrations above 1
µM (Student t-test, p < 0.05). Among the
metabolites of atrazine tested at 30 µM, only
Atrz-DE and Atrz-DI signiﬁcantly increased
aromatase activity above control. The most
noticeable difference between JEG-3 and
H295R cells is the basal activity of aro-
matase, which was at least an order of mag-
nitude greater in JEG-3 cells (about 15 pmol
androstenedione/hr/mg cellular protein)
than in H295R cells (about 1–1.5 pmol
androstenedione/hr/mg cellular protein);
also, basal activity in JEG-3 cells was
inducible by only 2-fold after 24-hr exposure
to 100 µM 8Br-cAMP, whereas aromatase
activity was inducible by over 5-fold in
H295R cells. In MCF-7 cells, basal aro-
matase activity was undetectable, and neither
8Br-cAMP, atrazine, simazine, nor propazine
was able to induce the activity to detectable
levels, under our culture and assay condi-
tions; the same was true for mRNA levels
(data not shown).
Vitellogenin production in carp hepato-
cytes. Vitellogenin concentrations in
unexposed or DMSO-exposed male carp
hepatocytes were undetectable. A lowest-
observed-effect concentration of 17β-estradiol
of about 2 nM produced a detectable amount
of vitellogenin of about 100–400 ng/mg cel-
lular protein; the EC50 of 17β-estradiol
induced vitellogenin concentrations to
4,000–6,000 ng/mg protein. Coexposure of
hepatocytes to 100 nM 17β-estradiol and 0.1,
1, or 10 µM tamoxifen inhibited 17β-estra-
diol-induced vitellogenin synthesis by 54%,
89%, and 91%, respectively. The readily
aromatizable androgens testosterone and 17α-
methyltestosterone did not induce vitel-
logenin synthesis at concentration between
0.6 nM and 1 µM (6-day exposures), indicat-
ing that aromatase activity is either very low
or not present in male carp hepatocytes in pri-
mary culture under our conditions. Exposure
of male carp hepatocytes to various concen-
trations (0–30 µM) of the triazines or their
metabolites did not signiﬁcantly induce vitel-
logenin production (Figure 6A). The only
exception was a slight, but statistically signiﬁ-
cant (p < 0.05) and concentration-dependent
estrogenic response by Atrz-DE-DI (DACT),
which increased vitellogenin production from
2% of the response by 100 nM 17β-estradiol
at 1 µM (not shown) to about 8% of the
response by 100 nM 17β-estradiol at 30 µM
(Figure 6A). None of the compounds could
produce a concentration-dependent antiestro-
genic response in the presence of 100 nM
17β-estradiol (Figure 6B).
Discussion
We recently reported that several chloro-s-tri-
azine herbicides induce the catalytic activity
and mRNA expression of human aromatase
in vitro in H295R adrenocortical carcinoma
cells (20). The present study extends these
observations by demonstrating that atrazine,
simazine, propazine, and two metabolites
shared by these Atrz-DE and Atrz-DI—were
able to induce aromatase activity in H295R
cells, whereas the fully dealkylated metabo-
lite Atrz-DE-DI (DACT) and the three
hydroxylated metabolites of atrazine were
not active. In addition, the compounds that
induced aromatase activity in H295R cells
also induced this activity in JEG-3 cells,
although with lesser efficacy. A difference
between the two cell lines is that JEG-3 cells
exhibited a 15-fold greater basal aromatase
activity than H295R cells, and inducibility
by 8Br-cAMP was lower (< 2-fold) than in
H295R cells (over 5-fold). Thus, the rela-
tively high level of basal aromatase gene
expression in JEG-3 cells and relatively low
inducibility by the cAMP analog partly
explains the lesser response to the triazines.
MCF-7 cells did not exhibit aromatase
activity in this study, nor did they respond
to induction by cAMP analogs or triazine
herbicides. The expression of aromatase in
MCF-7 cells has been the subject of con-
ﬂicting reports. Although many studies have
not detected aromatase activity in MCF-7
cells (28), some report the presence of low
aromatase activity (29–31) and of stimula-
tion of estrogen-receptor–mediated cell pro-
liferation by androgens in this cell line (30).
The expression of aromatase in MCF-7 cells
is poorly understood, and although at least
one study reported stimulation of this
enzyme by cAMP (31), we have not been
able to stimulate MCF-7 cells to express
detectable levels of activity using 8Br-cAMP
or forskolin. The above suggests that major
qualitative differences exist in characteristics
among batches of MCF-7 cells in culture,
which may complicate the use of this cell
line as an in vitro screening tool for effects
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Figure 6. Exposure of male carp hepatocytes to triazines and metabolites. (A) Effect of 100 nM estradiol
(E2) or 30 µM of the three parent triazines and six metabolites on vitellogenin production in freshly isolated
male carp hepatocytes. (B) Effect of a coexposure of freshly isolated male carp hepatocytes to 100 nM E2
and 30 µM of each of the three parent triazines or their six metabolites individually, on the induction of
vitellogenin synthesis. Each concentration was tested in quadruplicate.
*Signiﬁcantly different from control (DMSO) (two-tailed Student t-test, p < 0.05). 
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A Bof androgens and estrogens, or effects of
xenobiotics on steroidogenic and/or steroid
metabolizing enzymes. In any case, our
ﬁndings indicate that, unlike in cell systems
in which the expression of aromatase activ-
ity is clearly cAMP-dependent (H295R and
JEG-3), triazine herbicides do not induce
aromatase activity in MCF-7 cells, in which
this expression is relatively refractory to
cAMP.
Regarding a structure–activity relation-
ship for aromatase induction by the different
triazine compounds, it appeared that the rel-
atively lipophilic parent triazines and mono-
dealkylated metabolites were active, whereas
the more hydrophilic fully dealkylated and
2-hydroxylated (dechlorinated) metabolites
were inactive. These results indicate that bio-
kinetic factors such as metabolism may play
a considerable role in the biologic activity of
triazine herbicides. Whether the structure-
activity relationship observed for aromatase
induction in vitro corresponds with the
potential to increase estradiol levels or cause
estrogen-mediated toxicities in vivo is not
certain. Indeed, atrazine, simazine, and
propazine appear to have similar effects on
mammary tumor incidences in vivo (32), but
toxicologic information on the fully dealky-
lated metabolite of the triazines is insuffi-
cient to make a judgment. To substantiate
the aromatase induction hypothesis, addi-
tional experimental evidence is required to
determine whether aromatase induction
occurs in vivo and in which target tissues this
induction would take place. Given the
recent evidence that plasma estradiol and
estrone levels are increased in atrazine-
treated male Wistar rats (33), it is apparent
that the presence of ovarian aromatase is not
essential for the effects of atrazine. The fur-
ther observation that estrone levels appear to
be preferentially increased in vivo (33) may
indicate a tissue-speciﬁc effect on aromatase.
If aromatase induction is shown to play a
role in vivo, it could be hypothesized that the
induction would occur in tissues that con-
tain relatively greater levels of androstene-
dione than testosterone as precursor—tissues
such as adrenal cortex and adipose.
The lack of response of male carp hepato-
cytes to the triazines and their metabolites is
consistent with the observed lack of interac-
tion of these compounds with the estrogen
receptor and inability to cause estrogen recep-
tor-mediated responses in vitro (13–15). In
addition, measurable aromatase activity was
not found in the hepatocytes because readily
aromatizable androgens were not able to
elicit vitellogenin induction. However, we
do not rule out the presence of low levels of
aromatase activity in male carp hepatocytes
in primary culture, and future investigations
will be needed to address this question.
In conclusion, the effects of the triazine
herbicides and some of their metabolites on
aromatase activity may provide a partial expla-
nation for the observed increases in plasma
estradiol concentrations in female Sprague-
Dawley rats (7) and estradiol and estrone con-
centrations in male Wistar rats (33) exposed to
atrazine, together with the observed estrogen-
mediated toxicities in vivo (7). Future studies
are needed to investigate the inducibility of
aromatase by the various triazine herbicides
and their metabolites in vivo, and compare the
developed structure-activity relationship for
induction to in vivo estrogenic toxicities and
to the in vitro results of the present study.
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Pellets were resuspended at stepped suspen-
sion concentrations from 10/13 mg/mL to
10 mg/mL, except SC1, which was adjusted
to one-tenth the concentration of other sam-
ples. These suspensions were stored at 4°C. 
Cell isolation. We obtained heparinized
blood from healthy donors by venipuncture
and diluted it 1:1 in HBSS. We isolated
monocyte–lymphocyte fractions by Ficoll
density centrifugation and plated them in 9-
cm-diameter plastic tissue culture dishes for
monocyte adherence (23). We cultured the
adhering cells for 9 days in RPMI1640
HEPES modiﬁcation (Sigma Chemical Co.,
St. Louis, MO, USA) with 10% FBS, 100
U/mL penicillin, and 100 µg/mL strepto-
mycin. This culture medium was changed
every 2 days. Adherent cells were separated
after 6 days, and suspended in serum-free
RPMI1640. 
Chemiluminescence measurements. The
method of measurement of lucigenin-depen-
dent CL from 6-day-old human monocyte-
derived macrophages exposed to various
mineral ﬁbers has been described (24): The
lucigenin responses increased with the
increasing age of cultures over 6 days, and
Nyberg and Klockars (24) obtained a corre-
lation between lucigenin-dependent CL and
superoxide production measured with the
cytochrome C reduction assay at 6 days of
culture. 
The isolated cells (1 × 105 cells) were
transferred into a luminometer tube con-
taining mineral sample suspension (65 µL),
10% FBS, 0.1 mM lucigenin, and in some
experiments 1,000 U/mL superoxide dis-
mutase (SOD). The final volume of each
tube was 1 mL. The light emission of each
sample was detected at 15-min intervals
with a luminescence reader (ALOKA BLR-
201; Mitaka, Tokyo, Japan). We measured
all samples including the negative control
(no fiber) with the same cell suspension at
10-sec intervals. We performed all reactions
at 37°C in RPMI 1640, each measurement
4 times.
Statistical analysis. We analyzed the
ability to induce CL per ﬁber of each sample
as described previously (20). Briefly, we
examined the relation between the estimated
number of fibers administered and CL
response by linear regression. The slope (β1)
of the regression line was taken as a measure
of the ability to induce CL per fiber. We
excluded the data of β1 for r2 < 0.9. We also
examined the relation between ﬁber size and
ability to induce CL by linear regression, and
calculated the increase in the rate of induc-
tion with two β1. We examined the time
course of the increase in the ability to induce
CL by power regression. Finally, we exam-
ined the relation between fiber size and
increased ability to induce CL using linear
regression. 
Results
The time course of the ability to induce CL
per ﬁber (β1). We tested the CL response of
all JFM preparations and controls at con-
stant rotation every 15 min by using a stock
of cells in suspension. We needed β1 to com-
pare the CL response of each sample at a
value not related to the number of fibers
administered. Table 1 shows β1 and r2. All
ﬁber samples except for WO1 induced a CL
response in a dose-dependent manner. Each
response was almost completely inhibited by
SOD, which is a superoxide scavenger (data
not shown). WO1 was excluded in subse-
quent analyses because its CL response
increased rectilinearly and the linearity of its
dose response was low (Table 1). Moreover,
we also excluded the β1 data for r2 < 0.9 at
each measurement time. 
As shown in Figure 1, each JFM stan-
dard reference sample produced a sigmoid-
type increase in β1. The pattern of increase
in β1 for each sample was similar, although
the values differed. 
The similarity of the increase in β1 to
JFM samples. We calculated the rate of
increase in β1 to demonstrate the similarity
of the response pattern to various mineral
ﬁbers. Table 2 shows the rate for each time
point. Although each rate of increase was
different at 15–30, the kinetics of the rate
were relatively similar in these cases. As
shown in Figure 2, the rate of β1 decreased
for the power regression line. Table 3 shows
constants and the r2 of the power regression
lines. These comparisons showed the similar-
ity of each CL response more clearly.
However, the thickest fiber (RF3) and the
thinnest ﬁber (TO1) had slightly lower cor-
relations than other samples. The rate of
RF3 was low in the acute phase, and the rate
of TO1 was high in the acute phase. 
The relationship between β1 and fiber
length. Figure 3 shows a representative time-
dependent relation between geometric-mean
length and β1, used to examine the effect of
ﬁber length on CL response. The results are
shown in Table 4 with constants and the r2
of the regression lines. A close correlation
existed between length and β1 at each time
point, although four samples under approxi-
mately 6 µm in length (SC1, PT1, MG1,
and TO1) had a low β1. Therefore, a further
close correlation existed between length and
β1 with samples > 6 µm in length (GW1,
RW1, RF1, RF2, RF3, SC1, and PT1) after
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Table 1. Constants and r2 of the regression lines for CL and estimated number of ﬁbers.
Timea 01 53 04 56 07 59 0 105 120 
(min) β1
b r2c β1 r2 β1 r2 β1 r2 β1 r2 β1 r2 β1 r2 β1 r2 β1 r2
GW1 15.34 0.110 280.0 0.960 1,052 0.958 2,492 0.942 3,489 0.927 4,333 0.941 4,643 0.920 4,642 0.947 4,735 0.940
RW1 9.869 0.406 345.4 0.966 1,072 0.979 1,920 0.961 2,735 0.959 3,581 0.952 3,946 0.924 4,209 0.937 4,352 0.938
MG1 0.436 0.339 21.97 0.972 66.20 0.902 112.1 0.818 153.8 0.815 182.0 0.819 179.8 0.798 162.7 0.761 142.2 0.735
RF1 0.664 0.020 168.3 0.920 517.9 0.992 1,021 0.985 1,601 0.975 1,955 0.952 2,035 0.928 1,877 0.865 1,580 0.780
RF2 –0.75 0.028 214.3 0.985 562.2 0.988 893.9 0.967 1,219 0.944 1,447 0.921 1,538 0.916 1,439 0.897 1,327 0.848
RF3 7.742 0.422 177.0 0.978 371.0 0.992 539.1 0.979 669.1 0.937 910.5 0.982 914.7 0.970 997.0 0.970 1,021 0.967
PT1 –0.03 0.162 2.130 0.971 6.100 0.940 9.600 0.896 11.40 0.818 10.40 0.685 8.900 0.608 6.700 0.484 4.800 0.373
SC1 0.307 0.228 7.600 0.917 24.40 0.992 49.20 1.000 77.80 0.996 110.6 0.996 123.1 0.994 128.9 0.992 132.4 0.990
TO1 –0.03 0.203 1.520 0.977 3.200 0.974 7.000 0.988 11.00 0.913 12.00 0.822 11.10 0.738 9.400 0.662 7.300 0.607
WO1 –0.29 0.072 –5.69 0.450 –2.90 0.041 8.900 0.124 28.20 0.338 61.80 0.580 95.30 0.688 118.8 0.765 137.1 0.786
aTime after administration; CL responses of 54 samples were measured in constant rotation at 15–min intervals with the same stock suspension of cells. bβ1 (× 10–9) is the slope of the
regression line for the estimated number of ﬁbers administered and CL response with 5 concentrations and a duplicate negative control. The CL response is the mean value of the four
measurements. cSquare of the correlation coefﬁcient of the regression line. 
Figure 1. Time course of ability to induce CL from
macrophages exposed to various mineral fibers
(β1 of Table 1). Each point is the mean from four
measurements. The defects are the cases where
r2 is < 0.9 (shown in Table 1). 
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PT130 min. The relation between length and β1
lasted from the acute phase of the reaction to
120 min. 
The relationship between β1 and fiber
width. The World Health Organization
(WHO) classifies mineral fibers based on
length, width, and the aspect ratio of the
fiber (25). Figure 4 shows the relation
between geometric-mean width and β1 at 15
and 45 min. The results are shown in Table
5 with constants and the r2 of the regression
lines. As shown in Figure 4 and Table 5, we
observed a close correlation between width
and β1 for eight samples < 1.8 µm in width
at 15 min (r2 = 0.8766); however, this rela-
tionship did not continue (r2 at 45 min =
0.5138). β1 correlated with width more than
with length at 15 min, but it correlated with
length more than with width after 30 min. 
The relationship between increase rate of
β1 and width. We examined the relationship
between rate of β1 and fiber width to
demonstrate the effect of the width from 15
to 60 min. Figure 5 shows a representative
relationship between rate of β1 and fiber
width. The results are shown in Table 6 with
constants and the r2 of the regression lines.
Although the tendency of this relationship at
15–30 min resembles that of β1 and width at
15 min (Figure 4A), we observed a correla-
tion at 30–45 min [r2 = 0.5309 (Figure 5B)]
and at 45–60 min [r 2 = 0.7473 (Figure
5C)]. However, a slope of the regression line
decreased over the time course. Moreover, as
shown in Table 2, the increase of β1 was
similar in each sample after 60 min.
Therefore, we saw no correlation at 60–75
min (Table 6). 
The relationship between increase rate of
β1 and length. We also examined the rela-
tion between rate of β1 and ﬁber length. The
correlation between these could not be rec-
ognized at any time point (data not shown). 
The relationship between CL response
and fiber sample weight. The relationship
between sample weight and CL response at
45 min is shown in Figure 6A. These data
were the most rectilinear for the
dose–response curve in the time-course mea-
surement. Table 7 shows a slope of regres-
sion line of the dose–response curves in mass
concentration. MG1 had the highest level,
and GW1 and RF3 had the lowest level.
However, the linearity of dose–response
curves did not continue in some samples.
The relationship between sample weight and
CL response at 120 min is shown in Figure
6B as reference. The dose–response curve of
some samples was saturated at various levels.
Short ﬁbers tend to saturate the dose–response
curve at low dosage. 
Discussion
The results of the present study demonstrate
the time course and rate of the induction of
lucigenin-dependent CL in human mono-
cyte-derived macrophages for various man-
made and natural mineral ﬁbers. Moreover,
we examined the time-dependent relation-
ships between fiber size and these parame-
ters. Even when the dosed number of ﬁbers
differed for each sample, the ability to
induce CL per ﬁber could be approximated
using our analysis. 
Many intrapleural studies led to the con-
clusion that the fibrous shape of asbestos
dust particles is the cause of their carcino-
genicity in humans and that basically all
types of elongated dust particles such as min-
eral and vitreous ﬁbers can induce tumors if
they are sufﬁciently long, thin, and durable
in the tissue (10,26). If this conclusion is
true, common reactivity in the mechanism
of tumor induction should exist between
asbestos and mineral and vitreous fibers.
Numerous studies have suggested that ROS
may underlie the pathogenesis of asbestos-
related lung diseases (11,27). However,
amphibole asbestos, which includes iron in
its ﬁbers, plays a special role in ROS-medi-
ated pathology because it catalyzes the gener-
ation of the reactive hydroxyl radical from
hydrogen peroxide (11,28,29). In asbestos,
the hydroxyl radical can alter various bio-
logic effects (11–13). In biologic systems,
superoxide usually acts as the reductant pro-
ducing Fe2+, which rapidly decomposes
hydrogen peroxide to hydroxyl radicals
(29,30). The action of superoxide makes a
chain of reactions in which the net process
converts hydrogen peroxide to the hydroxyl
radical (29,31). Paradoxically, superoxide
activity may decide hydroxyl radical activity
in vivo, because hydrogen peroxide has
always been made in vivo if Fe3+ exists in
close proximity. Various mineral ﬁbers cause
a signiﬁcant increase in the release of super-
oxide from macrophages (18,19). Moreover,
tumorigenic fibers do not always have
hydroxyl radical activity in vitro (14). Silicon
carbide ﬁbers, one type of tumorigenic ﬁber,
have no hydroxyl radical activity (14). Our
ﬁndings here suggest that macrophages have
common superoxide reactivity for various
types of ﬁber and that the activity of super-
oxide from macrophages has an important
role in biologic effects, depending on fiber
length. 
In early animal intraperitoneal studies, it
was suggested that the induction of pleural
sarcoma increased with the length of fibers
with diameters < 1.5 µm (32). However, a
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Table 2. Time course of the rate of increase in β1, in 15-min intervals.
12 3 4 5 6 7
No.a (15–30) (30–45) (45–60) (60–75) (75–90) (90–105) (105–120)
GW1 3.757 2.369 1.400 1.242 1.072 1.000 1.020
RW1 3.104 1.791 1.424 1.309 1.102 1.067 1.034
MG1 3.012 —b ——— — —
RF1 3.078 1.971 1.569 1.221 1.041 — —
RF2 2.623 1.590 1.364 1.186 1.063 — —
RF3 2.096 1.453 1.241 1.361 1.005 1.090 1.024
PT1 2.845 — — — — — —
SC1 3.216 2.013 1.582 1.421 1.113 1.047 1.027
TO1 2.131 2.165 1.572 — — — —
Average 2.874 1.907 1.450 1.290 1.066 1.051 1.026
SD 0.498 0.296 0.120 0.082 0.036 0.033 0.005
aTime-course order of the rate of increase in β1. The rates were calculated between continuing two data points, in minutes.
For example, the values at 1 are β1at 30 min divided by the β1at 15 min. bThe defects were the cases where r2< 0.9. 
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Figure 2. Time course of the increase in β1. The
defects are the cases where r 2 is < 0.9. The
curves were approximated by power regression. 
Table 3. Constants and the r 2 of the power
regression lines for time course of the rate of
increase in β1. 
Fibers Aa Ba r2b nc
GW1 3.601 –0.720 0.961 7
RW1 2.849 –0.563 0.970 7
MG1 – – – 1
RF1 3.123 –0.669 0.9959 5
RF2 2.512 –0.550 0.9829 5
RF3 1.983 –0.356 0.8972 7
PT1 – – – 1
SC1 3.136 –0.693 0.9889 7
TO1 2.240 –0.245 0.5681 3
aConstants of the power regression line for the time
course of the rate in Figure 2. For convenience, number-
ing was used to estimate the regression line. Equation, Y
= AXB; Y = rate of increase in Table 2, X = numbering of
the rate in Table 2. bSquare of the correlation coefﬁcient
of the power regression line. Though constant, A
changes with the numbering; constant B and r2 are ﬁxed.
cEffective number.relation between ROS and fiber width has
not been shown. We also tried to analyze the
effect of ﬁber width on the ability to induce
CL. Our results showed that wide fiber (a
width of 2.4 µm) has a low ability to induce
CL and that thin ﬁbers cause a large acceler-
ation in the induction of CL in the acute
phase. However, our findings suggest that
the superoxide-mediated biologic effect of
width is weak because the effect of width on
the ability to induce CL was smaller than
that of length. If a biologic effect of width
does exist, thin ﬁbers may be stronger than
thick ﬁbers of the same length. 
WHO has classiﬁed ﬁbers > 5 µm long,
< 3 µm diameter, with an aspect ratio > 3:1
(25). Our findings suggest that many air-
borne WHO ﬁbers induce superoxide release
from macrophages depending on fiber
length. 
Long asbestos fibers are more effective
than short fibers in eliciting the release of
superoxide from macrophages (16). However,
the molecular mechanism by which asbestos
may augment the release of oxygen metabo-
lites from phagocytic cells is unclear. One
hypothesis is that oxidant release occurs non-
speciﬁcally during “frustrated” phagocytosis
by alveolar macrophages and polymorphonu-
clear leukocytes that are unable to ingest long
asbestos ﬁbers completely (33). However, our
findings do not support this hypothesis,
because the time-dependent pattern (sigmoid
type) and increase of ability to induce CL
were similar for each sample except wollas-
tonite (Figures 1,2). These findings suggest
that though the release of superoxide from
macrophages occurs nonspeciﬁcally for many
mineral ﬁbers, the intensity had already been
decided when fibers were phagocytosed to
some extent. If the release of superoxide
occurs during “frustrated” phagocytosis, the
intensity of that of short fibers should
decrease with the advance of phagocytosis. 
We speculated as to the reason why the
ability to induce CL increased with fiber
length when samples were longer than
approximately 6 µm. The regular transition
in the rate to induce CL in each sample sug-
gests that the intensity of the CL response is
decided at the initial stage of phagocytosis.
However, it cannot be considered that
macrophages recognized fiber length at the
initial stage of phagocytosis. In observations
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Figure 3. The relationship between geometric-mean length and β1 of Table 1. The line is a regression line
for samples > 6 µm in length. The data for r2 < 0.9 were excluded. (A) Data at 15 min; this correlation is the
lowest. (B) Data at 45 min; this correlation is the highest. 
Figure 4. The relationship between geometric-mean width and β1 of Table 1. The continuous line is a
regression line with samples < 1.8 µm in width. (A) Data at 15 min; this correlation is the highest. (B) Data
at 45 min. 
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Table 4. Constants and the r2 of the regression lines for β1 of Table 1 and ﬁber length. 
Timea 01 53 0 4 56 0 7 59 0 105 120
Ab 0.080 2.027 68.27 149.7 211.2 332.1 360.7 367.3 376.2
Bb –4.062 –6.286 –259.1 –700.4 –983.5 –2,200 –2,423 –2,456 –2,509
r2c 0.677 0.852 0.906 0.916 0.907 0.965 0.957 0.946 0.943
nd 99 9 7 7 6644
Ae 1.068 23.04 82.77 186.8 263.2 332.1 360.7 367.3 376.2
Be –7.910 –102.2 –465.1 –1,241 –1,741 –2,200 –2,423 –2,456 –2,509
r2f 0.738 0.819 0.937 0.976 0.962 0.965 0.957 0.946 0.943
n 77 7 6 6 6644
aTime after administration (min). bAnalysis for nine samples. A and B are constants of the regression line for β1 and ﬁber
length. Equation: Y = AX + B; Y = β1 of Table 1, X = geometric-mean length of ﬁbers, A, B = constants (× 10–9). cSquare of
the correlation coefﬁcient of the regression line with whole samples. dEffective number. The data < 0.9 in r2 of Table 1
were excluded, except for time 0. The data of time 0 are reference data. All effective data after 75 min were samples > 6
µm in length. eAnalysis for seven samples > 6 µm in length. A,B and equation were the same as b. fSquare of the correla-
tion coefﬁcient of the regression line with samples > 6 µm in length. 
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Table 5. Constants and the r2 of the regression lines for β1 of Table 1 and ﬁber width, except RF3. 
Timea 01 5 3 0 4 56 0 7 5 9 0 105 120
Ab 5.930 232.8 719.7 1,196 1,686 1,917 2,134 2,429 2,519
Bb -0.911 -32.26 -88.98 68.85 119.7 426.2 386.6 580.1 571.3
r2c 0.311 0.877 0.775 0.514 0.515 0.387 0.407 0.545 0.556
nd 88 866 5533
aTime after administration (min). bAnalysis for eight samples < 1.8 µm in width. A and B are constants of the regression line for β1 and ﬁber width. Equation: Y = AX+B; Y = β1 of Table 1, X
= geometric-mean width of ﬁbers, A,B = constants (× 10–9). cSquare of the correlation coefﬁcient of the regression line. dEffective number. The data < 0.9 in r2 of Table 1 were excluded,
except for time 0. The data of time 0 are reference data. by optical microscope, short fibers were
perpendicularly phagocytosed, and long
fibers were often tangentially phagocytosed
(data not shown). Therefore, we speculated
that tangential phagocytosis has a stronger
effect on the ability to induce CL than per-
pendicular phagocytosis. If this speculation
is true, a cause of the enhanced ability to
induce CL may be the increase in the tan-
gential phagocytic rate with lengthening of
ﬁber. Moreover, we speculated that tangen-
tial phagocytosis shifts to perpendicular
phagocytosis with fibers under approxi-
mately 6 µm in length. 
In general, many experimental protocols
have been conducted based on the mass con-
centration of fiber samples. Therefore, we
also show the CL response per sample
weight (Figure 6A) to allow comparison
with other experimental results. In compari-
son by mass concentration, our data showed
that the CL response is weak in both the
short samples and samples such as glass wool
and rock wool, which have low fiber num-
bers per unit weight. Mass concentration
study of glass wool and rock wool showed
no signiﬁcant increase in tumor incidence in
rats (4,5). The data in Figure 6A are consis-
tent with these in vivo results. Moreover, a
durable special application fiber glass
(MMVF33, 106 ﬁbers/cc > 20 µm) induced
lung fibrosis and a single mesothelioma in
hamsters; however, insulation fiber glass
(MMVF10a, 151 ﬁbers/cc > 20 µm) did not
induce lung fibrosis or tumors (34). The
data in Figure 1 are consistent with the ﬁnd-
ing that the glass ﬁber is not inert. 
Previous studies with various mineral
particles have suggested that the fibrous
geometry of particulates is of critical impor-
tance in the generation of superoxide from
macrophages (16,18,35). For example, for
amosite asbestos, dramatic enhancement of
release of superoxide has been found with
long ﬁbers but not short ones (35). The dis-
tribution of length of the long ﬁbers (50% >
approximately 14 µm long) is similar to that
of RF1 (mean length 12.0 µm), and the dis-
tribution of length of the short ﬁbers (10% >
approximately 10 µm long) is similar to that
of MG1 (mean length 3.0 µm). Therefore,
our data on the relationship between fiber
length and ability to induce CL are consis-
tent with the asbestos data. Moreover, our
findings suggest that this relationship con-
tinues over the time course without effect of
fiber clearance. In contrast, murine peri-
toneal macrophages exposed to equal num-
bers of short and long crocidolite asbestos
ﬁbers exhibited comparable hydrogen perox-
ide release (36). However, the mean length
of the long crocidolite ﬁber was 5.4 µm, and
the mean length of short fiber was 1.2 µm.
Our ﬁnding that the ability to induce CL was
similar among ﬁbers under approximately 6
µm in length was also consistent with the
hydrogen peroxide data. 
These assays were performed with sus-
pended cells over a time course of 2 hr.
Many previous published studies of effects of
asbestos and mineral ﬁbers on oxidant pro-
duction from alveolar macrophages have
used cells in suspension. However, many
studies of the effect of ﬁber length on oxidant
production and using monocyte-derived
macrophages have used adherent cells. For
some applications, suspended cells work better
than adherent cells for comparing the
response of cells. First, the number of cells in
each vial will be identical with that of cell
suspension. Second, the cells will have dif-
fuse contact with the ﬁbers. We believe that
this advantage contributes to linearity of the
dose–response curve of CL response. Finally,
the cells may smoothly phagocytose the
ﬁber. We consider that these advantages help
reduce experimental error. 
One problem is whether wollastonite is
an exception. Although WO1 was excluded
in our analyses, r2 and β1 of WO1 increased
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Figure 5. The relationship between geometric-mean width and rate of β1. The continuous line is a regres-
sion line on the whole. (A) Data at 15–30 min. (B) Data at 30–45 min. (C) Data at 45–60 min; this correlation
is the highest. The data for r2 < 0.9 were excluded. 
Figure 6. The relationship between sample weight and CL response. (A) Data at 45 min. (B) Data at 120
min. The data of WO1 were excluded. 
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Table 6. Constants and the r 2 of the regression lines for the rate of increase in Table 2 and ﬁber width.
No.a 12 34567
Ab –0.161 –0.290 –0.139 0.012 –0.029 0.029 0.001
Bb 3.016 2.213 1.597 1.276 1.101 1.012 1.025
r 2c 0.055 0.531 0.747 0.010 0.316 0.505 0.044
nd 97 76644
aTime-course order of the rate of increase in Table 2. bConstants of the regression line for the rate in Table 2 and ﬁber
width. Equation: Y = AX+B; Y = the rate in Table 2, X = geometric-mean width of ﬁbers. cSquare of the correlation coefﬁ-
cient of the regression line. dEffective number. The data < 0.9 in r2 of Table 1 were excluded. 
Table 7. A slope of regression line of each dose–response curve at 45 min in mass concentration.
Sample GW1 RW1 MG1 RF1 RF2 RF3 PT1 SC1 TO1
Slope (CL/mg) 1.744 3.264 7.285 8.980 7.777 1.887 5.658 20.18 4.495
Each r2 was the same as that of Table 1.
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for WO1 may be retarded; however, our
data are not sufﬁcient to deﬁne WO1 as an
exception. 
In conclusion, it is suggested that
macrophages nonspeciﬁcally induce superox-
ide for various ﬁber types depending on ﬁber
length. Although the generation of hydroxyl
radical may be the most important difference
between amphibole asbestos and other min-
eral fibers, superoxide is a tumor promoter
and is involved in the generation of hydroxyl
radical. Our ﬁndings suggested that even inert
mineral ﬁbers were not safe if the conditions
of durability, clearance, and respirability are
satisfied. Our findings have also revealed
important differences from the hypothesis
that oxidant release occurs during “frustrated”
phagocytosis. A remaining problem is to elu-
cidate the reasons why macrophages have
high superoxide activity for long ﬁbers.
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Air Pollution and Retained Particles in the Lung
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Epidemiologic studies indicate that current
levels of particulate air pollution are associated
with adverse health outcomes, including
increased cardiopulmonary mortality (1,2).
Although evidence suggests that short-term
impacts of particulate air pollution are dis-
placing deaths by more than months, of
greater public health signiﬁcance is the poten-
tial for long-term impacts that may shorten
lives by years or that may lead to chronic car-
diopulmonary morbidity. Several prospective
cohort studies provide evidence of such long-
term effects, including associations between
ambient particles and lung cancer (3–5).
Whereas acute effects may be limited to those
individuals with existing cardiopulmonary
disease, chronic exposures may affect a much
larger proportion of the exposed population.
Although the epidemiologic evidence points
to a causal relationship with particles originat-
ing in combustion processes, the biological
mechanism(s) as well as the exact types and
sizes of particles involved are the subjects of
intensive investigation. One hypothesis is that
the ultraﬁne particle size fraction is responsi-
ble for the epidemiologic observations (6).
This hypothesis is partly based on the fact
that the majority of atmospheric particles, by
number, are in the ultraﬁne mode. These par-
ticles, produced in combustion processes, are
likely to contain condensates of toxic metals
and surface acidity. In animal models, ultra-
fine particles appear to induce an intense
inﬂammatory reaction and are believed to be
translocated to the pulmonary interstitium in
large numbers (7,8). 
Despite the interest in the topic, little is
known of the types, sizes, and locations of
ambient atmospheric particles in human
lungs. Direct measurements of deposited par-
ticles in humans are difficult, but animal
models show that virtually all types of inhaled
particles can be translocated across the alveo-
lar epithelium to the interstitium, from which
location they are cleared slowly or not at all
(9). Analysis of lung parenchymal particle
burden can thus provide an indication of the
types and numbers of particles to which an
individual has been exposed. Also, such analy-
ses can show where potentially toxic particles
accumulate. Recently, we used analytical elec-
tron microscopy to determine parenchymal
particle burden in the lungs of long-term resi-
dents of Vancouver who had never smoked
tobacco (10). Our analysis indicated that
96% of the retained particles were < 2.5 µm
in aerodynamic diameter (PM2.5), therefore
suggesting that epidemiologic investigations
should focus on this size class of particles. 
In demonstrating biological plausibility it
is important to establish a link between
ambient concentrations, exposure, and dose.
In this study we examined lungs from female,
nonsmoking, long-term residents of Mexico
City, Mexico, a region with high ambient
particle levels, and Vancouver, British
Columbia, Canada, a region of much lower
levels. In doing so we asked a fundamental
question: Does residence in a location with
high air pollution levels result in a higher
level of biologically delivered dose of pollu-
tants? It is our hypothesis that exposure to
high levels of particulate air pollution is
reﬂected in increased interstitial particle bur-
dens. Although this hypothesis may appear
simplistic, there has been no direct demon-
stration that increased ambient particle expo-
sure in fact results in higher particle retention
(and, by implication, deposition) in the lung
over a lifetime. Such a ﬁnding would provide
pathologic evidence to support the epidemio-
logic data associating particulate matter expo-
sure with adverse health outcomes such as
mortality. This would provide additional evi-
dence that the observed epidemiologic associ-
ations, especially those related to chronic
exposures, are in fact biologically plausible. A
failure to prove this hypothesis would suggest
either that the observed epidemiologic associ-
ations may be driven by soluble particles
(which would be cleared from the airways
and parenchyma) or that the epidemiologic
ﬁndings are not valid and hence argue against
their plausibility.
Materials and Methods
Case selection. The study protocol was
reviewed and approved by the University of
British Columbia Clinical Research Ethics
Board (Approval C96-0511). Lungs for this
study were obtained from a general autopsy
service at a cardiovascular referral hospital in
Mexico City and were compared to lungs
obtained from a general hospital autopsy pop-
ulation in Vancouver. To reduce the possibil-
ity of occupational dust exposures, only lungs
from women were examined. Occupational,
smoking, and residential histories were
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Epidemiologic evidence associates particulate air pollution with cardiopulmonary morbidity and
mortality. The biological mechanisms underlying these associations and the relationship between
ambient levels and retained particles in the lung remain uncertain. We examined the parenchymal
particle content of 11 autopsy lungs from never-smoking female residents of Mexico City, a
region with high ambient particle levels [3-year mean PM10 (particulate matter ≤ 10 µm in aero-
dynamic diameter)= 66 µg/m3], and 11 control residents of Vancouver, British Columbia,
Canada, a region with relatively low levels (3-year mean PM10 = 14 µg/m3). Autopsy lungs were
dissolved in bleach and particles were identiﬁed and counted by analytical electron microscopy.
Total particle concentrations in the Mexico City lungs were signiﬁcantly higher [geometric mean
= 2,055 (geometric SD = 3.9) × 106 particles/g dry lung vs. 279 (1.8) × 106 particles/g dry lung]
than in lungs from Vancouver residents. Lungs from Mexico City contained numerous chain-
aggregated masses of ultraﬁne carbonaceous spheres, some of which contained sulfur, and aggre-
gates of ultrafine aluminum silicate. These aggregates made up an average of 25% of the total
particles by count in the lungs from Mexico City, but were only rarely seen in lungs from
Vancouver. These observations indicate for the ﬁrst time that residence in a region with high lev-
els of ambient particles results in pulmonary retention of large quantities of ﬁne and ultraﬁne par-
ticle aggregates, some of which appear to be combustion products. Key words: air pollution,
environmental exposure, particles, pulmonary retention. Environ Health Perspect 109:1039–1043
(2001). [Online ________]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1039-1043brauer/abstract.htmlobtained by interviews with relatives using a
standardized questionnaire. All subjects were
lifetime nonsmokers, and none had known
occupational dust exposure, including, for
the Mexico City lungs, domestic wood
smoke exposure. Exposure to environmental
tobacco smoke was assessed by evaluation of
calcium particles in tissue samples. Retained
calcium particles indicate exposure to
tobacco smoke (11). The lungs from Mexico
were collected from women who had been
lifetime residents of Mexico City, and the
lungs from Vancouver were from residents
who had lived in Vancouver for ≥ 20 years.
In both locations, inclusion criteria were
restricted to cases > 60 years old at time of
death. The mean ages were 67 ± 19 (SD) and
64 ± 9 years for Vancouver and Mexico City,
respectively. None of the patients had died of
lung disease, and the lungs were all morpho-
logically normal except for the presence of
minor degrees of pneumonia at autopsy.
Four additional cases from Mexico City were
examined, but three were excluded because
particle levels in the samples were too high to
allow for quantitative electron microscopy
analysis. An additional sample from Mexico
City was excluded because approximately
30% of the particles were determined to con-
tain calcium, an indicator for tobacco smoke
exposure (11). The total number of retained
particles for this case was similar to the other
cases from Mexico City. Four additional cases
from Vancouver were analyzed, but were
excluded from the data analysis because inter-
views could not be conducted; consequently
occupational histories were not obtained. For
three of these cases, retained particle concen-
trations were similar to the other cases from
Vancouver, whereas the concentrations from
the fourth case, which appeared to be an out-
lier, were signiﬁcantly higher.
Tissue dissection and particle counting
procedure. All tissues were handled with
dust-free gloves. Dissections were performed
on formalin-fixed lungs using a dissecting
microscope. From each specimen, we selected
for analysis a sample of parenchyma weighing
1–2 g from the central portion of the lung,
avoiding large airways, and an equivalent size
sample that was dried to constant weight to
allow expression of results as particles per
gram dried tissue. We selected the central tis-
sue sample so that we would analyze compa-
rable tissues from Vancouver and Mexico
City cases. Tissue samples were dissolved in
bleach and centrifuged at 30,000 × g for 20
min; the sediment was washed once to
remove the bleach and recentrifuged at
30,000 × g for 20 min to ensure that very
small particles were not lost during prepara-
tion. The preparation was resuspended and
collected on 0.1µm filters (Millipore-MF;
Millipore Corp., Bedford, MA, USA) and
then transferred to coated electron micro-
scope grids (10). We previously showed that
this approach effectively collects particles of
≥ 0.010 µm (12).
For this study, particles larger than
0.010 µm were counted, sized, and identi-
fied using an electron microscope (Phillips
400T; Phillips Electronics, Alomelo, The
Netherlands) equipped with an energy dis-
persive X-ray spectrometer (Kevex; Thermo-
Kevex X-Ray, Scotts Valley, CA, USA).
Approximately 100 particles were counted
per sample; particles were measured and
identiﬁed by a combination of morphology
and chemistry as determined by X-ray spec-
troscopy. For this study particles were charac-
terized as silica, silicates, singlet particles of
metals (particles analyzing only as iron,
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Table 1. Concentrations of particles (millions of particles per gram of dry tissue) of different types counted
in individual samples of lungs from Vancouver residents.
Metals Carbon +
(single Carbon sulfur Kaolin-like Iron
Sample Silica Silicate particles) Agg Agg Agg Agg Misc
42318 67 280 75 ND ND ND ND 8
42313 9 40 16 ND ND ND ND ND
42324 81 119 46 ND ND ND ND ND
42304 60 143 56 ND ND ND ND ND
42329 145 220 95 ND ND ND ND ND
2458 307 119 72 ND ND ND ND ND
2459 249 49 16 ND ND ND ND ND
2460 325 150 40 ND ND ND ND ND
2461 56 71 62 ND 2 ND ND ND
2464 105 139 84 ND ND ND ND ND
2467 66 88 35 ND ND ND ND ND
Mean 133 128 54 0 0.2 0 0 0.7
SD 109 7 26 0 0.6 0 0 2.4
Percent of totala 37.9 43.0 18.8 0.0 1.0 0.0 0.0 1.9
Abbreviations: Carbon Agg, aggregated particles producing no X-ray peak; Carbon + Sulfur Agg, aggregrated particles
producing only a sulfur X-ray peak; Iron Agg, aggregated particles analyzing as iron, sometimes with a small silicon peak;
Kaolin-like Agg, aggregated particles with a composition similar to kaolinite; Misc, miscellaneous; ND, not detected. 
aMean percentage of each type of particle relative to the total number of all types of particles for each case. 
Table 2. Concentrations of particles (millions of particles/g dry tissue) of different types counted in indi-
vidual samples of lungs from Mexico City residents. 
Metals Carbon +
(single Carbon sulfur Kaolin-like Iron
Sample Silica Silicate particles) Agg Agg Agg Agg Misc
2416 128 132 48 48 ND 135 10 16
2417 252 1,619 352 100 100 353 ND ND
2418 217 1,026 116 ND 16 150 251 17
2419 366 230 107 53 32 97 ND 53
2420 192 187 42 16 16 11 37 ND
2423 316 185 86 95 23 24 ND 23
2425 7,262 11,923 2,604 3,776 ND 871 ND ND
2426 173 236 79 165 52 43 ND 25
2427 770 1,057 258 542 171 199 ND ND
2428 3,395 8,068 4,243 3,820 1,697 848 ND 212
2448 319 1,033 73 344 25 442 ND 24
Mean 1,217 3,915 1,384 1,537 549 312 132 71
SD 2,215 2,336 728 895 236 288 99 52
Percent of total 24.6 38.2 10.1 10.9 3.2 9.3 2.1 1.6
Abbreviations: Agg, aggregated particles; Misc, miscellaneous; ND, not detected.
aMean percentage of each type of particle relative to the total number of all types of particles for each case.
Figure 1. (Ln)Concentration of total particles per
gram of dry tissue in Mexico City and Vancouver
samples. The top and bottom of boxes indicate the
25th and 75th percentiles, respectively, and the
length of boxes is interquartile distance. Upper
and lower whiskers extend to the largest and
smallest measured values that are 1 interquartile
distance from the 75th and 25th percentiles,
respectively. Circles are data points that are
greater or less than 1 interquartile distance from
the 75th or 25th percentiles. The line inside the box
indicates the median value. 
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Locationaluminum, or titanium), and aggregated par-
ticles (Tables 1 and 2). With one exception,
the aggregated particles were only seen in
Mexico City lungs. We classiﬁed aggregated
particles as follows: a) purely carbonaceous if
they were composed of more or less spherical
particles that produced no X-ray signal [we
previously demonstrated our ability to detect
purely carbonaceous aggregates by carrying a
sample of pure ultraﬁne carbon black through
our preparative procedure, including adding a
sample to lung tissue (12)]; b) carbonaceous +
sulfur if they had a similar morphologic
appearance but produced a small sulfur peak;
c) kaolinite-like if they were composed of
platy particles with an aluminum:silicon ratio
similar to kaolin; and d) iron aggregates if
they produced X-ray peaks for iron or iron
with a small amount of silicon. For purposes
of calculating particle numbers and sizes, we
treated each aggregate as one particle, but we
made additional measurements to determine
the sizes of particles that made up the car-
bonaceous and carbon + sulfur aggregates.
Retained particle concentrations were not
normally distributed and were therefore log-
transformed before all statistical analyses.
Ambient air samples. A limited number
of ambient PM2.5 particle samples were col-
lected on filters in Mexico City and
Vancouver. The purpose of this sampling
was to establish whether the types of parti-
cles observed in tissue samples were of simi-
lar composition and morphology to those
found in ambient air. All particle samples
were collected by intermittent sampling (1
min of sampling in each 8-min period, for a
total of 1,440 min) over a 7-day period in
order to provide a sample that was represen-
tative of typical particle types. In both loca-
tions, samples were collected between
October 1999 and January 2000. Particles
were collected with Harvard Impactors on
polytetrafluoroethylene (Teflon) membrane
(Teflo; Pall Life Sciences, Ann Arbor, MI,
USA) filters at a flow rate of 4 L/min. In
Vancouver, samples were collected at a
National Air Pollution Surveillance
monitoring site (Kitsilano), and in Mexico
City, samples were collected at two sites that
are part of the Mexico City ambient moni-
toring network: one located in the center of
the city (Hangares) and another in the
southwest (Tlalpan). Three-year average
PM10 concentrations were 66 µg/m3 for
seven monitoring sites in Mexico City and
14 µg/m3 from nine sites in Vancouver (13). 
After sample collection, filters were
weighed and then processed for electron
microscopy. The filters were wet with 0.1
mL of 95% ethanol, sonicated in 1 mL of dis-
tilled, deionized water, centrifuged, and trans-
ferred to electron microscope grids following
the same procedures used for the tissue 
samples.
Results
We found signiﬁcantly higher (p < 0.001, t-
test) concentrations of retained particles in
tissue samples from Mexico City than in
those from Vancouver (Figure 1, Tables 1
and 2). The geometric mean total particle
concentrations in the Mexico City lungs was
2,055 × 106 particles/g dry lung [geometric
SD (GSD) = 3.9] as compared to 279 (GSD
= 1.8) × 106 particles/g dry lung in the
Vancouver samples, a nearly 10-fold differ-
ence. Examination of individual mineral
species showed higher particle concentra-
tions in the Mexico City samples for every
particle type examined (compare mean con-
centrations in Tables 1 and 2).
In addition to the mixture of silicates
and other crustal material typically found in
tissue samples, the samples from Mexico
City contained on average 25.5% aggregated
ultraﬁne particles (Table 2). In particular, we
observed chain aggregates of approximately
spherical particles that produced no energy
dispersive X-ray signal and were, therefore,
presumably carbonaceous (Figure 2). Many
of these also contained trace amounts of sul-
fur, which is suggestive of combustion
source particles. The morphology of the
chain aggregates was remarkably similar to
those isolated from Mexico City ambient air
samples (Figure 2A) and from diesel exhaust
(14). In sharp contrast to the Mexico City
samples, only 1 aggregate (carbonaceous +
sulfur) was detected in the 11 Vancouver tis-
sue samples (Table 1). In Mexico City tissue
samples, a large number of aluminum sili-
cate aggregates with a chemical composition
similar to kaolinite were also identified, as
were occasional aggregates consisting of iron
particles that also gave a small X-ray peak for
silicon. The origin of these particles was
unclear, but they were never observed in
Vancouver lungs. On average, the aggregated
carbonaceous particles and carbonaceous par-
ticles + sulfur made up 14% of the total par-
ticles; the kaolinite-like aggregates made up
9%, and the iron aggregates 2% (Table 2).
However, if every particle in the aggregates
was counted as a single particle, these parti-
cles would make up the vast majority of the
particles detected in the Mexico City tissue
samples. 
Tables 3 and 4 show the sizes of particles
in the lung tissue samples from the two sites.
Overall, the geometric mean particle size in
the lungs was similar in both cities, with a
mean for all of the cases of 0.35 µm for
Mexico City samples and 0.39 µm for
Vancouver samples. Table 4 also shows the
geometric mean diameters for the aggregated
particles detected in lungs from Mexico
City. Some of the aggregates were quite
large, ranging up to about 4 µm, but most
were smaller than 1 µm. Table 5 shows the
mean sizes of the particles that made up the
carbonaceous and carbon + sulfur aggregates.
These were almost all ultraﬁne particles. The
structure of the kaolinite-like aggregates and
iron aggregates prevented measurement of
individual particle sizes.
Comparison of air samples from the two
locations indicated a similar distinction in
overall mass (and particle number) concen-
trations and in composition, with more than
20 times as many aggregates observed in
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Figure 2. Representative illustration of chained aggregated spherical particles giving no signal (i.e., car-
bonaceous particles) from (A) a Mexico City air sample and (B) a Mexico City lung. Bars = 0.1 µm.
Table 3. Geometric mean (GSD) particle diame-
ters (µm) for individual samples of lungs from
Vancouver.
Carbon + 
Sample All particles sulfur Agg
42318 0.69 (2.3) ND
42313 0.69 (2.2) ND
42324 0.52 (2.2) ND
42329 0.65 (2.5) ND
2458 0.31 (2.7) ND
2459 0.22 (2.3) ND
2460 0.33 (2.4) ND
2461 0.31 (2.6) 0.33 (0)a
2464 0.31 (2.3) ND
2467 0.34 (2.3) ND
ND, not detected. Each aggregate was counted as one
particle. No carbon aggregates, kaolin-like aggregates,
or iron aggregates were detected in any of the samples
from Vancouver.
aOnly one aggregate identiﬁed. Mexico City samples than in those collected
in Vancouver. A more quantitative compari-
son was not possible because many of the
ambient samples collected in Mexico City
contained too many aggregates to reliably
count. For the limited samples that we col-
lected, the mean PM2.5 particle mass concen-
tration measured in Mexico City was 29.5
µg/m3 (n = 11) compared to a mean concen-
tration of 10.5 µg/m3 for the samples (n = 6)
collected in Vancouver. The geometric mean
diameter of ambient carbon aggregates
(counting the entire aggregate as one particle)
from Mexico City was approximately 1.1
µm, with individual particles within the
aggregates in the range of 0.04– 0.15 µm.
Because of their complex morphology, it was
not possible to determine individual particle
sizes for the kaolinite-like aggregates observed
in air samples collected in Mexico City. 
Discussion 
Our observations indicate that long-term
residence in an area of high ambient particle
concentrations is associated with greater
numbers of retained particles in the lung;
this shows for the first time that the aggre-
gated ultrafine particles in ambient air can
also be found in lung tissue. Our ability to
detect retained aggregated ultraﬁne particles
provides evidence that aggregates in air do
not disaggregate once they are inhaled,
although the sizes in tissue samples were
slightly smaller than in air. We cannot deter-
mine absolutely if the aggregates we
observed in tissue samples are the same as
those observed in air samples. However, the
similarities between the two (Figure 2) make
it unlikely that the aggregates observed in
the lungs form after inhalation of airborne
ultraﬁne particles or that they are artifacts of
the extraction procedure.
This work, and conclusions that may be
drawn from it, is subject to several limitations.
In both locations, we observed a large degree
of intersubject variability in numbers of
retained particles (Figure 1, Tables 1 and 2).
This is likely the result of variable exposures as
well as interindividual differences in particle
clearance and translocation efficiency.
Although we have clearly found a difference
in the number of retained particles between
tissue samples of residents of Vancouver and
Mexico City, we were unable to identify dif-
ferences in the numbers of retained particles
in individuals living in higher and lower pol-
lution regions of Mexico City. 
Because of the complexity of the analysis
and the difﬁculties in obtaining autopsy sam-
ples that meet our inclusion criteria (non-
smoking women > 60 years at death, > 20
year residence in Vancouver or Mexico City,
no occupational dust exposure, no deaths
from respiratory disease), our sample size was
limited and the measured concentrations of
retained particles should not be considered
quantitatively representative of those for indi-
viduals living in Vancouver or Mexico City.
However, our analysis shows that the sample
size was sufficient to indicate a statistically
significant difference between the groups
from the two locations. The exclusion of four
samples from Mexico City with particle levels
that were too high to allow for quantitative
electron microscopy analysis does not alter
this finding. Had we been able to quantify
the high particle levels on these samples, the
differences between the two locations would
have been even greater. 
Our inclusion criteria allowed us to at
least partially control for confounding by sex,
smoking, age, and duration of residence
while we also screened samples for calcium
particles as indicators of environmental
tobacco smoke exposure. Although we
believe that these are the major potential con-
founding variables of concern for this analy-
sis, it is possible that other unrecognized
factors pertaining to differences between the
study populations from the two locations
contributed to the observed differences. 
The number of retained particles we
observed is certainly a marked underestimate
of the number inhaled because many particles
are soluble and therefore would not be
detected by our procedures. Further, our ana-
lytical approach cannot differentiate between
particles originating in airspaces and those
that have entered the interstitium, so that we
cannot determine what proportion of mea-
sured particles have been very recently
inhaled. However, our data clearly indicate
that, despite exposure to similar types of parti-
cles, individuals who reside in an area of high
compared to low ambient particle concentra-
tions retain much greater numbers of ambient
particles. This ﬁnding may seem trivial, but it
should be considered in the context of the low
mass concentrations of particles in ambient
air compared to occupational dust exposures
that lead to disease. This ﬁnding suggests that
even the gravimetrically small particle burden
found in regions with high concentrations of
ambient particles is able to overwhelm local
clearance mechanisms, presumably as a result
of particle toxicity.
In conclusion, we observed signiﬁcantly
higher numbers of retained particles in lung
tissue samples from long-term residents of
Mexico City, a region with high ambient air
pollution, relative to samples from long-term
residents of Vancouver, a region with much
lower ambient pollution levels. Because we
restricted our analysis to tissue samples from
nonsmoking women, it is likely that the dif-
ferences observed were due to differences in
ambient exposures. Additionally, aggregates
of ultrafine particles can be found in large
numbers in the lungs of individuals from
Mexico City, but were only rarely observed in
samples from Vancouver. These particles are
morphologically and chemically similar to
particles found in ambient air, and at least
some of these particles appear to be combus-
tion derived on the basis of morphologic and
chemical similarities to particles from motor
vehicle exhaust. Our observations demon-
strate, therefore, that long-term exposure to
ambient particles, and especially to aggregated
ambient ultrafine combustion products,
results in higher retention of these particles in
lung tissue. Because the ﬁndings demonstrate
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Table 4. Geometric mean (GSD) particle diameters (µm) for individual samples of lungs from Mexico City.
All Carbon Carbon +
Sample particles Agg sulfur Agg Kaolin-like Agg Iron
2416 0.47 (2.6) 0.40 (2.0) ND 0.65 (2.3) 0.13 (1.2)
2417 0.39 (2.5) 0.56 (2.1)  0.48 (1.1) 0.52 (1.3) ND
2418 0.23 (2.5) ND 0.89 (1.1) 0.78 (2.1) 0.62 (1.7)
2419 0.41 (2.4) 0.44 (1.7) 2.0 (2.8) 0.61 (1.5) ND
2420 0.37 (2.5) 0.32 (1.5) 0.43 (0) 0.64 (1.8) 0.64 (1.8)
2423 0.38 (2.7) 0.62 (1.6) 1.4 (2.2) 1.29 (1.3) ND
2425 0.35 (2.8) 0.44 (1.3) ND 0.38 (2.7) ND
2426 0.29 (2.3) 0.40 (1.7) 0.48 (1.8) 0.44 (2.1) ND
2427 0.36 (2.7) 0.30 (1.6) 0.40 (1.7) 0.67 (1.7) ND
2428 0.25 (2.2) 0.36 (1.4) 0.35 (1.3) 0.52 (1.6) ND
2448 0.36 (3.4) 0.44 (1.7) 0.31 (3.8) 1.28 (2.6) ND
ND, not detected. Each aggregate was counted as one particle. 
Table 5. Geometric mean (GSD) particle diameters
(µm) for individual particles in aggregates in sam-
ples of lungs from Mexico City and Vancouver.
Carbon + 
Sample Carbon Agg sulfur Agg
Mexico
2416 0.073 (1.1) ND
2417 0.077 (3.6) 0.12 (1.0)
2418 ND 0.25 (1.0)
2419 0.073 (2.9) 0.097 (2.7)
2420 0.054 (1.0) 0.090 (2.5)
2423 0.12 (1.9) 0.17 (1.7)
2425 0.069 (1.7) ND
2426 0.046 (2.8) 0.075 (2.1)
2427 0.049 (1.9) 0.058 (1.9)
2428 0.027 (1.3) 0.047 (1.9)
2448 0.038 (2.3) 0.019 (1.0)
Vancouver
2461 ND 0.041 (1.0)a
ND, not detected. 
aOnly one aggregate identiﬁed. a link between ambient particle concentra-
tions and a measure of biologically relevant
dose, they support the biological plausibility
of adverse health effects being associated with
exposure to particulate air pollution.
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Acute Sensory Responses of Nonsmokers at Very Low Environmental
Tobacco Smoke Concentrations in Controlled Laboratory Settings
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Over the past years, several studies evaluating
acute health impacts and sensory responses
from exposure to environmental tobacco
smoke (ETS) have been performed. Chamber
studies, evaluating lung functions of asthmat-
ics and other sensitive subjects, have used
sidestream ETS (sETS) concentrations
between 2 and > 15 ppm carbon monoxide
(1–3), and studies focusing on sensory symp-
toms have used ETS at lower concentrations
(4–7). For eye irritations, a tolerable limit of
1.5–2 ppm CO has been reported (5–8).
Significant increases of perceptive eye and
nasal irritations as well as annoyance were
observed at respirable suspended particulate
matter (RSP) concentrations of 58 µg/m3,
corresponding to a time-weighted average
concentration of 0.22 ppm CO, and led to a
signiﬁcant decrease in air quality acceptability
(7). The authors estimated that an 80% air
quality acceptability rate corresponded to an
RSP concentration of 103.3 µg/m3. Based on
an average ETS-RSP yield per cigarette of
13.7 mg (9), this concentration corresponds
to one cigarette diluted in an average western
European living room. Cain et al. (4)
reported similar observations.
Regarding the typical exposure concen-
trations encountered in field studies, RSP
concentrations are reported at 120 µg/m3
when someone is smoking (10). More recent
personal exposure studies in the United
States and in Europe showed median RSP
concentrations that were markedly lower
(11–14). However, these data are based on
sample intervals averaged over 8-hr periods.
Short-term RSP concentrations have been
reported to be much higher (10,15).
Furthermore, an alarming increase in the
active smoking rate has been observed in
some countries. In Switzerland, an increase
of greater than 40% has been reported in the
14–24 years age group (16). 
The awareness that perceptual and com-
fort aspects are important factors in a healthy
building is growing, and indoor air quality
guidelines are taking this more and more
into consideration (17). ETS, as a contribu-
tor to sick building syndrome (18), poten-
tially causes widespread sensory impacts and
discomfort in many places where smokers
and nonsmokers coexist. This concept is
supported by the observation that people
with a history of atopy or respiratory illness
are more sensitive to the acute, irritating
effects of ETS than people without such a
medical history (19). However, odor thresh-
olds and thresholds of perceptive irritations
with respect to ETS have not been deter-
mined conclusively. The World Health
Organization recommends that unwanted
odorous compounds should not be present
in concentrations exceeding the ED50 (effec-
tive dose that makes 50% of the exposed
population respond) detection threshold.
Sensory irritants should not be present in
excess of the ED10 (effective dose that makes
10% of the exposed population respond)
detection threshold (20). That many public
buildings, schools, and restaurants still do
not implement smoking policies in several
parts of the world today indicates that ETS
is potentially present and constitutes a social
problem now and in the future. 
The goal of this study was to determine
odor detection thresholds of sETS in a labo-
ratory setting. Acute sensory symptoms,
breathing patterns, annoyance, and the
indoor air quality acceptability were deter-
mined at very low sETS concentrations in an
exposure chamber. On the basis of sETS
emission rates, we established fresh air vol-
umes necessary to dilute one cigarette to
threshold concentrations. In addition, we
used startle reﬂexes that are assessed by elec-
tromyogram recordings of the M. orbicularis
oculi and elicited by an acoustic stimulus as
an objective indicator of annoyance.
In this study, we aimed to determine air
quality standards required to protect non-
smokers from adverse health effects caused
by impacts of ETS on the human sensory
system as well as to provide measures for
establishing acceptable indoor air quality.
We show that ETS odor thresholds are
about 100 times lower, and nasal and eye
irritations about 10 times lower, than
reported in previous studies (4,7). On a
practical level, separately ventilated areas for
smokers and nonsmokers or a complete
smoking ban are required to protect non-
smokers effectively from the sensory impacts
and the annoyance potential of ETS.
Methods
Experimental design. In this study, we per-
formed three experimental sessions. During
one session, we conducted an olfactory experi-
ment determining sETS odor detection
thresholds. Data obtained laid the foundation
of a laboratory exposure study investigating
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Articles
The objective of this study was to provide a basis for effectively protecting nonsmokers from
acute sensory impacts and for preventing deterioration of indoor air quality caused by environ-
mental tobacco smoke (ETS) emissions. With an olfactory experiment we determined odor detec-
tion thresholds (OT) of sidestream ETS (sETS), and with a full-body exposure experiment we
investigated sensory symptoms at very low sETS exposure concentrations. OT concentrations for
sETS are three and more orders of magnitude lower than ETS concentrations measured in ﬁeld
settings and correspond to a fresh air dilution volume of > 19,000 m3 per cigarette, over 100
times more than had previously been suggested for acceptable indoor air conditions. Eye and
nasal irritations were observed at one order of magnitude lower sETS concentrations than previ-
ously reported, corresponding to a fresh air dilution volume of > 3,000 m3 per cigarette. These
ﬁndings have great practical implications for deﬁning indoor air quality standards in indoor com-
partments where ETS emissions occur. Our study strongly supports the implementation and con-
trol of smoking policies such as segregating smoking areas from areas where smoking is not
permitted or instituting smoking bans in public buildings. Key words: environmental tobacco
smoke, indoor air quality, odor threshold, sensory symptoms, ventilation. Environ Health
Perspect 109:1045–1052 (2001). [Online ________]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1045-1052junker/abstract.htmlsensory symptoms in nonsmokers at very low
sETS concentrations. Figure 1 illustrates the
basic design scheme of the experimental setup
for both studies. Moreover, we performed a
cigarette emission study in the empty expo-
sure chamber to describe the results obtained
in terms of cigarette equivalents. We could
thus compare sETS generated for both the
exposure and olfactory study to sETS not
biased by the experimental setup.
We generated sETS in a glove box 0.6
m3 in volume by a Borgwaldt smoke genera-
tor (Borgwaldt, Hamburg, Germany). On
the basis of sales statistics of the Swiss
Community of the Cigarette Industry, we
chose six cigarette brands and evenly distrib-
uted them on the smoke generator (21).
Throughout the duration of a session, two
randomly chosen cigarettes burned until
they passively extinguished after 5–6 min.
When burning ceased, another two ciga-
rettes were lit. The mainstream fraction of
the tobacco smoke aerosol was exhausted out
of the glove box into a ventilation hood.
Fresh air was introduced into either the
olfactometer or the full-body exposure
chamber by a fresh air unit, equipped with
two radial ventilators providing a fresh air
ﬂow of 1.5 m3/min. The air was ﬁltered by a
glass ﬁber ﬁlter (Camﬁl 1E-110; Camﬁl AB,
Trosa, Sweden) and an active charcoal gran-
ulate (CN-50 6 × 12 1.7–3.4 mm; Siegfried
AG, Zoﬁngen, Switzerland).
Cigarette emission experiment. To estab-
lish the amount of sETS emitted by one ciga-
rette, we multiplied average baseline-corrected
ETS concentrations throughout the burning
time of the cigarette (570 sec) by the amount
of fresh air introduced into the empty expo-
sure chamber during the same time period
(25.7 L/sec). During the cigarette emission
experiment, one cigarette of the most com-
monly smoked brand in Switzerland was lit
and inserted through the ceiling into the
empty exposure chamber 2 m3 in volume via
a PVC tube. The experiment was repeated six
times. Because the cigarettes smoldered pas-
sively, they remained burning for 9.5 min.
During this time no mainstream smoke was
generated (i.e., no puffs were taken). Because
of the rather high air exchange rates (45/hr),
we assumed a homogenous distribution of
sETS. The cigarettes remained burning until
they passively extinguished.
Subjects. We chose 24 female nonsmok-
ers to participate in the olfactory and the full-
body exposure experiments. Written consent
was obtained from the subjects before the
experiments. The Ethics Commission of the
Federal Institute of Technology (Zurich,
Switzerland) approved the study.
The subjects were required to be healthy,
not to have a record of allergy to pollen or
dust, not to be anosmatic, and not to have
smoked in the last 5 years. Moreover, the
subjects were not permitted to use either
eyeglasses or contact lenses and were asked
to refrain from being exposed to ETS on the
day of the study. The subjects were between
18 and 35 years of age and were paid for
their participation. Of the 24 who partici-
pated in the full-body exposure study, 18
took part in the olfactory experiment. In a
preliminary questionnaire, the participants
were asked to indicate their degree of annoy-
ance by ETS, automobile exhaust fumes, sol-
vents, and perfumes.
Olfactory experiment. To obtain sETS
odor thresholds, we performed two types of
experiments based on the method of limits
(22). In one, the subjects were asked to evalu-
ate the air by placing their nose into the duct
of the olfactometer only upon presentation of
the stimuli (type A); in the other, the subjects’
noses remained within the duct throughout
the duration of the experiment (type B). In
four to eight repetitions, stimuli were pre-
sented in ascending concentrations for both
experiments. A potential odor threshold value
within a trial was obtained when the subject
perceived the ascending concentration of
stimuli for the ﬁrst time. A valid odor thresh-
old value was given when a subject stated per-
ceiving an odor during two consecutively
ascending concentrations. We calculated odor
thresholds by subtracting the sETS baseline
concentration before the stimuli had been
presented from the maximum concentration
of the sETS indicator during stimuli presenta-
tion. The data were obtained from 18 female
nonsmokers who were divided into six panels
of three subjects per panel.
An olfactometer developed at the Institute
for Hygiene and Applied Physiology (Zurich,
Switzerland) was used (23). Air is drawn via a
Teﬂon-coated ventilator from the surround-
ing environment and guided through a sys-
tem of glass tubing to four Teflon-coated
nose ducts. Fresh air is constantly washed
through the system at a rate of 147 L/min,
reaching an air speed of 0.85 m/sec at the
ducts from where the sensory measurements
are carried out. One of the four nose ducts
was used for monitoring ETS indicators. We
fed sETS manually into the fresh air stream
by rotameters. The maximum dilution factor
of the olfactometer is 39,400. This was dou-
bled with a further dilution before entering
the olfactometer by a factor of two.
Full-body exposure experiment. The
experimental procedure performed for each
participant within the exposure chamber is
described qualitatively in Figure 2. 
Each session consisted of eight condi-
tions of interest. In four of the eight
episodes, different amounts of sETS, distin-
guished by the air ﬂow rates of 200 mL/min,
500 mL/min, 1,200 mL/min, or 3,600
mL/min, were fed from the glove box into
the fresh air stream passing though the expo-
sure chamber (sETS condition). The small-
est flow rate was determined to generate
sETS concentrations that were approxi-
mately equivalent to concentrations observed
at the 95th percentile of the odor threshold.
Before each of these sETS conditions, air
without sETS (zero condition) was adminis-
tered. We randomized the sequence of sETS
conditions over 24 subjects. For each subject
the administered ETS episode pattern was
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Figure 1. Scheme of the experimental setup for the odor threshold and the full-body exposure study. The
equipment shown in the middle panel was used for both setups. Generated in the glove box and diluted by
a fresh air delivery system, sETS was fed into either the olfactometer to determine odor detection thresh-
olds or into the exposure chamber to assess sensory symptoms.
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experimentrandomly selected out of a pool of 24 possi-
ble patterns. The session commenced with a
zero condition that was succeeded by a ran-
domly selected sETS condition. Zero condi-
tion and sETS condition then followed in
alternating order. Each episode commenced
with a 2-min time span of startle stimuli that
was followed by a questionnaire and pro-
ceeded by an eye blink count. We continu-
ously monitored breathing patterns
throughout the session. To minimize dis-
tractions, a beige cotton curtain surrounded
the exposure chamber. The experimenter did
not have any eye contact with the subject. 
For the sensory questionnaires, each sen-
sory symptom was scaled on a vertical axis
within which the participants were told to
mark a horizontal reference anywhere on the
scale that reflected their perception of the
given symptom (Table 1)
The exposure chamber was constructed
out of Plexiglas (height, 1.6 m; length, 1.4
m; width, 0.9 m). It was possible to seat a
subject comfortably in front of a small desk.
The fresh air unit providing particle free air
at a constant volatile organic compound
(VOC) background concentration main-
tained a constant air ﬂow (1.5 m3/min). Air
was fed into the chamber via a ventilation
duct (0.25 m in diameter) situated knee
height near the far corner of the chamber on
the right hand side facing the participant.
The exhaust air left the chamber by a duct
(0.25 m in diameter) behind the subject’s
head. In this way the air was forced to pass
by the subject’s face. Although the air
exchange rate of the ventilation system was
45/hr, air velocities in the vicinity of the face
remained < 0.1 m/sec. Air sampling tubes
were placed through holes in the center part
of the ceiling near head height.
Instrumentation. A number of sETS
constituents were continuously monitored
throughout the duration of the experiments:
particle-bound polycyclic aromatic hydrocar-
bons (pPAH), total volatile organic com-
pounds (tVOC), and particle number
concentrations. In the cigarette emission and
full-body exposure experiment, CO was
additionally monitored, and a number of
discrete particle number and particle mass
distributions were carried out. CO2, parame-
ters of thermal comfort, and VOCs were also
assessed in the full-body exposure study. 
We measured pPAH by means of a
photoelectric aerosol sensor (PAS, type: LQ1-
TV, Matter Engineering Inc., Wohlen,
Switzerland) (24,25) For total volatile organic
compounds a flame ionization detector was
used (Model VE7; J.U.M. Engineering,
Karlsfeld, Germany). We measured CO with
an APMA-300E CO Monitor (Horiba Ltd.,
Japan). To assess the total particle number
concentrations, we used a condensation
nucleus counter (version 3025; TSI, St. Paul,
MN, USA). For particle number versus size
distributions, we used a scanning mobility
particle sizer (version 2.3; TSI Inc.) in the size
range between 0.015 and 0.673 µm mobility
diameter at a resolution of 64 channels per
decade on a logarithmic diameter axis. A 10-
stage Quartz Crystal Microbalance Cascade
Impactor System allowed the assessment of
size-specific particle masses (Model PC-2;
California Measurements Inc., Sierra Madre,
CA, USA) at a mid-point aerodynamic cutoff
ranging from 0.07 µm to 35 µm.
For the chemical analysis of the VOC
samples, a known volume of air was pumped
through a stainless-steel tube filled with an
adsorbent (Tenax TA; Tenax GmbH,
Düsseldorf, Germany). The transfer of the
sample to capillary gas chromatography (col-
umn: DB-5ms, 30 m; J&W Scientiﬁc, Agilent
Technologies, Palo Alto, CA, USA) was done
by thermodesorption (Perkin Elmer ATD
400; Perkin Elmer Instruments, Wellesley,
MA, USA). The gas chromatrgraph (Fisons
6000; Fisons Instruments, Beverly, MA, USA)
was equipped with an ﬂame ionization detec-
tor for quantiﬁcation and a mass spectrometer
(Fisons MD800) for identification of the
detected VOCs. The sorbent tubes were
loaded with toluene-d8 as an internal stan-
dard. Concentrations are given as toluene
equivalents. The Tenax tubes were exposed
for 60 min at a sample rate of 100 mL/min.
The sampling and analysis of these VOCs
was performed by the Swiss Federal
Department for Economics and Occupation
(Zurich, Switzerland). For the aldehyde
analysis, samples were drawn through a
stainless-steel tube at a sampling rate of 1.3
L/min with 2,4-dinitrophenylhydrazine as
an adsorbent. Aldehydes are desorbed, and
via high pressure liquid chromatography the
different species are determined. The alde-
hyde analysis was performed by the Institut
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Table 1. A streamlined version of the sensory symptoms questionnaire.
Assessed judgment Scale 
Air temperature 3, too high; 0, just right; –3, too low
Relative humidity
Odor strength 6, overwhelming; 5, very strong; 4, strong; 3, moderate; 2, weak; 
Eye irritation 1, very weak; 0, not at all
Nasal irritation
Throat irritation
Arousal 6, overwhelming; 5, very strong; 4, strong; 3, moderate; 2, weak;
Annoyance 1, very weak; 0, not at all
Odor perception 1, extremely pleasant; 0.67, pleasant; 0.33, rather pleasant; 0, neutral;
–0.33, rather unpleasant; –0.67, unpleasant; –1, extremely unpleasant
Odor perception, air quality 1, acceptable; –1, unacceptable; a value > 0 is acceptable; a value < 0 is
unacceptable
Figure 2. Experimental procedure during one session of the exposure experiment. The sequence of sETS
concentrations was randomized over 24 subjects. Each episode commenced with a startle response mea-
surement, followed by a questionnaire and an eye blink count. Breathing pattern measurements were
performed during the entire session.
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The data for both the VOCs and the 
aldehydes are not shown. 
We measured the air temperature and rel-
ative humidity with an instrument from
ROTRONIC AG (Bassersdorf, Switzerland).
Wind speeds were assessed by a Dantec low
velocity flow analyzer type 54N50 (Dantec
Inc., Copenhagen, Denmark). Carbon diox-
ide measurements were performed with the
EGQ-10 measuring instrument (Sauter AG,
Basel, Switzerland).
We recorded respiratory parameters by
Respitrace cardio respiratory diagnostic tech-
nology (SensorMedics Technology, Yorba
Linda, CA, USA) based on inductive plethys-
mography. Data analysis was performed with
RespiEvents software (version 4.2c; Nims,
Miami Beach, FL, USA). Breathing bands
that assessed breathing patterns were fitted
over the subject’s breasts and abdomen. We
calibrated the bands before and after the
experiment using a spirometer (Spiro-Junior;
Erich Jaeger, Würzburg, Germany).
We used an SR-EMG System (San Diego
Instruments Inc., San Diego, CA, USA) to
assess the startle response signal. This device is
a modularized electromyograhic system of two
units, an amplifier modifier and a stimulus
generator unit. For the startle response mea-
surements, we placed two electrodes on the M.
orbicularis oculi of the left eye of the subject.
A broad-band white noise (100–1,000 Hz) at
65 dBA as a background was presented to the
subject during a 2-min period over a set of
headphones. During this period a series of 10
acoustic impulses of 100 dBA for a time span
of 40 msec were generated.
Results
Cigarette Emission Experiment 
The emission rates per cigarette for pPAH,
PM2.25, particle numbers, CO, and tVOC
are shown in Table 2. 
To estimate the degree that coagulation
and adsorption processes may alter the phys-
ical characteristics of the sETS aerosol, we
compared particle number and particle mass
distribution measurements from directly
emitted sETS to machine-generated sETS
that had been transferred from the glove box
to the exposure chamber. The particle num-
ber distribution of one cigarette burning in
the exposure chamber shifted from a geo-
metric mean diameter of 0.085 µm (geomet-
ric standard deviation = 0.002 µm) to an
average geometric mean diameter of 0.172
µm (geometric standard deviation = 0.002
µm) when initially generated in the glove
box (average of 3 measurements). Parallel to
the increase in mean diameter, the particle
number concentration would have to
decrease over time. Based on the particle
emission rate of 9.3 × 1012 particles per ciga-
rette (Table 2), the estimated particle con-
centration in the glove box (0.6 m3) after
two cigarettes had burned was 3.1 × 107 par-
ticles/cm3. The following calculations were
performed to estimate the actual particle
number concentrations if coagulation
processes in the glove box had not taken
place (26):
[1]
[2]
[3]
where N(t) = particle number concentration
at time t; N0 = initial particle number con-
centration = 3.1 × 107;K = coagulation coef-
ﬁcient; Cc = slip correction factor ~ 1.2 for a
particle with a geometric mean diameter of
0.085 µm; t = approximate burning time of
a cigarette including time to transfer to the
exposure chamber, ~ 420 sec; d(t) = particle
diameter at time t; and d0 = initial particle
diameter = 0.085 µm.
The solution to Equation 1 equals 5.5 ×
106 particles/cm3 (i.e., 5.7 greater particle
numbers if coagulation had not taken place),
and the geometric mean diameter increased
by a factor of 1.78 (Equation 3). Compared
to the initial particle number concentration,
this is equivalent to a theoretical decrease by a
factor of 5.7 after coagulation in the glove box
and adsorption of the smaller particles onto
the PVC tubes has taken place. The observed
increase in geometric mean diameter by a
factor of 2.02 is similar to the calculated
increase of 1.78. In addition, the particle
mass distribution revealed a shift to larger
diameters within the accumulation mode
(0.1–2 µm) after sETS had been generated in
the glove box and transferred to the exposure
chamber (data not shown). These results
show that substantial coagulation and particle
removal have taken place in the time span
between aerosol generation within the glove
box and its analysis in the exposure chamber.
Olfactory Experiment 
The obtained odor thresholds of sETS
expressed in terms of measured particle
numbers, pPAH, and tVOC concentrations
are depicted in Figure 3. 
The comparison of both experiment
types shows an increase in sensitivity of the
odor threshold based on median sETS con-
centrations by a factor of 2–4 while the sub-
jects’ noses remained in the ducts. The
variability of all measurements expressed by
the ratio between the 95th and 5th per-
centile lies between 9 and 35 (type A) and
between 6 and 21 (type B). The variability
based on the ratios between maximum and
minimum odor threshold concentration do
not exceed 300 for type A, while for type B a
maximum ratio of 175 was observed. 
Subjects 
We chose 24 healthy, female nonsmokers for
the full-body exposure study assessing a variety
of sensory symptoms, startle responses, and
breathing patterns in a range of very low ETS
concentrations. Before the study the partici-
pants were asked to state how bothered they
dt
d
N
Nt
()
=
()

 

 
0
0
13 /
KC . c =×
− 30 1 0
10
   
Nt
N
NK t ()=
+
0
0 1
Articles • Junker et al.
1048 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health Perspectives
Table 2. Average sETS emission rates per cigarette. 
Mean concentration during Air volume during burning sETS generation per
Indicators burning time ± SD time of one cigarettes (m3) cigarette ± SD
pPAH 1,661 ± 117 ng/m3 14.65 24.3 ± 1.7 µg
PM2.25
a 387 ± 78 µg/m3 14.65 5.7 ± 1.1 mg
Particle numbersb (6.3 ± 0.5) × 105/cm3 14.65 (9.3 ± 0.7) × 1012
CO 4.88 ± 0.47 ppm 14.65 89 ± 9 mg
tVOCc 3,722 ± 414 ppb 14.65 113 ± 13 mg
The experiment was repeated six times. 
aOne proﬁle was generated. bParticle numbers were averaged out of three repetitions. ctVOC masses were calculated on
the basis of propane equivalents.
Figure 3. Odor detection thresholds of sETS
expressed in terms of particles per cubic centi-
menter (number of values: 98 for type A, 60 for
type B), pPAH, in nanograms per cubic meter
(number of values: 98 for type A, 74 for type B),
and tVOC, in parts per billion (number of values:
51 for type A, 75 for type B) concentrations. Two
experiment types were performed: type A, nose in
(5 sec) and out (30 sec) of duct; type B, nose stays
in duct. Box plots were generated with Systat 8.0.
Number in boxes are median concentrations.
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*generally felt toward ETS, automobile exhaust
fumes, perfumes, and solvents. On a voting
scale from 1 to 5 (1 = not at all bothered; 5 =
very bothered), the subjects were, on average,
more bothered by ETS (4.3) and automobile
exhaust fumes (3.9) than by perfumes (2.2)
and solvents (2.6). None of the subjects was
very bothered by all of these agents.
Full-Body Exposure Experiment
The following sections describe the environ-
mental conditions and the chemical species
the subjects were exposed to. The results of
the sensory symptom questionnaire, breath-
ing patterns, eye blink rates and startle reﬂex
measurements are presented.
Environmental conditions. Table 3 sum-
marizes the average ETS concentrations of
the four ETS conditions the subjects were
exposed to. The ETS conditions were ran-
domly distributed in an odd succession. Also
shown are four alternating zero conditions. 
The tVOC concentrations during the
zero-air condition represent values that can
cause possible discomfort and irritation
according to the guidelines suggested by
Mølhave (27). This remains unexplained,
because the subsequent VOC concentrations
measured by Tenax tubes with a sampling
time of 60 min were not above the limit of
detection (data not shown). The study pop-
ulation perceived the odor as neutral (neither
pleasant nor unpleasant), and judged the
quality of indoor air as acceptable. 
The concentrations of VOCs and alde-
hydes to which the subjects were exposed
increased with the degree of sETS infiltra-
tion into the exposure chamber. The data
(not shown) suggest that for nicotine and 3-
ethenyl-pyridine the surfaces of the glove
box and the tubing acted as a sink.
Sensory responses. On the basis of the
questionnaire results, we compared the aver-
age absolute sensory symptom values during
the four ETS conditions to the sensory
symptom values of the directly preceding zero-
air condition (Table 4; only lowest sETS con-
dition shown). The differences between the
intensity of a sensory symptom at an ETS
condition and symptom intensity of the pre-
ceding zero condition were statistically signiﬁ-
cant for all perceived sensory symptoms except
perceived air temperature and relative humid-
ity. The average concentrations at the lowest
sETS were 468 particles per cm3, 7.3 ng/m3
pPAH, and 19 ppb tVOC. This corresponds
to an estimated ETS-PM2.25 (particulate mat-
ter ≤ 2.25 µm diameter) concentration of
about 4.4 µg/m3. At these concentrations the
percentage of occupants judging the quality of
air to be acceptable was 33%.
The results for the sensory symptoms
show that even at very low ETS concentra-
tions, subjects perceived a significant
increase in sensory impact (eye, nasal, and
throat irritations). Furthermore, they felt sig-
nificantly more annoyed and reported the
quality of air to be less acceptable than under
zero conditions.
Humans are capable of discriminating rel-
ative changes only in perception (28). Figure
4 takes this circumstance into account.
Plotted are relative increases of the intensity of
a sensory symptom (intensity at an ETS con-
dition minus intensity at the preceding zero
condition) against relative increases of log-
transformed sETS concentrations (ETS con-
centration at an ETS condition minus ETS
concentration at its preceding zero condition).
Furthermore, p-values of a linear regression
model are depicted.
Based on a Pearson’s linear regression
model, the log-transformed ETS indicators
such as particle numbers, pPAH, and tVOC
concentrations show a linear trend with odor
strength, eye irritation, arousal, annoyance,
odor perception, acceptability of indoor air
quality, wanting to open the window, want-
ing to leave the room, and complaining at
work. Nasal irritations, on the other hand,
show a linear trend with the particulate indi-
cators only.
To determine which sensory channel
(odor, nose, eyes, throat, arousal) contributes
most to the observed decline of the indoor
air quality, we performed a stepwise multiple
linear regression model. Only the linear
combination of the variables odor strength
(F = 12.1, p = 0.001) and arousal (F = 7.39,
p = 0.008) related to the degree of indoor air
quality acceptability (r2 = 0.5, p < 0.001).
The contributions of eye, nasal, and throat
irritations, however, did not show a signiﬁ-
cant relation (p > 0.4).
Startle reﬂex measurements. In the past,
the startle reflex has been used as a tool to
evaluate emotional qualities of a foreground
stimulation (29,30). Because the startle reﬂex
is not confounded by voluntary muscle activ-
ity, it is well suited to assessing motor behav-
ior caused by a foreground stimulus. The
startle reflex amplitude is affected by the
extent to which the foreground stimulus can
attract attention (31), especially when fore-
ground stimuli and startle stimuli constitute
different modalities (32). The startle response
is facilitated when attention is directed to an
acoustic startle stimulus, whereas the
response is attenuated when attention is
drawn away from the stimulus (33). These
ﬁndings suggest that the redirecting of atten-
tion toward an annoying stimulus can be
measured by the startle reﬂex.
Figure 5 depicts differences between star-
tle electromyographic amplitudes determined
during the four ETS episodes and their
directly preceding zero-air condition. All
EMG signals have been normalized by the
startle amplitude of the first zero episode.
Log-pPAH concentrations correlated nearly
signiﬁcantly to EMG amplitudes (negative r)
when rank orders (p = 0.058) were not con-
sidered. Although we observed a negative
trend as sETS concentrations increased, a
significant difference existed only between
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Table 3. Average concentrations of the continuously monitored environmental parameters during four exposure episodes depicted as sETS ﬂow rates.
Environmental parameters 1st Zero 200 mL/min 2nd Zero 500 mL/min 3rd Zero 1,200 mL/min 4th Zero 3,600 mL/min
Particle numbers (cm3) 0.02 468 0.03 1,456 0.04 3,860 0.05 17,343
(0.03)a (110) (0.03) (266) (0.04) (795) (0.04) (1.891)
PPAH (ng/m3) 1.6 9.3 1.8 22.8 2.1 58.5 2.2 218.8
(0.9) (2.4) (1.0) (4.2) (0.9) (9.9) (0.9) (32.0)
CO (ppm) 0.16 0.21 0.16 0.27 0.15 0.39 0.15 1.07
(0.08) (0.10) (0.08) (0.10) (0.07) (0.10) (85) (370)
tVOC (ppb) 1,244 1,256 1,238 1,282 1,232 1,340 1,231 1,702
(58) (56) (56) (52) (59) (54) (64) (137)
CO2 (ppm) 636 628 630 632 636 648 622 639
(79) (44) (62) (83) (93) (61) (74) (46)
Temperature (°C) 23.8 24.0 23.8 23.8 23.9 23.9 23.9 23.7
(3.4) (3.0) (2.9) (2.8) (2.7) (2.8) (2.8) (2.9)
Relative humidity (%) 27.9 27.2 27.4 27.3 27.1 27.3 27.0 27.1
(3.8) (3.3) (3.6) (3.4) (3.4) (3.5) (3.2) (3.5)
ETS-PM2.25
b (µg/m3) 0.7 5.1 34.0 115.5 430.7
(0.0) (1.4) (5.4) (31.6) (96.4)
The 1st, 2nd, 3rd, and 4th zero correspond to conditions without sETS exposure (compare to Figure 2). 
aSDs in parentheses. bPM2.25 measurements were performed on a separate occasion with the quartz crystal cascade impactor while the exposure chamber was vacant. the highest concentrated sETS episode and
its preceding zero condition (pairwise t-test,
p < 0.05). 
IAQ acceptability and ventilation
requirements. Because detection of an sETS
odor can be the key factor for indoor air qual-
ity acceptability, the question arises of how
much fresh air is needed to dilute the sETS
emissions of one cigarette to concentrations
where no odor would be perceived. We
divided sETS emissions per cigarette depicted
in Table 2 by median odor threshold concen-
trations (Figure 3; while noses remained in the
ducts). Thus, we obtained dilution volumes
per sETS indicator. We then calculated the
average dilution volumes based on volumes
obtained from particle number, pPAH, and
tVOC concentrations. To correct for coagula-
tion and adsorption, we multiplied particle
numbers by a factor of 5.7 (see “Cigarette
Emission Experiment”). We assumed that the
mass of the sETS emissions per cigarette is
homogeneously distributed within a compart-
ment and that no sinks are present. This pro-
duced an average fresh air volume of > 19,000
m3 per cigarette in order to dilute to sETS con-
centrations where no odor would be perceived.
By the same method we observed eye
and nasal irritations at dilution volumes cor-
responding to 3,000 m3 per cigarette (lowest
sETS concentration episode). At these sETS
concentrations, 67% of the occupants
judged the air unacceptable.
Breathing patterns and eye blink rates.
Breathing pattern parameters (inhalation
volume and inhalation flow rate) used as
markers for olfactory or trigeminal activation
(34,35) did not show any significant
decrease during ETS exposure. There was a
positive yet insigniﬁcant correlation between
eye blink counts and log-transformed ETS
particle concentrations.
Discussion
Cigarette Emission Experiment
Compared to other investigations, particle
mass emissions observed in this study are
about half as high as stated in the literature
(8,10). This result is caused partly by the cir-
cumstance that our study measured not RSP
(aerodynamic diameter of 3.5 µm) but
PM2.25. Furthermore, the cigarettes were not
actively smoked but smoldered passively.
The absence of exhaled mainstream smoke
can reduce particulate matter of ETS by
15–43% (36). As for CO, concentrations are
about 50% higher than reported by Martin
and colleagues (9), whereas tVOCFID con-
centrations are approximately four times
higher than reported by the same authors,
possibly caused by the longer burning time
of the cigarette that extinguished passively in
our experiment. The greater relative contri-
bution of tVOC measured in propane equiv-
alents may result from organic compounds
emitted from the smoldering ﬁlter material. 
Olfactory Experiment
We hypothesize that the observed increase in
sensitivity of the odor threshold while the
subjects’ noses remained in the olfactometer
ducts compared to when the subjects’ noses
were placed into the ducts only upon presen-
tation of the stimuli originates from an
increase in mental concentration. Compared
to an odor threshold variability of several
orders of magnitude reported for some single
chemicals (37), the variability of the
observed sETS odor thresholds not exceed-
ing a maximum value of 300 are low.
Odor thresholds of sETS obtained from
the olfactory experiments showed that a
median odor sensation was perceived at
very low concentrations equivalent to an
ETS-PM2.25 concentration of approximately
0.6–1.4 µg/m3. Because the olfactory stimuli
were presented in ascending order, odor
threshold values obtained in this experimen-
tal setting are considered to be the lowest
attainable. The absolute values of these
thresholds in terms of particle numbers,
tVOC, and pPAH concentrations point out
that, for field settings, an odor sensation
would lie in the noise of the background
concentrations. Typical long-term average
concentrations reported in indoor settings
where smoking takes place (10,11) are two
orders of magnitude higher than concentra-
tions at these threshold values. Compared to
short-term concentrations, however, the
determined odor threshold concentrations is
up to three or more orders of magnitude
lower than reported in field settings
(10,15,38). The reason for the low threshold
values found here is most likely the fact that
our reference fresh air was cleared by an
ultraﬁne particle ﬁlter and by an active car-
bon ﬁlter (see Figure 1).
Regarding the VOCs that can induce an
odor sensation at concentrations near the
determined odor threshold values, published
odor thresholds for single chemicals suggest
that not many compounds would be able to
produce these thresholds (39,42). Among
them, only pyridine could potentially create
an odor sensation provided that minimum
reported odor threshold values are taken as a
criterion. This leads to the conclusion that
other, perhaps unidentiﬁed compounds with
an odor threshold in the nanogram or even
picogram per cubic meter range could be
responsible for the observed odor sensations.
Furthermore, particles may be able to facili-
tate an odor sensation. Cain and colleagues
(8) observed a slight decrease in odor inten-
sity when ETS particles were electrostatically
precipitated.
Full-Body Exposure Experiment
Environmental conditions. Based on the cig-
arette emission experiment, the highest
episode concentration the subjects were
exposed to is equivalent to one cigarette
being smoked in a room about 100 m3 in
volume. Particle numbers concentrations
averaged 1.7 × 104/cm3; pPAH concentra-
tions averaged 218 ng/m3. Although these
indicators are not typically assessed in ETS
exposure studies, these values correspond to
measurements obtained in field settings. A
study performed by Morawska et al. (39)
measured particle numbers of 5 × 104 at a
rock concert. Junker et al. (40) reported
pPAH concentrations of 336–990 ng/m3in
buildings for recreational activities. The low-
est episode concentration is equivalent to one
cigarette being smoked in a space of about
3,000 m3, given a homogenous distribution
of the emission. The average particle number
and pPAH concentrations measured
468/cm3 and 9.3 ng/m3, respectively. As dis-
cussed above, the absence of exhaled main-
stream ETS in this study underestimates the
particulate exposure concentrations of the
subjects compared to ﬁeld settings (36). The
gas-phase constituents of exhaled main-
stream smoke, however, contributes only a
small amount to ETS (36), so discrepancies
in ﬁeld settings are assumed to be small.
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Table 4. Average perceived sensory responses of the sETS condition at a ﬂow rate of 200 mL/min and the
preceding zero condition. 
Response Symptom at zero air condition Symptom at 200 mL/min
Temperature (–3, 3) –0.56 –0.53
Relative humidity (–3, 3) 0.61 0.79
Odor strength (0, 6) 0.65 2.09#
Eye irritation (0, 6) 0.61 0.97*
Throat irritation (0, 6) 0.82 1.49**
Nasal irritation (0, 6) 0.55 0.94**
Arousal (0, 6) 0.41 1.79#
Annoyance (0, 6) 0.44 1.94#
Odor perception (–1, 1) 0.06 –0.22#
Air quality acceptability (–1, 1) 0.58 –0.03#
Percent acceptable 92 33#
The values in the parentheses correspond to the minimum and maximum values referred to on the vertical scale (Table 1). 
*p < 0.05, **p < 0.01, and #p<0.001, based on a pairwise t-test. Values of p for higher ﬂow rates (not shown) are even lower. Compared to ﬁeld settings, the observed
coagulation and particle removal processes
overestimated the geometric mean diameters
of the sETS aerosol. It has been reported
that geometric mean diameters of ETS 10
min after having been generated by a
human smoker increase 20–50% (39). In
this study, the geometric mean diameter of
the aerosol doubled, probably because the
initial particle number concentration within
the glove box is greater than would be mea-
sured in the ﬁeld. Additionally, the interac-
tion of small sETS particles with other
surfaces would likely be larger than in a typ-
ical ﬁeld setting.
Cain et al. (8) reported that the types of
cigarettes generating sidestream smoke may
create variations in the concentrations of
ETS constituents. However, Nelson et al.
(43) observed that ETS generated from a mix
of the most widely used cigarette types is not
significantly different from one country to
another. The cigarette brands used in this
study were chosen on the basis of sales statis-
tics of the Swiss Community of the Cigarette
Industry (21) and therefore represent ETS
similar to that generated in other countries.
Sensory symptoms, startle reﬂex measure-
ments, and eye blink rates. Because signifi-
cant perceived sensory symptoms were
observed at the lowest sETS exposure tested
in this study, we conclude that thresholds of
perceived sensory symptoms are even lower.
Observed concentrations facilitating eye,
nasal, and throat irritations correspond to an
estimated ETS–PM2.25 concentration of
about 4.4 µg/m3. This is equivalent to a
dilution volume of about 3,000 m3 per ciga-
rette. Before this study, similar ﬁndings were
reported at an ETS–RSP concentration of
58 µg/m3 (7), although signiﬁcant nasal irri-
tations were not observed.
Only a few studies investigated the effect
of odors on the startle reﬂex. Ehrlichman et
al. (44) and Miltner et al. (30) investigated
acoustic startle reflex modulation during
short exposure to pleasant and unpleasant
odors. Unpleasant odors enhanced startle
amplitude, whereas pleasant odors had no
effect. Later work (45) provided some evi-
dence that a decreased startle reﬂex resulted
from pleasant odors. These findings agree
with the interpretation of Lang et al. (29)
that the startle reﬂex amplitude is modulated
by the emotional valence of the foreground
stimulus. In contrast, we found a dose-
dependent decrease in startle reflex ampli-
tude with increasing concentrations of ETS.
The differences between previous results and
those of our study lie in the duration of the
presented stimulus and in the analysis tech-
nique. Ehrlichman and Miltner presented
the foreground odor stimulus for a very
short period (one sniff) as Lang did with
slides, rated high or low in valence. Startle
amplitude was analyzed between the differ-
ent trials only. We analyzed the difference in
startle amplitude between, before, and dur-
ing ETS stimulation, separately for each ETS
concentration. Schicatano and Blumenthal
(33) showed that distracting attention by
attending to a visual search task reduced
acoustic startle response amplitude.
Therefore, we interpret our finding of a
dose-dependent decrease of startle reflex
amplitude as a directing of attention toward
the increasing concentration of ETS.
Signiﬁcant eye blink increases have been
reported at concentrations > 1.3 ppm CO
(46) and have been observed to increase in
time (5,7). In this study, the concentration
level as well as the duration of the episodes
was not sufficient to create a significant
increase in eye blink rates.
IAQ acceptability and ventilation
requirements. Cain et al. (8) found that the
degree of dissatisfaction evoked from ETS,
strongly correlated to the perceived intensity
of irritation or odor, depends on the channel
(eye, nose, throat, odor) most severely
affected. We found that the detection of the
arousing sETS odor alone was sufficient to
create dissatisfaction. However, dissatisfac-
tion was not facilitated by the intensity of
the perceived irritation, mainly because the
sETS concentrations our subjects were
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Figure 4. Scatter plots of background-corrected sensory responses (response at an ETS concentration
episode minus response at the preceding zero concentration episode) and log-transformed ETS concentra-
tions of 24 exposed subjects. The data depicted in the white boxes do not correlate signiﬁcantly in a Pearson’s
linear regression model (p > 0.01). The data in the light gray boxes are highly signiﬁcantly correlated to the lin-
ear trend (p < 0.01), and for the data in the dark gray boxes a very highly signiﬁcant correlation exists (p < 0.001).
Figure 5. Differences between startle EMG ampli-
tudes measured at an ETS condition (200 mL/min,
500 mL/min, 1,200 mL/min, and 3,600 mL/min) and
the directly preceding zero-air condition for 22
subjects. The data of 22 of the 24 subjects were
analyzed. Two data sets were rejected because
they consisted of incomplete startle responses
(this was possibly due to an inadequate placement
of the electrodes onto the subject). The data have
been normalized by EMG amplitudes measured
during the ﬁrst zero episode for each subject. NS,
nonsignificant difference; significant difference
determined by a pairwise t-test (p < 0.05).
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beforeexposed to were much lower than in the
study of Cain and colleagues. 
To create acceptable indoor air quality
conditions, the sETS emissions of one cigarette
would have to be diluted by an estimated fresh
air volume of 19,000 m3. This is at least two
orders of magnitude higher than proposed by
Cain et al. (4) for an estimated acceptability of
75–80% and an 80% acceptability by Walker
and colleagues (7) in a full-body exposure
study. These discrepancies are large. As stated
above, the main reason is most likely the
extremely clean reference air used in our study.
Another factor may be that in our study a full-
body exposure experiment was performed,
whereas in the investigation of Cain et al. (4)
subjects perceived the air at a snifﬁng station.
Although these subjects did not smoke
throughout the duration of the study, no infor-
mation was given concerning their smoking
status. Discrepancies with Walker et al.’s (7)
study may emanate from the questions the
subjects were asked about acceptability. Walker
et al. employed a yes/no response to determine
overall acceptance, whereas our study
employed a voting scale ranging from clearly
acceptable to just acceptable and from just
unacceptable to clearly unacceptable. Studies
by both Cain et al. (4) and Walker et al. (7)
extrapolated the required fresh air volume (or
the ETS concentrations) to where 80% of the
subjects judged the quality of air to be accept-
able. However, small changes in the slope of
the log-scaled dose–response curves (ETS ver-
sus acceptability) will greatly inﬂuence the esti-
mation of the of the 80% acceptability
threshold. Obtained estimations must there-
fore be interpreted with great caution.
Controlled laboratory exposure studies
conducted to date have not adequately con-
sidered low sETS concentrations that have
adverse effects on perceived sensory symp-
toms. Furthermore, these studies have used
ETS concentrations well above threshold
concentrations of acceptable indoor air qual-
ity. To obtain realistic threshold concentra-
tions for perceived sensory symptoms as well
as acceptable indoor air quality, much lower
exposure concentrations must be considered.
In this study, we observed perceived sensory
effects and a deterioration of indoor air qual-
ity at much lower sETS concentrations than
previously reported. As Repace and Lowry
(48) concluded, investigating cancer risk
associated with ETS exposure, the degree to
which ventilation rates would have to be
increased to preserve indoor air quality in
smoking areas would be impractical and eco-
nomically unfeasible. We conclude that to
protect nonsmokers effectively from adverse
sensory symptoms and to provide acceptable
indoor air quality, segregation of smoking
and nonsmoking areas or smoking bans
within public buildings should be enforced.
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Gaseous Pollutants in Particulate Matter Epidemiology: Confounders or
Surrogates?
Jeremy A. Sarnat,1 Joel Schwartz,1 Paul J. Catalano,2 and Helen H. Suh1
1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA; 2Department of Biostatistics,
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Daily variations in air pollution have been
associated with daily variations in deaths and
hospital visits in a large number of locations
around the world (1–3). Of the criteria air
pollutants, the strongest and most consistent
associations have been found for ambient
particulate matter. Because ambient particle
levels are often correlated with ambient con-
centrations of other gaseous pollutants, it is
possible that the observed associations
between particles and adverse health effects
may be due to confounding by other corre-
lated pollutants and not to the ﬁne particles
themselves (4,5). 
The issue of confounding in air pollution
epidemiology has been examined in several
large multicity studies (6,7). These studies
proceeded on the assumption that the best
way to assess the independent effects of two
or more pollutants is to include the pollutants
in the regression model at the same time.
Samet et al. (6), for example, analyzed ambi-
ent air pollution [particulate matter ≤ 10 µm
(PM10), ozone, nitrogen dioxide, carbon
dioxide, and sulfur dioxide] and daily mortal-
ity data from 20 cities with varying pollution
proﬁles and found PM10 to be a signiﬁcant
predictor of daily mortality controlling for the
gaseous copollutants. Schwartz (7) examined
10 cities separately during the summer and
winter and reported identical associations
between daily mortality and PM10. Because
the relationship among ambient PM10 and its
copollutants differed substantially by season,
the observed identical summer and winter
associations were offered as compelling evi-
dence that particle associations were not
affected by confounding from other pollu-
tants. Similarly, Fairley (8) examined the rela-
tionship between ambient PM2.5, PM10,
PM2.5–10, sulfate, CO, O3, and NO2 and cor-
responding mortality. Fairley observed signiﬁ-
cant associations for numerous pollutants
when the pollutants were examined individu-
ally. When the gaseous pollutants were exam-
ined along with PM2.5, the significant
associations for the gases disappeared, while
the association for PM2.5 became stronger; this
suggests that ﬂuctuations in ambient PM2.5
concentrations are driving the health effect
associations. All of these epidemiologic studies
conducted to date, however, have investigated
the potential for confounding using ambient
pollutant concentrations, as none were able to
include information about the personal expo-
sures to the various air pollutants. 
Information concerning personal expo-
sures is critical to our ability to determine
whether confounding is a potential problem
within epidemiologic studies. The coefﬁcient
for PM2.5 represents the independent effect of
particles controlling for the other pollutant in
a two-pollutant model, if each ambient pollu-
tant measurement is a surrogate for actual
exposures to that same pollutant. We began
to examine the relationship between ambient
pollutant concentrations and corresponding
personal exposures and its copollutants in our
exposure study of older adults living in
Baltimore, Maryland (9). Results from this
study showed that, despite signiﬁcant associa-
tions among the ambient pollutant concentra-
tions, personal exposures to PM2.5 were not
significantly correlated with personal expo-
sures to any of its copollutants, including O3,
NO2, and PM2.5–10. Moreover, personal
PM2.5 exposures were signiﬁcantly associated
with its corresponding ambient concentra-
tions, but the personal ambient associations
were not significant for O3, NO2, or
PM2.5–10. These ﬁndings suggest that for this
Baltimore cohort, true confounding of PM2.5
by its copollutants is implausible and that
ambient PM2.5 concentrations are reasonable
surrogates of their personal PM2.5 exposures. 
In this study, we further evaluated the
role of ambient O3, NO2, SO2, and CO as
confounders of ambient PM2.5 using data
from the Baltimore study of older adults and
using additional data collected in Baltimore
for individuals with chronic obstructive pul-
monary disease (COPD) and children. Our
goal, in particular, was to understand for
which exposure each ambient measurement
was a surrogate.
Methods
Personal multipollutant exposures and corre-
sponding ambient concentrations were mea-
sured for 56 subjects (three cohorts: 20 older
adults, 21 children, and 15 individuals with
COPD) living in the metropolitan Baltimore
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Air pollution epidemiologic studies use ambient pollutant concentrations as surrogates of per-
sonal exposure. Strong correlations among numerous ambient pollutant concentrations, however,
have made it difﬁcult to determine the relative contribution of each pollutant to a given health out-
come and have led to criticism that health effect estimates for particulate matter may be biased due
to confounding. In the current study we used data collected from a multipollutant exposure study
conducted in Baltimore, Maryland, during both the summer and winter to address the potential
for confounding further. Twenty-four-hour personal exposures and corresponding ambient con-
centrations to ﬁne particulate matter (PM2.5), ozone, nitrogen dioxide, sulfur dioxide, and carbon
monoxide were measured for 56 subjects. Results from correlation and regression analyses showed
that personal PM2.5 and gaseous air pollutant exposures were generally not correlated, as only 9
of the 178 individual-speciﬁc pairwise correlations were signiﬁcant. Similarly, ambient concentra-
tions were not associated with their corresponding personal exposures for any of the pollutants,
except for PM2.5, which had signiﬁcant associations during both seasons (p < 0.0001). Ambient
gaseous concentrations were, however, strongly associated with personal PM2.5 exposures. The
strongest associations were shown between ambient O3 and personal PM2.5 (p < 0.0001 during
both seasons). These results indicate that ambient PM2.5 concentrations are suitable surrogates
for personal PM2.5 exposures and that ambient gaseous concentrations are surrogates, as opposed
to confounders, of PM2.5. These ﬁndings suggest that the use of multiple pollutant models in epi-
demiologic studies of PM2.5 may not be suitable and that health effects attributed to the ambient
gases may actually be a result of exposures to PM2.5. Key words: air pollution, carbon monoxide,
confounding, exposure error, personal exposure, PM2.5, nitrogen dioxide, ozone, sulfur dioxide.
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were nonsmokers and lived in nonsmoking
private residences (i.e., either single-family
houses or apartments). Sampling was con-
ducted during the summer (29 June–23
August 1998) and winter (2 February–13
March 1999). Fourteen of 56 subjects partici-
pated in both sampling seasons. During both
the summer and winter sampling periods,
subjects included older adults and children.
Subjects from the older adult cohort consisted
of retired, healthy adults with an average age
(± SD) of 75 ± 6.8 years. Subjects from the
children’s cohort consisted of healthy school-
children between 9 and 13 years of age.
During the winter, personal exposures for
individuals with COPD were also measured
along with the older adults and children.
Subjects from the COPD cohort consisted of
individuals with physician-diagnosed moder-
ate-to-severe COPD with an average age of
65 ± 6.6 years. Although the subjects were
from a range of socioeconomic backgrounds
and geographic locations within Baltimore,
subject selection was random and was not
intended to be representative of sensitive pop-
ulations in general. Subjects completed and
returned informed consent forms before their
participation in the study.
All subjects were monitored for 12 con-
secutive days in each of the one or two sea-
sons, with the exception of children who,
during the summer, were measured for 8
consecutive days. We measured 4–16 sub-
jects during each 12-day monitoring period.
A total of 800 person-days of exposure data
were collected for some of the following pol-
lutants: PM2.5, PM10, O3, NO2, SO2, ele-
mental carbon (EC), organic carbon (OC),
and volatile organic compounds (VOCs;
Table 1). Because PM10 and VOCs were
only sampled for the older adult cohort and
there were questions concerning the preci-
sion of the OC measurements, these expo-
sures were not included in this analysis. 
A subset of PM2.5 ﬁlters was analyzed for
SO4
2– concentration. For these filters, per-
sonal exposure to PM2.5 of ambient origin
was estimated using the expression: 
where personalij represents the personal
exposure to SO4
2– for subject i on day j, and
ambientj represents the ambient concentra-
tion measured at the stationary site on day j.
The effective penetration of ambient PM2.5
to personal exposures for all fine particles
was assumed to equal that for SO4
2–. Since
recent studies have shown that fine particle
deposition rates and penetration efﬁciencies
vary by particle size and other factors such as
air exchange rates (10), SO4
2–-based esti-
mates used in the current study provide only
an indication of exposure to PM2.5 of ambi-
ent origin rather than a definitive value.
With the exception of NO2, the gaseous
copollutants measured during the study were
primarily (if not exclusively) ambient in ori-
gin. To estimate exposures to NO2 of ambi-
ent origin, analyses involving personal NO2
exposures were performed by controlling for
the potential nonambient contributions
from gas stoves, the primary nonambient
source of NO2 for these cohorts. 
Personal exposure samples were collected
using a specially designed multipollutant
sampler that consisted of personal environ-
mental monitors (PEMs) to collect PM2.5,
PM10, EC, and OC; sorbent tubes filled
with activated carbon to collect VOCs; and
passive samplers to collect O3, NO2, and
SO2. Subjects were permitted to remove the
sampler during prolonged periods of inactiv-
ity (i.e., sleeping, watching television) and
during activities when the sampler could be
damaged (i.e., showering, intense physical
activity). When the sampler was removed
from the subject’s body, subjects were
instructed to keep the sampling inlets as
close as possible to their breathing zone. The
design and performance of this sampler have
been described, in detail, elsewhere (9,11).
We measured 24-hr integrated ambient
PM2.5 and PM10 concentrations using
Harvard Impactors at a centrally located
site. Continuous ambient PM2.5 mass con-
centrations were obtained from a pair of
PM2.5 tapered element oscillating microbal-
ances (TEOMs; model 1400A; Rupprecht
& Patashnick, Co., Inc., Albany NY) oper-
ated by the Maryland Department of the
Environment. Ambient O3, NO2, SO2, CO,
and VOC data were obtained from local sta-
tionary ambient monitoring sites operated
by the Maryland Department of the
Environment for monitoring citywide pollu-
tant concentrations. Additional ambient
PM2.5 concentrations were obtained from
the U.S. Environmental Protection Agency
that was collected as part of a personal expo-
sure study (12). O3, NO2, SO2, and CO
were measured using UV photometric analyz-
ers, chemiluminiscence monitors, pulsed ﬂuo-
rescent monitors, and nondispersive infrared
monitors, respectively. All of the participants’
residences were located within an approxi-
mately 40-km radius from each of the station-
ary sites which were located either within the
city of Baltimore or Baltimore County. PM2.5
concentrations were obtained from the Old
Town monitoring station; O3 from the
Living Classroom, and Essex monitoring
stations during the summer and from the
Essex monitoring stations during the winter;
NO2 from the Old Town, Living Classroom,
and Essex stations during the summer and
from the Old Town and Essex stations during
the winter; SO2 from the Rivera Beach moni-
toring station; and CO from the Old Town
monitoring station. In cases where pollutant
concentrations were measured at multiple
sites, concentrations were averaged across the
sites. Additional data collected included daily
time–activity diaries and household character-
istic surveys that provided supplemental infor-
mation relating to pollutant exposures. 
Standard quality assurance procedures
were followed for this study (13). We
assessed collected data for bias, precision,
and completeness. Completeness for per-
sonal PM2.5, O3, NO2, SO2, SO4
2–, and EC
was 92, 83, 90, 91, 91 and 91%, respec-
tively. Completeness for the ambient pollu-
tant concentrations was > 98% for all of the
sampled pollutants. Precision, accuracy, and
limit of detection information are detailed in
Chang et al. (11) and Sarnat et al. (9). All
samples were field-blank corrected. Teflon
PEM ﬁlters were also corrected for barometric
pressure. 
Sampler measurement error (sampler
error) was calculated by collocating replicate,
fully conﬁgured sampling packs for 24 hr (±
10%). Sampler error was estimated as the
root mean squared difference of the collo-
cated samplers, divided by the square root of
two, divided by the mean concentration of
the samples. Based on precision data from
this study and previous studies, we assumed
that precision was relative and that sampler
error values for the outdoor range of concen-
trations applied to the entire range of per-
sonal exposure concentrations (9).
Correlation of sampler error in the
dependent and independent variables was
assumed to be independent of each other, a
valid assumption based on previous labora-
tory and ﬁeld characterization tests (14). In
univariate regression analysis (such as the
mixed-model approach used in the current
analysis) sampler error in the dependent
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Table 1. Sampling plan.
Older
Cohort adults COPD Children
Season
Summer (n)1 5 1 0
Winter (n)1 5 1 51 5
Sampling duration
(days and season) 12 12 8 (summer)
12 (winter)
Pollutants
PM2.5 √√√
PM10 √
O3 √√√
NO2 √√√
SO2 √√√
VOCs √
EC/OC √√ (winter only)
CO (ambient measurements only)variable may lead to biased correlations
between the variables but will not bias the
estimates of slope or intercept (15). Sampler
error in the independent variable, on the
other hand, may bias estimates of the slope
and intercepts as well as reduce model sensi-
tivity. To account for the effects of this
error, we corrected the slope by adjusting the
variance associated with the sampler error:
, [1]
where β ˆ
true is the slope of the regression cor-
rected for sampler error, β ˆ
obs is the slope of
the observed or naïve regression results, σ ˆ2
obs
is the variance of the observed exposures or
concentrations, and σ ˆ2
true is the estimated
observed variance of the exposures or con-
centrations minus the estimated variance
attributable to sampler error. The true stan-
dard error of the mixed-model slope (i.e., the
estimated standard error minus the fraction
attributable to sampler error) can be esti-
mated using the delta method, which is
expressed in Equation 2 (15) where S ˆE(β ˆ
true)
is the estimated standard error of the true
slope of the regression, Var ˆ (β ˆ
true) is the esti-
mated variance of the true slope of the
regression, and Var ˆ (β ˆ
obs) is the estimated
variance of the observed slope of the regres-
sion. The true significance of the slope was
subsequently determined as the (β ˆ
true)
divided by S ˆE(β ˆ
true).
Data analysis. Units for PM2.5, SO4
2– and
EC concentrations and exposures are reported
in micrograms per cubic meter. Units for O3,
NO2, and SO2 concentrations and exposures
are reported in parts per billion. Units for CO
concentrations and exposures are reported in
parts per million. Negative values for the
gaseous pollutants as well as values less than
their respective limits of detection were
included in the data analyses as measured to
avoid bias in estimating relations among mea-
surements (16). Graphical techniques and
Shapiro-Wilks tests for normality indicated
that most of the pollutants were normally or
nearly normally distributed. 
We examined four sets of associations to
assess the relationship between PM2.5 and its
copollutants, including the association
between a) ambient PM2.5 concentrations
and ambient copollutant concentrations; b)
ambient pollutant (both PM2.5 and copollu-
tants) concentrations and their respective
personal exposures; c) personal PM2.5 expo-
sures and personal copollutant exposures; and
d) ambient copollutant concentrations and
personal PM2.5 exposures. In addition, mod-
els using PM2.5 components, such as SO4
2–,
EC, and PM2.5 of ambient origin were exam-
ined to identify factors that may affect the
above associations.
Analyses of the associations between
ambient PM2.5 concentrations and ambient
pollutant concentrations were conducted
using univariate time-series regression analysis
assuming a ﬁrst-order autoregressive structure
for the error. Because personal exposures were
measured repeatedly for each subject, analyses
of personal exposure data were conducted
using mixed models and individual-specific
Spearman’s correlation coefficients (rs).
Pollutant exposures and concentrations were
modeled as fixed-effects variables, and sub-
jects were modeled as random variables to
account for between subject variation. Models
were fitted using a compound symmetry
covariance matrix which yielded the lowest
Akaike Information Criteria diagnostic values
compared with other covariance matrices
examined (e.g., autoregressive, banded
toeplitz). Data from the three cohorts were
analyzed in aggregate, with the exception of
cases where signiﬁcant differences in associa-
tions among the cohorts were found. It
should be noted that, due to the intrasubject
correlation, coefﬁcients of determination (R2)
or other measures of scatter are not statisti-
cally valid and are, therefore, not reported.
Consequently, strength of association was
determined by the signiﬁcance of the slope of
the mixed models. Distributions of individ-
ual-specific rs values are also reported as
another indicator of the strength of the
observed associations. The primary objective
of the analysis was to examine the predictive
power of a single pollutant exposure or con-
centrations for other exposures or concentra-
tions. Therefore, the models are almost
exclusively univariate models with the sole
exception being models that control for the
impact of indoor NO2 contributions from
gas stoves, which have a cooking-fuel interac-
tion term. All of the above analyses were
computed using SAS software (SAS Institute,
Cary, NC). Statistical signiﬁcance is reported
at the 0.05 level unless otherwise speciﬁed.
Exclusion of data points. Data points were
voided due to sampling problems (e.g., pump
or battery failures, tube disconnection) or lab-
oratory analysis irregularities. Time–activity
data indicated that two subjects (one older
adult who participated during both sampling
periods and one child who participated dur-
ing the summer sampling period) were heav-
ily exposed to environmental tobacco smoke
(ETS) throughout the course of their partici-
pation in the study. Days of heavy or pro-
longed exposure to ETS were not included in
the analyses, since collected samples did not
typify exposures for a nonsmoker or someone
living in a residence with nonsmokers. 
Results
Summary statistics for the measured ambient
concentrations and personal exposures, strati-
ﬁed by season and by cohort are presented in
Figure 1. A summary of household character-
istic and time activity data is presented in
Table 2. In general, cohort-speciﬁc differences
in household characteristics and time–activity
patterns were not apparent, which may be
due to the relatively small size of each cohort.
There were, however, a number of observed
differences that varied by cohort, but these
were probably not specifically related to
cohort afﬁliation. Most of the monitored chil-
dren and individuals with COPD lived in sin-
gle-family houses (35 of 40 subjects), whereas
subjects from the older adult cohort lived
equally in apartments (18 of 30 subjects) and
single-family homes. Approximately one-half
of the subjects (34 of 69) lived in residences
with gas stoves, a potential source of NO2
and CO, although few participants spent sub-
stantial periods of time cooking. Time–activ-
ity diary results showed that older adult
subjects spent less than 2% of the day, on
average, engaged in stove-related cooking
activities. Only three of the subjects lived in
residences with attached garages, another
potential source of PM2.5, CO, and NO2.
Similarly, there were approximately an equal
number of subjects from each cohort living
near (100 yards) busy roads. Few subjects
indicated on their time–activity diaries any
exposure to ETS during their respective sam-
pling periods. Older adults and children spent
similar fractions of time outdoors during the
summer (4.7% and 5.7% of the day, respec-
tively). Time spent outdoors during the win-
ter was not examined but was assumed to be
limited for all subjects. 
Are ambient copollutant concentrations
signiﬁcantly associated with ambient PM2.5
concentrations? Signiﬁcant associations were
found between ambient PM2.5 and corre-
sponding ambient copollutant concentrations
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Equation 2.during both the summer and winter. For O3
and CO, the strength and the direction of
this association varied by season (Tables 3
and 4). During the summer, ambient PM2.5
was significantly and positively associated
with ambient O3 and NO2 (rs = 0.67 and
0.37, respectively). During the winter, ambi-
ent PM2.5 was significantly and positively
associated with ambient NO2 and CO (rs =
0.75 and 0.69, respectively). A significant,
negative association was found between
ambient PM2.5 and O3 during the winter (rs
= –0.72). Ambient PM2.5 and SO2 were not
significantly associated during the winter
(rs = –0.17). 
Are personal exposures to copollutants
significantly associated with personal expo-
sures to PM2.5? In contrast to the ambient
concentrations, virtually none of the personal
copollutant exposures were signiﬁcantly asso-
ciated with corresponding personal PM2.5
exposures (Table 5). The summertime associ-
ation between personal PM2.5 and NO2
(slope = 0.18, p < 0.01) was the sole excep-
tion to this ﬁnding. There was some evidence
that the strength of the personal PM2.5–NO2
association was largely driven by older adult
subjects (slope = 0.21, p = 0.01), as results
using data only from the children were not
significant (slope = 0.06, p  = 0.62).
Conversely, although insigniﬁcant when data
from all the cohorts were analyzed together,
summertime personal PM2.5 and O3 were
signiﬁcantly associated for children (slope =
0.37, p = 0.03), but not for older adults
(slope = 0.07, p = 0.73). The fraction of time
spent outdoors during the summer differed
little by cohort, so reasons for these cohort
differences are not known but may result
from different activity patterns. 
Similar, yet slightly stronger, associations
were found when personal exposures to PM2.5
of ambient origin, as opposed to total PM2.5,
were regressed on personal copollutant levels
(Table 5). During both the summer and win-
ter, the signiﬁcance of the slope (as evidenced
by the t-statistics for the mixed model slopes)
between personal PM2.5 of ambient origin
and both personal O3 and NO2 increased, as
compared to models using total personal
PM2.5, but remained insignificant. Results
from models that included a cooking-fuel
interaction term showed that gas stoves did
not signiﬁcantly affect the strength of the per-
sonal PM2.5–NO2 associations (summertime
p = 0.61; wintertime p = 0.44). During the
summer, cooking fuel was shown to interact
signiﬁcantly with the strength of the associa-
tion between personal exposure to PM2.5 of
ambient origin and personal NO2 (0.02),
with subjects living in residences with gas
stoves having stronger associations as com-
pared to those living in residences with elec-
tric stoves. Cooking fuel was not shown to
inﬂuence the wintertime association between
personal exposures to PM2.5 of ambient origin
and NO2 signiﬁcantly (p = 0.22). 
An analysis of the individual-speciﬁc pair-
wise correlation coefficients showed similar
weak associations between personal PM2.5
and corresponding personal copollutant expo-
sures. Only 9 of the 178 individual-specific
pairwise correlations were signiﬁcant (3 dur-
ing the summer and 4 in the winter for
PM2.5–NO2; 1 during the summer for
PM2.5–O3; and 1 during the winter for
PM2.5–SO2; Figure 2). Of these significant
correlations, three between personal PM2.5
and personal NO2 were negative, an inverse
relationship from that observed between the
ambient concentrations of these two pollu-
tants. Similar results were found for personal
PM2.5 of ambient origin. Of 115 total corre-
lations examined using personal PM2.5 of
ambient origin, only 5 were signiﬁcant.
Are ambient pollutant concentrations
associated with their respective personal expo-
sures? The weaker associations among the per-
sonal pollutant exposures as compared to
associations among the ambient pollutant
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Table 3. Correlations among ambient concentrations (Spearman’s r).
PM2.5 O3 NO2 SO2 CO
PM2.5 1.00 0.67* 0.37* — 0.15
O3 –0.72* 1.00 0.02 — –0.06
NO2 0.75* –0.71* 1.00 — 0.75*
SO2 –0.17 0.41* –0.17* 1.00 –0.32*
CO 0.69* –0.67* 0.76* –0.12 1.00
Top right represents summertime correlations. Lower left represents wintertime correlations. 
*Signiﬁcant at the 0.05 level.
Table 2. Summary of cohort-speciﬁc household characteristics and time–activity data.
Older adults  Children COPD
Summer Winter Summer Winter  Winter 
(n = 15) (n = 15) (n = 10) (n = 15) (n = 15)
Single-family houses 5 7 10 14 11
Gas stoves 4 8 5 8a 9
Attached garages 0 1 0 1a 1
Percentage of time outdoors 4.7%b — 5.7% — —
Storm windows  — 10 — 8a 8
Near (100 yards) busy road  4 5 5 8a 7
aIncludes data for 11/15 subjects only. bIncludes data for 9/10 subjects only.
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Figure 1. Boxplots showing the distribution (5th, 10th, 25th, median, 75th, 90th, and 95th percentiles) of
ambient concentrations and personal exposures by season and pollutant. concentrations were not unexpected given
that ambient concentrations for gaseous pol-
lutants were not associated with their respec-
tive personal exposures (Table 6), as also
shown in our previous paper (9) as well as in
other exposure studies (17,18). Of the mea-
sured pollutants, PM2.5 was the only pollu-
tant for which ambient concentrations were
signiﬁcantly (and positively) associated with
their respective personal exposures. (Although
personal SO2 was signiﬁcantly associated in
the winter with corresponding ambient con-
centrations, their association was negative:
slope = –0.05, p = 0.005). The strong per-
sonal-ambient associations for PM2.5 were
found during both the summer and winter (p
< 0.0001), providing further evidence of the
strong longitudinal association between ambi-
ent PM2.5 and corresponding personal expo-
sures (9,19,20). Personal-ambient associations
for personal PM2.5 of ambient origin were
similarly strong and with increased signifi-
cance during the winter (the t-value rose from
3.56 to 14.11; Table 6). The presence of gas
stoves did not signiﬁcantly affect the personal-
ambient NO2 associations (summertime
interaction with cooking-fuel type, p = 0.56;
wintertime p = 0.57). 
The interpersonal variability of the per-
sonal-ambient association varied by pollutant
(Figure 2). For both seasons, the median cor-
relation between ambient concentrations and
personal exposures was highest for PM2.5
(summer median rs = 0.65, 13 of 24 signiﬁ-
cant correlations; winter median rs= 0.22, 10
of 44 significant correlations). Even higher
correlations were shown for SO4
2–, a compo-
nent of PM2.5 that is predominantly of 
ambient origin (summer median rs= 0.88, 13
of 14 signiﬁcant correlations; winter median
rs = 0.71, 16 of 29 signiﬁcant correlations).
Among the gaseous copollutants, the winter-
time personal-ambient association for NO2
was the strongest with 7 of 44 subjects hav-
ing signiﬁcant correlations between ambient
NO2 and their personal NO2 exposures. 
Are ambient copollutants surrogates for
personal exposure to PM2.5? Although ambi-
ent copollutant concentrations were gener-
ally not associated with their respective
personal exposures, they were associated
with personal PM2.5 during both seasons
(Table 7). The sole exception was summer-
time ambient CO, which was not signifi-
cantly associated with personal PM2.5. The
direction of the associations between per-
sonal PM2.5 and the ambient copollutant
concentrations mirrored those of the corre-
sponding ambient associations between
PM2.5 and its respective copollutants.
Results from cohort-speciﬁc models examin-
ing these associations were not consistently
significant, which may be due to the rela-
tively small sample size since the slope and
intercepts were relatively stable. The chil-
dren’s summertime association between
ambient O3 and total personal PM2.5 was
the sole exception, being both insignificant
(p = 0.99) and significantly different from
results involving the older adults (p = 0.03).
The associations between ambient
copollutant concentrations and personal
PM2.5 of ambient origin were consistently
stronger than those for total personal PM2.5.
Additionally, all of the cohort-stratiﬁed asso-
ciations between ambient copollutant con-
centrations and personal PM2.5 of ambient
origin were significant. [The wintertime
association between ambient SO2 and per-
sonal PM2.5 of ambient origin for the older
adults was signiﬁcant, but at the 0.1 level (p
= 0.09).] Furthermore, when associations
were examined using maximum 1-hr aver-
ages for O3 and CO instead of the integrated
24-hr averages of these pollutants, model
results were comparable (Table 8). Finally,
ambient PM2.5 was not associated with
exposures to any of its gaseous copollutants
during either season. 
Are ambient copollutant concentrations
surrogates for personal exposure to PM2.5
from speciﬁc sources? Personal EC and SO4
2–
were also measured during the winter for the
cohort of COPD patients, and we used data
from this cohort and season to identify fac-
tors that affected the association between the
ambient copollutant concentrations and per-
sonal PM2.5 exposures from different ambi-
ent sources (Table 9). Speciﬁcally, SO4
2–, a
secondary pollutant formed from coal-fired
power plants, was used as a marker of
regional pollution, and EC was used as an
indicator of mobile source pollution. For the
COPD cohort, ambient NO2, SO2, and CO
were significantly associated with personal
PM2.5 of ambient origin with t-values that
were consistently higher than those observed
for models using exposure to total PM2.5.
These results suggest that personal exposures
to the copollutants for this cohort were pri-
marily surrogates for ambient particles. The
associations between the ambient copollu-
tants and the personal SO4
2– and EC varied
by pollutant. Personal SO4
2– was signifi-
cantly and negatively associated with ambient
O3 and SO2 (p = 0.0009 and 0.0125, respec-
tively), and personal EC was significantly
associated with ambient O3, NO2, and CO
(p < 0.0001 for all). This suggests that ambi-
ent O3 is primarily a surrogate for secondary
particle exposures, whereas ambient CO and
NO2 is primarily a surrogate for particles
from trafﬁc.
Estimating the effects of sampler mea-
surement error on the results. The relative
precision for a given sampler (i.e., the per-
centage of variability attributable to sampler
and analytical error) varied by pollutant, sea-
son, and ﬁlter batch (Table 10). During the
summer, relative precision for the personal
exposure samplers was similar (range: 8% for
PM2.5 to 14% for NO2), whereas during the
winter the precision was more variable
(range: 5% for PM2.5 to 39% for NO2). The
relative precision of the ambient monitors
(under 5% for all pollutants) was consistently
lower than that observed for the personal
samplers. Table 10 shows that although sam-
pler error may have elevated the degree of
overall variability in the exposures, true 
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Table 4. Association between ambient PM2.5 concentrations and ambient copollutant concentrations.
Season Model No. Slope t-Value Intercept
Summer Ambient PM2.5 = ambient O3 48 0.84* 5.98 –5.61
Winter 37 –0.67* –5.56 32.31*
Summer Ambient PM2.5 = ambient NO2 48 0.65* 2.21 11.12
Winter 37 1.02* 6.22 –2.74
Summer Ambient PM2.5 = ambient CO 48 6.50 0.57 21.95*
Winter 37 15.93* 5.56 5.84*
Winter Ambient PM2.5 = ambient SO2 37 –0.34 –0.93 23.05*
Estimates generated using time series regression analysis.
*Signiﬁcant at the 0.05 level. 
Table 5. Association between personal PM2.5 exposures and personal copollutant exposures.
Total personal PM2.5 exposure Personal exposure to PM2.5 of ambient origin
Season Model Subjects (n) Slope t-Value Intercept Subjects (n) Slope t-Value Intercept
Summer Personal PM2.5 = personal O3 24 (193) 0.21 1.31 19.78* 15 (130) 0.22 1.56 13.12*
Winter 45 (434) –0.05 –0.20 18.51* 30 (282) –0.18 –1.66 9.01*
Summer Personal PM2.5 = personal NO2 24 (213) 0.18* 2.51 18.65* 15 (150) 0.17* 3.03 12.77*
Winter 45 (467) –0.02 –0.68 19.04* 30 (289) –0.16 –0.83 9.23*
Winter Personal PM2.5 = personal SO2 45 (465) –0.19 –0.65 18.68* 30 (289) 0.03 0.18 8.98*
*Signiﬁcant at the 0.05 level.variability in the exposures accounted for the
majority of overall variability (> 66%), even
for exposures whose mean concentrations
were extremely low (e.g., O3 and SO2).
These results suggest that true variability con-
tributed more to the overall variability in
exposures than sampler error. As a result,
there was likely sufﬁcient variability in expo-
sures to detect signiﬁcant associations when
they truly existed.
Because sampler error increases the likeli-
hood of type II errors, we conducted further
analyses to quantify its effect on models with
insignificant results. For models examining
the association between ambient copollutant
concentrations and personal PM2.5 expo-
sures, reduced model sensitivity was not
likely to affect the interpretation of the
results, as the slopes were highly signiﬁcant in
spite of any sampler error. Furthermore, the
estimates of slope for the models examining
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Table 8. Association between personal PM2.5 exposures and hourly maximum ambient O3 and CO concentrations.
Total personal PM2.5 exposure Personal exposure to PM2.5 of ambient origin
Season Model Subjects (n) Slope t-Value Intercept Subjects (n) Slope t-Value Intercept
Summer Personal PM2.5 = ambient O3 24 (225) 0.26* 6.22 4.33 15 (154) 0.27* 8.02 –3.66
Winter 45 (487) –0.30* –5.23 28.31* 30 (301) –0.27* –10.57 17.54*
Summer Personal PM2.5 = ambient CO  24 (225) 2.66 1.61 18.16* 15 (154) –0.69 –0.40 14.94*
Winter 45 (487) 1.50* 2.64 15.94* 30 (301) 2.09* 7.97 5.12*
*Signiﬁcant at the 0.05 level.
Table 7. Association between personal PM2.5 exposures and ambient copollutant concentrations.
Total personal PM2.5 exposure Personal exposure to PM2.5 of ambient origin
Season Model Subjects (n) Slope t-Value Intercept Subjects (n) Slope t-Value Intercept
Summer Personal PM2.5 = ambient O3 24 (225) 0.28* 4.00 10.94* 15 (150) 0.37* 6.23 0.04
Winter 45 (487) –0.29* –4.68 23.86* 30 (301) –0.36* –14.04 15.60*
Summer Personal PM2.5 = ambient NO2 24 (225) 0.42* 3.83 12.38* 15 (154) 0.38* 3.79 6.27*
Winter 45 (487) 0.24* 3.44 13.16* 30 (301) 0.26* 7.30 3.06*
Summer Personal PM2.5 = ambient CO  24 (225) 5.36 1.34 18.30*  15 (150) 1.87 0.50 13.42*
Winter 45 (487) 3.99* 3.17 15.00* 30 (301) 6.30* 10.97 3.24*
Winter Personal PM2.5 = ambient SO2 45 (487) –0.24* –2.06 20.75* 30 (301) –0.17* –2.74 10.38*
*Signiﬁcant at the 0.05 level.
Table 6. Association between ambient concentrations and respective personal exposures.
Total personal PM2.5 exposure Personal exposure to PM2.5 of ambient origin
Season Model Subjects (n) Slope t-Value Intercept Subjects (n) Slope t-Value Intercept
Summer Personal PM2.5 = ambient PM2.5 24 (225) 0.46* 9.96 10.20* 15 (154) 0.34* 11.12 5.56*
Winter 45 (481) 0.26* 4.36 13.27* 30 (301) 0.39* 19.88 1.19*
Summer Personal O3 = ambient O3 24 (196) 0.01 1.21 1.84
Winter 45 (449) 0.00 0.03 0.46
Summer Personal NO2 = ambient NO2 24 (217) 0.04 0.37 9.52*
Winter 45 (484) –0.05 –0.53 18.16*
Winter Personal SO2 = ambient SO2 45 (487) –0.05* –2.82 0.54*
*Signiﬁcant at the 0.05 level.
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Significant individual-specific correlation coefficients
Ambient copollutant concentration vs. ambient PM2.5 concentrations
Personal exposure to copollutant vs. ambient concentration of same copollutant
Personal exposure to copollutant vs. personal exposure to PM2.5
Personal exposure to copollutant vs. ambient PM2.5 concentrations
Figure 2. Boxplots showing the distribution (5th, 10th, 25th, median, 75th, 90th, and 95th percentiles) of individual speciﬁc Spearman’s correlation coefﬁcients (rs)
for (A) summertime and (B) wintertime plots (n = 24 and 44, respectively).the associations between ambient pollutant
concentrations and their respective personal
exposures were essentially unbiased given the
relatively high precision of the ambient pol-
lutant monitors. As shown in Table 11 for
the older adult cohort, the true signiﬁcance
of the models did not change, with all of the
models remaining insignificant. For each
model, estimates of both the true slope and
true standard error increased, resulting in no
appreciable difference in statistical signifi-
cance. It should be noted that our ability to
examine statistical significance may be lim-
ited by our relatively small sample size. With
a larger sample size, it is possible that the 
corrected parameter estimates might become
more statistically significant due to correct-
ing the attenuation bias in the uncorrected
estimates. 
Discussion and Conclusions 
For copollutants to be confounders of the epi-
demiologic associations between particles and
adverse health effects, two conditions must be
satisﬁed. They must be correlated with expo-
sure to particles, and they must be correlated
with the health outcome. We have shown
that personal exposures to the gaseous air pol-
lutants are not correlated, at least in our
cohorts, with personal exposures to PM2.5.
Hence the gaseous copollutants cannot be
confounders of PM2.5 associations. Yet several
studies have reported that ambient concentra-
tions of gaseous air pollutants did confound
observed associations between ambient parti-
cles and health. Why did this happen?
Ambient PM2.5 concentrations were
strongly associated with corresponding
ambient concentrations of several gaseous
copollutants in Baltimore, although the
strength and direction of these associations
differed by season. These results are consistent
with findings from other studies and likely
reflect common sources and meteorological
conditions (4,20). Based on ambient results
alone, therefore, it is possible that confound-
ing by gaseous copollutants may impact
observed associations between ambient PM2.5
and adverse health. 
With the exception of PM2.5, however,
ambient pollutant concentrations were weak
indicators of their respective personal expo-
sures. In many respects, these weak associa-
tions were not surprising given ﬁndings from
earlier single-pollutant exposure studies that
showed similarly strong longitudinal per-
sonal-ambient associations for particulate
matter (19,21,22) and weak associations for
the gases (17,18,23,24). For the gases, these
weak associations can be attributed in part to
low personal exposures, where personal
exposures to O3 and SO2, in particular, were
extremely low. Additionally, weak personal-
ambient associations for the gases may be
because variations in time spent outdoors,
rather than variations in ambient concentra-
tions, are the principal factor driving ﬂuctua-
tions in exposures to reactive gaseous
pollutants over time. For a less reactive gas,
such as NO2, indoor sources may also
weaken the association. This did not appear
to affect the current results unduly, as similar
results were shown for subjects living in resi-
dences with gas stoves as compared to electric
stoves. 
As could be expected from the previous
pollutant relationships, the associations
among the personal PM2.5 and gaseous pol-
lutant exposures were also weak and did not
change in direction or signiﬁcance when per-
sonal exposures to PM2.5 of ambient origin
were used in the analyses. These weak associ-
ations among personal PM2.5, O3, NO2 and
SO2, together with the strong personal-
ambient associations for PM2.5, provide evi-
dence that the observed PM2.5-associated
health effects are not due to confounding by
the gaseous pollutants, at least for individu-
als with similar exposure proﬁles and living
in similar urban locations. Additionally, dif-
ferential sampler error, while present in
varying amounts, accounted for at most
39% of overall exposure variability for the
samplers used. This ﬁnding suggests that the
reported associations were not unduly
affected by reduced statistical power due to
sampler error. 
While exposures to the gaseous copollu-
tants are unlikely to be potential con-
founders of PM2.5, ambient copollutant
concentrations were surrogates of personal
PM2.5. For all of the measured copollutants
during both seasons, ambient copollutant
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Table 9. Associations between ambient copollutant concentrations and personal exposure to PM2.5 and
its components for individuals with COPD, winter 1999.
Independent
Dependent variable variable Slope t-Value p-Value
Ambient SO4
2– Ambient O3
Personal exposure to total PM2.5 Ambient O3 –0.25 –3.43 0.0008
Personal exposure to PM2.5 of ambient origin  Ambient O3 –0.27 –9.63 0.0001
Personal SO4
2– Ambient O3 –0.02 –3.38 0.0009
Personal EC  Ambient O3 –0.04 –5.34 0.0001
Ambient SO4
2– Ambient NO2
Personal exposure to total PM2.5 Ambient NO2 0.09 0.96 0.3376
Personal exposure to PM2.5 of ambient origin  Ambient NO2 0.29 8.3 0.0001
Personal SO4
2– Ambient NO2 0.00 –0.09 0.9321
Personal EC  Ambient NO2 0.05 5.06 0.0001
Ambient SO4
2– Ambient SO2
Personal exposure to total PM2.5 Ambient SO2 –0.20 –1.44 0.1524
Personal exposure to PM2.5 of ambient origin  Ambient SO2 –0.16 –2.49 0.0139
Personal SO4
2– Ambient SO2 –0.03 –2.53 0.0125
Personal EC  Ambient SO2 –0.01 –0.54 0.5927
Ambient SO4
2– Ambient CO
Personal exposure to total PM2.5 Ambient CO 1.36 0.88 0.3823
Personal exposure to PM2.5 of ambient origin  Ambient CO 4.42 6.74 0.0001
Personal SO4
2– Ambient CO –0.05 –0.32 0.7529
Personal EC  Ambient CO 1.02 6.38 0.0001
Table 10. Estimating the effects of sampler error.
Personal COV Sampler error Percent of true Ambient COV
Season Pollutant (%) (%) variabilitya (%)
Summer PM2.5 44 8 92 48
O3 104 9 91 25
NO2 81 14 86 27
Winter PM2.5 54 5 95 47
O3 566 9 91 57
NO2 73 39 (28)b 61 32
SO2 2,071 31 69 51
COV, coefﬁcient of variation.
aRepresents COV minus variability attributable to sampler error. bIndicates values after removing three outliers likely
caused by ﬁlter contamination. 
Table 11. Association between personal PM2.5 exposures and personal copollutant exposures using
slopes corrected for sampler error: models for older adults 
Season Personal PM2.5 vs.  True slope True SE True t-value
Summer Personal  O3 0.08 0.22 0.3
Personal NO2 0.24 0.09 2.6
Winter Personal O3 –0.29 0.36 –1.0
Personal NO2 –0.10 0.11 –1.4
Personal SO2 –0.85 0.93 –0.9concentrations were shown to be better pre-
dictors of personal PM2.5 than of their
respective personal exposures. Associations
involving personal PM2.5 of ambient origin
were even stronger. One-hour maximum
ambient concentrations of O3 and CO,
which have also been associated with adverse
health in epidemiologic studies, were simi-
larly strongly correlated with personal expo-
sures to both total PM2.5 and that of
ambient origin, indicating that the results
were insensitive to the averaging time of
these gaseous pollutants. In contrast, ambi-
ent PM2.5 was a poor predictor of personal
exposures to the gaseous copollutants.
Together, these results demonstrate that the
ambient concentrations of PM2.5, O3, NO2,
CO, and SO2 are serving as surrogates for
personal exposures to PM2.5 alone. 
Gaseous pollutants were stronger surro-
gates for PM2.5 of ambient origin, as evi-
denced by the higher t-statistics for these
comparisons. These stronger associations
may be due to shared outdoor sources for
the gaseous pollutants and PM2.5 of ambient
origin. Furthermore, some of the gaseous
pollutants appear to be acting as surrogates
for speciﬁc PM2.5 components, as shown by
the observed associations between ambient
gaseous pollutant concentrations and per-
sonal EC and SO4
2– exposures. For subjects
with COPD, ambient CO and NO2 were
not significantly associated with total per-
sonal PM2.5, but were associated with per-
sonal exposures to PM2.5 of ambient origin
and also to personal EC. These significant
associations may be due to the fact that
motor vehicles are a major source of CO,
NO2, EC, and, to a lesser degree, to PM2.5
of ambient origin. Conversely, ambient CO
and NO2 were not significantly associated
with personal SO4
2–, a pollutant not associ-
ated with motor vehicle emissions. O3, in
contrast, was predominantly associated with
personal SO4
2–, an indicator of long-range
transport and secondary particles. 
The differences in signiﬁcance among the
cohorts may be attributable to differences in
cohort-speciﬁc exposure patterns. For exam-
ple, it is possible that although the total frac-
tion of time spent outdoors was comparable,
children spent more time outside during the
peak O3–PM2.5 afternoon hours than older
adults. This could account for the signiﬁcance
of the summertime association between per-
sonal O3 and personal PM2.5 for children but
not for older adults. Observed cohort differ-
ences may also be due to differences in statis-
tical power for each cohort. 
If ambient copollutant concentrations
are surrogates, as opposed to confounders, of
PM2.5, the results suggest that using multiple
pollutant models in epidemiologic studies of
PM2.5 may not be suitable. As discussed by
Breslow and Day (25), it is inappropriate to
treat one variable as a confounder of another
when both variables are actually surrogates
of the same thing. In Baltimore, this would
apply to epidemiologic models that incorpo-
rate ambient PM2.5 as well as ambient O3,
NO2, SO2, or CO which have been shown
in our analyses to be surrogates of personal
PM2.5. Depending on the strength of the
true epidemiologic association, models that
include these collinear, yet nonconfounding
variables, will yield slopes for the causal pol-
lutant factor (PM2.5) that are underestimated
(5). Likewise, the models will yield a mis-
leading significant association for the
collinear copollutant. Consequently, the cor-
rect modeling approach may be to exclude
the gaseous pollutant concentrations for pol-
lutants that are surrogates for particles rather
than gaseous exposures and to employ sin-
gle-pollutant regression models instead.
Additionally, results from this analysis
clarify findings from epidemiologic studies.
For example, in the recently published
National Morbidity, Mortality, and Air
Pollution Study (NMMAPS), data from 90
cities were compiled to assess the percentage
change in mortality associated with changes
in ambient air pollutant concentrations (6).
The authors found that during the summer,
increases of 10 ppb in ambient O3 was asso-
ciated with a 0.4% increase in mortality
(95% CI; –0.20–1.01). Conversely, winter-
time data indicated that the same increase in
ambient O3 led to a mean decrease of 1.86%
in mortality (95% CI; –2.70–0.96), implying
a protective effect from exposure to O3. The
peculiar wintertime results were described by
the authors as “puzzling and may reflect
some unmeasured confounding factor” (6).
The results from the current analysis suggest
that these results could be due to the fact that
ambient O3 is a surrogate for personal PM2.5,
where the observed negative wintertime asso-
ciations between ambient O3 and mortality
reﬂect the negative association between ambi-
ent O3 and corresponding personal PM2.5. 
Other recent studies have reported posi-
tive associations between ambient CO and
respiratory hospital visits (26). Yet CO is
neither a respiratory irritant nor a moderator
of immune response in the respiratory tract,
making those associations biologically
implausible. PM2.5, in contrast, has been
shown to exacerbate respiratory infections
(27) as well as produce an inflammatory
response (28). The findings showing that
ambient CO is a surrogate for personal
PM2.5 of ambient origin may, therefore, pro-
vide a biologically plausible explanation for
the observed association between CO and
respiratory hospital visits as well. 
Our results were obtained in only one
location, which is a limitation of this analysis.
However, modulators of these associations
between ambient concentrations and personal
exposures, such as the amount of time spent
outdoors and degree of ventilation in the
home, were variable. Our sample included
subjects who spent more time than average
outdoors as well as subjects who spent less
time than average outdoors. In addition, we
had a wide range of indoor ventilation condi-
tions in the homes sampled. We therefore
believe that although different associations
might be found in other cities, the qualitative
results we report are unlikely to change. 
In summary, the above results highlight
the importance of properly characterizing
associations among ambient pollutant con-
centrations and their personal exposures to
air pollution epidemiologic studies. Studies
conducted in locations with strong associa-
tions among ambient pollutant concentra-
tions should not assume that associations
observed among ambient pollutant concen-
trations necessarily persist among personal
exposures to these pollutants, nor should
they assume that relationships among ambi-
ent pollutant concentrations are consistent
across seasons. In particular, ambient con-
centrations of gaseous air pollutants cannot
be considered as surrogates for their respec-
tive personal exposures without site-speciﬁc
evidence to support that assumption. Future
research should focus on how specific fac-
tors, such as ventilation, time spent out-
doors, and household characteristics, affect
the strength of these associations for certain
individuals and cohorts. 
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Antiandrogenic Pesticides Disrupt Sexual Characteristics in the Adult Male
Guppy (Poecilia reticulata)
Erik Baatrup and Mette Junge
Institute of Biological Sciences, Department of Zoology, University of Aarhus, Aarhus, Denmark
It is well documented that several chemicals
from agricultural, industrial, and household
sources possess endocrine-disrupting proper-
ties, which potentially pose a threat to human
and wildlife reproduction (1,2). Most work
has focused on the adverse effects of estro-
genic substances (3–5). The discovery that
certain environmental contaminants possess
antiandrogenic properties (i.e., disrupt the
normal function of the male sex hormones)
has added to the endocrine disruption debate
(6,7). The most intensively studied environ-
mental antiandrogens are the dicarboximide
fungicide vinclozolin and the insecticide
DDT metabolite p,p´-DDE (8–11).
Extensive studies have demonstrated that
vinclozolin and p,p´-DDE interfere with the
action of androgens in developing, pubertal,
and adult male rats (10–15). Exposure to vin-
clozolin and p,p´-DDE during the critical
period of sexual differentiation results in sex-
ual abnormalities expressed later in the adult
male rat, including reduced anogenital dis-
tance, retained nipples, reduced sex accessory
gland weights, urogenital malformations, and
reduced fertility (8,10,14,16–18). With the
same molecular mechanism and with almost
the same potency as the classical antiandro-
genic drug ﬂutamide, both p,p´-DDE and the
two primary vinclozolin metabolites, M1 and
M2, bind the androgen receptor (AR) and act
as antagonists by preventing transcription of
androgen-dependent genes (9,11,13,18).
Androgen-induced gene products play a key
role in the development and maintenance of
male sexual functions, including courtship
behavior (19) and spermatogenesis (20). 
The potential threat of environmental
antiandrogens to fish and wildlife has been
addressed by Monosson et al. (21). Although
the authors noted that the antiandrogenic
activity of p,p´-DDE is unknown in non-
mammalian species, they suggested that this
property may have contributed to the repro-
ductive abnormalities in the American alliga-
tors in Lake Apopka (22,23) and the near
absence of male bloaters in Lake Michigan
in the late 1960s.
Androgen receptors have been character-
ized in a few ﬁsh species. Sperry and Thomas
(24,25) identified two distinct androgen
receptors, AR1 and AR2, in brain and gonadal
tissues of kelp bass (Paralabrax clathratus) and
Atlantic croaker (Micropogonias undulatus)
with different tissue distributions and distinct
steroid and xenobiotic-binding specificities.
AR1 was found to bind only testosterone
with high afﬁnity, but AR2 bound a broader
range of natural androgens and antiandro-
gens, including p,p´-DDE and the vinclo-
zolin metabolites M1 and M2. In particular,
M2 binds AR2 in both testicular and ovarian
tissue with an afﬁnity nearly identical to the
AR in rats. Wells and Van der Kraak (26)
found a single class of high-affinity, low-
capacity AR in rainbow trout (Oncorhynchus
mykiss) brains and in ovaries, testes, and
brains of goldfish (Carassius auratus). This
study suggested a relatively high affinity
between p,p´-DDE and the goldfish testes
AR, whereas p,p´-DDE, M1, and M2
showed no significant competition for the
AR in any of the remaining tissues tested in
the two ﬁsh. Likewise, vinclozolin, M1, and
M2 failed to compete for high-afﬁnity testos-
terone binding sites (putative androgen
receptors) in the fathead minnow, Pimephales
promelas (27). Accordingly, as pointed out by
Sperry and Thomas (25), multiple androgen
receptor subtypes may be present through-
out teleost species and target tissues, with
differential affinities to natural androgens
and different susceptibilities to xenobiotic
interference.
Endocrine-disrupting chemicals (EDCs)
are believed to propagate their initial molec-
ular interactions to higher level effects in the
endocrine system and reproductive organs,
ultimately resulting in an impaired repro-
ductive capability. Thus, disruption of hor-
monal functions can be expressed at various
levels of the vertebrate endocrine system
(28). Molecular markers (e.g., vitellogenin
synthesis and AR binding studies) can be
highly sensitive to demonstrate the presence
of EDCs in the environment, but the verte-
brate endocrine system is so complex that it
is impossible to predict higher level effects
solely from events at the receptor level. For
that purpose it is necessary to identify end
points that are more directly related to the
reproductive fitness of the individual and
preferably with links to population-level
effects. We have addressed this objective in a
series of laboratory experiments for the pur-
pose of studying the effects of EDCs on
selected sexual characteristics in the guppy
(Poecilia reticulata). 
The guppy was chosen as an experimental
animal because it is a viviparous fish which
breeds year round and has a short reproduc-
tive period (29). The adult male has a bright
orange coloration and performs a distinct
courtship behavior. His anal ﬁn is developed
into a copulatory organ (the gonopodium)
for internal fertilization, and ejaculates of
sperm can be evacuated for sperm counting
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Environmental contaminants have been identiﬁed as endocrine disruptors through their antiandro-
genic activity. Thus, as androgen receptor antagonists, the fungicide vinclozolin and the principal
DDT metabolite p,p´-DDE have been demonstrated to induce demasculinization in rats. Whether
this is also the case in ﬁsh remains to be demonstrated. For a period of 30 days, groups of adult
male guppies were exposed to vinclozolin, p,p´-DDE, or the therapeutic antiandrogen ﬂutamide
(used as positive control) applied to the fodder at concentrations between 0.1 and 100 µg/g fodder.
Subsequently, sexual characteristics of relevance to the male reproductive capacity were measured
and compared with untreated control fish. All three chemicals caused profound alterations at
increasing levels of biological organization, even in these fully matured males. At the cellular level,
the three compounds induced a signiﬁcant reduction in the number of ejaculated sperm cells. At
the organ level, the sexually attractive orange-yellow coloration was reduced in area and discolored,
and treated ﬁsh also had smaller testes. Further, at the organismal level, computer-aided behavior
analyses demonstrated a severe disruption in male courtship behavior. We conclude that this
demasculinization is consistent with an antiandrogenic action of vinclozolin and p,p´-DDE and is
likely to compromise reproductive capability in this fish. Key words: antiandrogenic effects,
courtship behavior, endocrine disruptor, ﬂutamide, guppies, p,p´-DDE, Poecilia reticulata, sexual
characteristics, vinclozolin. Environ Health Perspect 109:1063–1070 (2001). [Online ________]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1063-1070baatrup/abstract.htmlwithout harming the ﬁsh (30,31). The hor-
monal pathways controlling the expression
of the male sexual characteristics are not
fully understood, but sperm production,
body coloration, and courtship behavior are
known to be regulated by androgens
(32–34). Hence, the male guppy offers a
suite of sexual characteristics that are both
accessible for quantiﬁcation and of relevance
for the study of EDCs on reproduction. In
this study, adult male guppies were exposed
for 30 days to vinclozolin, p,p´-DDE, and
the therapeutic antiandrogen flutamide,
administered in the food. Subsequently, we
assessed the effects of these three chemicals
on the number of ejaculated sperm cells at
the cellular level, body coloration, length of
gonopodium (copulatory organ), and rela-
tive gonadal weight at the organ level, and
ﬁnally courtship behavior at the organismal
level. Previous studies have demonstrated
that most of these end points are altered in
adult male guppies exposed to the natural
estrogen 17β-estradiol and the xenoestrogen
4-tert-octylphenol (31,35).
Material and Methods
Animals and experimental conditions. The
ﬁsh used in this study were healthy, wild-type
guppies (Poecilia reticulata) imported from
Colombia and bred through several genera-
tions in 500-L stainless-steel tanks at 25 ±
2°C and a daily 12-hr simulated daylight illu-
mination. These stock aquaria received fully
aerated water from a reverse osmosis system
(RO-water), which was mixed with local tap
water (9:1) and adjusted with NaCl to give a
conductivity of 600 µS/cm and a pH of 7.0 ±
0.3. Half of the water in the aquaria was
renewed weekly. The guppies were fed daily
with freshly hatched Arthemia sp. and com-
mercial flake food (TetraMinRubin and
TetraMin, Tetra Werke, Melle, Germany).
A total of 260 adult males were chosen
randomly from the stock aquarium and
divided into 10 experimental groups and 3
control groups. Each group was transferred
to a 16-L seamless glass aquarium (Struers
Kebo Laboratory, Copenhagen, Denmark)
ﬁlled with 4 L of RO-water and 4 L of water
from the culture tank. During the experi-
mental period of 30 days, the water was con-
stantly circulated through a natural ﬁlter of
aquarium gravel. Daily, feces were removed
and clean RO-water was added to 8 L. To
eliminate the risk of leached EDCs, no plas-
tic materials or plants were used in any
aquaria and plumbing.
The fish were exposed for 30 days
through their food to one of the three
antiandrogens: the dicarboximid fungicide
vinclozolin [3-(3,5-dichlorophenyl)-5-
methyl-5-vinyloxazolidine-2,4-dione],
p,p´-DDE (p,p´-1,1-dichloro-2,2-bis
(p-chlorophenyl) ethylene (both chemicals
from Riedel-de-Haën AG, Seelze, Germany),
and the commercial antiandrogen ﬂutamide
(4´-nitro-3´-trifluoromethylisobutyranilide;
Sigma Chemicals, St. Louis, MO, USA).
Flutamide is a speciﬁc inhibitor of the andro-
gen receptor and was therefore used as the
positive control of antiandrogenic effects. All
three chemicals were dissolved in acetone to
adequate concentrations, mixed thoroughly
with the commercial TetraMin fish fodder
and left for 24 hr in a fume cupboard for the
evacuation of acetone. This resulted in fod-
der contaminated with 1.0, 10.0, and 100.0
µg vinclozolin or flutamide per milligram
fodder and 0.1, 1.0 or 10.0 µg p,p´-DDE per
milligram fodder. The remaining three con-
trol groups received food that was mixed
with acetone only. Each group of 20 ﬁsh was
fed daily with 40 mg fodder, corresponding
to 0.2, 2, 20, or 200 µg chemical per fish.
Assuming an equal consumption of food by
the fish and that the average weight of an
adult male guppy is 130 mg, the ﬁsh at the
three application rates of vinclozolin or ﬂu-
tamide were dosed with 15, 150, and
1,500 µg chemical/g ﬁsh and ﬁsh were dosed
with p,p´-DDE at 1.5, 15, 150 µg/g ﬁsh.
After exposure, we measured male sexual
characteristics of importance to guppy repro-
duction and expected targets of antiandro-
genic action at increasing levels of biological
organization. The number of ejaculated
sperm cells were measured at the cellular
level, body coloration, length of gonopodium
(copulatory organ), and testis size (gonodoso-
matic index) at the organ level, and courtship
behavior at the organismal level.
Sperm count. Immediately after behavior
analysis, the male was lightly anesthetized in
ethyl-4-aminobenzoate (Sigma) and placed
on a glass plate under an Olympus SZ 40
dissection microscope mounted with a circu-
lar illumination of polarized light and a JVC
TK-1070E color video camera (Victor
Company of Japan LTD, Tokyo, Japan).
The gonopodium was swung forward and a
32-bit 1,024 × 1,024 pixel digital image of
the ﬁsh’s left side was captured by a VISTA
frame grabber (TRUEVISION, Santa Clara,
CA, USA) and stored on disk for later mea-
surements of gonopodial length and col-
oration. Sperm cells were stripped from the
male guppy by gently stroking the abdomen
with a small metal rod toward the
gonopodium, thereby evacuating an ejaculate
on the glass plate. The guppy ejaculate con-
sists of numerous spermatozeugmata (clusters
of sperm cells), which were collected with a
Finn-pipette and transferred to 90 µL of a
0.125 mM NaCl and 5.0 mM CaCl2 solu-
tion to aid the breakdown of the sperma-
tozeugmata. The pipette was filled and
emptied 30–40 times to ensured the final
disintegration of the spermatozeugmata.
Samples of the sperm cell suspension were
then transferred to an improved Neubauer
chamber hemacytometer (Paul Marienfeld,
Bad Mergentheim, Germany) and, after 10
min retention in a humid chamber, counted
using the general guidelines for human sperm
(39). This method gives a measure of the
total number of sperm cells in an ejaculate.
This method has high reproducibility in indi-
vidual guppies over time. Toft and Baatrup
(31) showed, using this method, that the
sperm count in uncontaminated guppies
remained constant when sampled at time 0,
day 30, and day 90.
Gonadosomatic, coloration, and gonopo-
dial indices. The fish was killed in ethyl-4-
aminobenzoate and ﬁxed in Lilly’s formalin
solution. We determined and calculated the
wet weights of whole body and testis and
calculated the gonadosomatic index (GSI) as
the gonadal weight as percentage of the
whole-body weight. 
The total area of the orange-colored spots
was measured in the digital image of the ﬁsh
and related to the whole body area (fins
excluded) as the coloration index. Hereafter,
the length of the gonopodium was measured
and related to the length of the fish as the
gonopodial index. Digital image analyses
were performed using GIPS software (Image
House, Copenhagen, Denmark).
Male courtship behavior. Sexually mature
guppies perform courtship behavior almost
continuously during the light hours, all year
round. Guppy sexual behavior has been
described thoroughly (36,37). Briefly, the
male places himself in front of the female and
stays within her field of view (posturing
behavior). From this position he performs
the sexual display toward the female known
as sigmoid display, where his body assumes
the shape of an “S” or “C” (hence the name
of this behavior), and vibrates while he swims
sideways displaying his sexually attractive
orange-yellow coloration. He either moves
along the length of the female to come into
position for a copulation, or he moves away
from the female, remaining in her field of
view to entice her to follow. These behav-
ioral maneuvers are so stereotyped and per-
formed so frequently (about 1/min), even in
a laboratory setting, that the male guppy’s
courtship behavior lends itself to quantiﬁca-
tion. This makes the guppy and its sexual
behavior a suitable biomarker of endocrine
disruption (35).
Analysis of courtship behavior. Guppy
courtship behavior was measured automati-
cally using the newly developed computer-
aided DISPLAY vision system (Institute of
Biological Sciences, University of Aarhus,
Denmark), which records and analyzes com-
plex behavior patterns in ﬁsh.
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with a 4-month-old, nonreceptive female in a
sand-blown 20 × 15 cm aquarium containing
1.8 L of 25°C water (water depth, 10 cm)
placed on a sheet of glass 50 cm above dif-
fusely-lit white paper. We used nonreceptive
females to preclude copulations and hence to
ensure constant female responses toward all
males. The entire setup was enclosed in a
metal frame covered with a blackout curtain.
When viewed from above, this arrangement
resulted in clear silhouettes of the two fish,
where the male was easily distinguishable
from the much larger female (Figure 1). The
pairs were left undisturbed for 5 min, after
which the scenario was recorded for 10 min.
A CV-M10 progressive scan (non-inter-
laced) CCD camera (JAI, Inc., Copenhagen,
Denmark) mounted 50 cm above the aquar-
ium displayed an image of the aquarium on a
monitor. Simultaneously, the analogue video
signal from the camera was digitized by a
DT3155 frame grabber (Data Translation,
Inc., Marlboro, MA, USA) into a 768 × 576-
pixel digital image, giving a 0.25-mm spatial
resolution of the visual ﬁeld. The frame grab-
ber was interfaced with a 300-MHZ Pentium
II personal computer.
Prior to recording, the interior of the
aquarium was framed by a software window
(region of interest), and appropriate size and
gray-level ranges corresponding to the fish
silhouettes were likewise set in the software.
These criteria were used for the conversion
of each 8-bit gray-scale image into a binary
(1-bit) image. Thus, all pixel assemblages
fulﬁlling both size and gray-level criteria (ﬁsh
silhouettes) were assigned the value 1, while
the remaining pixels in the image were given
the value 0. This new binary image was
stored in a frame ﬁle on disk for subsequent
analysis. During recording, an image was
captured and processed approximately every
1/12 sec, so each 10-min frame file con-
tained about 7,200 binary frames (occupying
only about 6 MB disk space).
The frame files, containing the time-
series of fish contours, were subsequently
analyzed by the DISPLAY program. An
exhaustive description of this software is
beyond the scope of this paper, but the most
important steps in the characterization and
quantification of the complex courtship
behavior are outlined below.
First, the position and orientation of the
two ﬁsh within the digital image (global coor-
dinate system) must be established in each
frame. The two oblong pixel assemblages,
representing the ﬁsh silhouettes, are converted
into two small coordinate systems by deter-
mining their principal axes. The axes can be
found by computing the eigenvectors (38) for
the position vectors of the pixels. The mean
pixel position vector is the origin of the coor-
dinate system spanned by the eigenvectors.
The eigenvectors constitute a unitary transfor-
mation which enables transformation of other
coordinate systems into a particular coordi-
nate system, such as the other ﬁsh’s coordi-
nate system or the global coordinate system.
Thus, all angle and distance measures can
easily be computed once the principal axes of
the pixel masses are determined. In order to
associate a directed coordinate system to the
pixel mass, the number of object-pixels
inside two circles of equal radius are counted
two standard deviations from the origin
along the y-axis in both directions. The
direction with the largest pixel count gives
the direction of the ﬁsh’s head. Furthermore,
object shape measures can be computed by
dividing the object pixel mass into parts. In
this case, the parts are simply positive and
negative (above and below the x-axis) posi-
tion vectors of the object pixels. Each part is
subsequently treated as a new object, and the
angle between the new y-axes provides a
measure of the ﬁsh curvature (Figure 1C).
For each frame it is now possible to deter-
mine the position and orientation of each ﬁsh
relative to the other, the distance between
them, and the curvature of the male. Further,
frame-to-frame comparisons enable calcula-
tion of speed and direction (relative to the
body’s longitudinal axis) of ﬁsh movements.
The composite courtship behavior of the
guppy, including posturing behavior and sig-
moid displays, can be broken down into its
constituting elements, including the mutual
position/orientation of the two ﬁsh and their
movement patterns. The following parame-
ters were extracted from each of the approxi-
mately 7,200 frames in the frame file: a)
position of female relative to the male mea-
sured as the angle (0–180°) between the
male’s y-axis and a line between the origins of
the two ﬁsh’s coordinate systems (centroids;
 ε in Figure 1A); b) position of male relative
to the female measured as the angle (0–180°)
between the female’s y-axis and a line between
the centroids of the two fish ( δ in Figure
1A); c) distance between the centroids of the
two ﬁsh (a in Figure 1A); d) male swimming
speed deﬁned as the frame-to-frame displace-
ment of his centroid divided by the time
between successive frames (v in Figure 1B); e)
male angular displacement measured as the
angle (0–180°) between the male y-axis and
the position vector of his centroid in the next
frame ( ϕ in Figure 1B), where high values
indicate sideways and backward swimming;
f ) male lateral velocity calculated as the mag-
nitude of the male velocity component per-
pendicular to the y-axis in the preceding
frame (u in Figure 1B), signifying the inten-
sity of sideways swimming; and g) male curva-
ture measured as the angle between the y-axes
of head region and the tail region, respectively
( ω in Figure 1C).
The frame-to-frame measurements of the
seven parameters were subsequently used to
identify periods with posturing behavior and
sigmoid displays within the entire 10-min
frame file. This was done by assigning a
range of pass values (search criterion) to each
parameter. Basically, a specific behavior is
recognized when all search criteria are ful-
ﬁlled simultaneously. Thus, before analyzing
the frame ﬁles, the appropriate combination
of search criteria describing the specific
behavior is set once for all. This is done by
repeatedly refining and verifying the search
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Figure 1. Composite courtship behavior of the male guppy automatically quantiﬁed by the DISPLAY vision
system using seven descriptive components. Abbreviations: a, distance between female and male; u,
male lateral velocity measured as the velocity component perpendicular to the longitudinal axis of the
male; v, male swimming velocity;  δ, angular position of the male relative to the female’s longitudinal
axis;  ε, angular position of the female relative to the male’s longitudinal axis;  ϕ, male angular dis-
placement relative to his longitudinal axis;  ω, male curvature measured as angle between the y-axes of
head region and tail region. (A) The two oblong pixel assemblages representing the male and female sil-
houettes from the digital image were converted into directed coordinate systems, which enabled the cal-
culation of position and orientation of each ﬁsh relative to the other and the distance between them. (B)
Frame-to-frame comparisons enabled calculations of speed and direction (relative to the body’s longitudi-
nal axis) of ﬁsh movements. (C) The body curvature was measured as the angle between the two y-axes
of coordinate systems aligned with the head and tail regions, respectively. criteria until the software’s interpretation of
the behavior in all situations agrees with this
particular behavior. This manipulation is
easily performed by combining a graphical
user interface for entering search criteria with
a real-time replay facility in the DISPLAY
program.
The measurement of the male’s posturing
behavior (i.e., the time he spent in front of
the female introducing the next sigmoid dis-
play) involved three search criteria. First, the
male must be in front of the female (pass val-
ues of  δ in Figure 1A set to 0 < δ < 90°).
Second, the male must at least partly face the
female ( ε criterion in Figure 1A set to 0 < ε
< 60°). Note that all angles are presented
without signs since there is no distinction
between the right side and left side of the
fish. Finally, the two fish must be within a
distance of a few centimeters (a in Figure 1A
set to < 60 mm).
The guppy sigmoid display is a much
more complex behavior. First, the combina-
tion of involved parameters and their ranges
of pass values changes during the course of
the display. Accordingly, a positive identiﬁca-
tion of the entire display by the software
requires temporal adjustments of the search
criteria. This was achieved by associating a
timer to each search criterion, engaging and
disengaging its function. The onset of the dis-
play is characterized by the male being within
the anterior part of the female’s ﬁeld of view
for at least 0.2 sec (0 < δ < 90°; time out 0.2
sec) at a distance of at least 22 mm (a > 22
mm) exposing the side of his body ( ε > 68°),
which is locked in a distinct curvature for at
least 0.5 sec (ω > 20°; time out 0.5 sec). After
this initial phase the rules are changed allow-
ing the male to move within the female’s
entire ﬁeld of view (0 < δ < 140°), but with
his body still locked in a curvature (ω > 5°)
with the convex side continuously facing her
(ε > 68°). Display termination is registered
when one or more of these criteria are no
longer fulﬁlled.
The frame ﬁles of all treated and control
ﬁsh were analyzed by the DISPLAY software.
The complete analysis of a 10-min frame ﬁle
takes about 25 sec with a 300 MHz Pentium
II computer. The time devoted to position-
ing behavior, number, and duration of the
sigmoid displays and the average values of the
measured parameters were saved in a data ﬁle
for subsequent statistical analysis.
Statistical analyses. Where necessary, data
sets were transformed to comply with the nor-
mality and variance homogeneity requirements
for analysis of variance (ANOVA) testing to
compare means among the treatment groups.
Subsequently, Dunnett’s test for multiple
comparisons was used to determine whether
treatment means were signiﬁcantly different
(p < 0.05) from the control group. All statisti-
cal tests were performed with SPSS software
(SPSS for Windows, release 9.0; SPSS Inc.,
Chicago, Ill, USA).
Results
In the group fed the highest concentration
of vinclozolin (100 µg/mg), 15% of the ﬁsh
died during the 30 days of treatment. The
corresponding mortalities with the highest
concentrations of DDE (10 µg/mg) and ﬂu-
tamide (100 µg/mg) were 70% and 35%,
respectively. Because the chemicals were
obviously toxic at these application rates,
these three groups were excluded from fur-
ther evaluation of antiandrogenic effects. In
contrast, at the 10 and 100 times lower
application rates, none of the ﬁsh displayed
obvious toxic responses such as body darken-
ing or changed swimming activity. The few
ﬁsh that were lost in these groups died solely
because of incorrect handling.
All three chemicals caused pronounced
effects on the adult male’s sperm count,
body coloration, testes size, and courtship
behavior. Below, the effects on these sexual
characteristics are presented in the order they
were measured.
Sperm count. The provoked ejaculate
from control fish contained an average 5
million sperm cells. All antiandrogen treat-
ments reduced this number, except in the
group fed p,p´-DDE at 0.1 µg/mg, where the
sperm count actually exceeded that of control
ﬁsh (Figure 2B). The lowest sperm count, at
1.6 million sperm cells, was measured in the
10 µg/mg ﬂutamide group. The ejaculates of
the remaining groups contained 3–4 million
sperm cells.
Coloration and gonopodial indices. The
demasculinizing effects of the antiandrogens
also inﬂuenced the area and color intensity of
the male orange coloration. In the control
group, an average 12% of the body surface
(coloration index) was coved with orange
spots, while this percentage was lower in the
treated groups (Figure 2C). Statistically, the
reduction in coloration index was only signif-
icantly different from the control ﬁsh in the
group treated with vinclozolin at 1 µg/mg.
Even with the naked eye it was obvious that
the treatments also caused discoloring of
these sexually attractive spots. Measurements
of the red, green, and blue color components
in the digital images demonstrated that this
fading was primarily caused by a signiﬁcant
brightening of the blue component in all
treated groups, with the exception of the low
dose p,p´-DDE group (data not shown).
The length of the gonopodium relative
to the length of the ﬁsh (gonopodial index)
was unaffected by the antiandrogens, as was
the size of the ﬁsh.
Gonadosomatic index. The weight of the
testis relative to the body weight (gonadoso-
matic index) was significantly lower in the
fish exposed to antiandrogens with the
exception of the group treated with the low
p,p´-DDE dose (Figure 2D). In the control
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Figure 2. The effects of a 30-day exposure to vinclozolin, p,p´-DDE, and ﬂutamide on four sexual characteristics of the adult male guppy. (A) Number of sigmoid
displays during the 10-min recording period. (B) Number of sperm cells in a provoked ejaculate. (C) Area of orange coloration as percentage of body area (col-
oration index). (D) Weight of testis as a percentage of whole-body weight (gonadosomatic index). Statistical differences between the control group and the
treated groups were tested with one-way ANOVA followed by Dunnett’s post-hoc multiple comparisons test. 
A B C D
12345678 12 3 4 56 7 7 8 910 11 12 13 1.5 2.0 2.5 3.0
No. of sigmoid displays Sperm count (millions) Coloration index (%) Gonadosomatic index (%)
Flutamide 10 µg/mg
Flutamide 1 µg/mg
DDE 1 µg/mg
DDE 0.1 µg/mg
Vinclozolin 10 µg/mg
Vinclozolin 1 µg/mg
Control
Not statistically significant p < 0.05 p < 0.0001group, the testes made up about 2.8% of the
body weight, whereas GSI values between
1.7 and 2.0% characterized ﬁsh treated with
the three chemicals.
Courtship behavior. Of the seven behav-
ioral elements (Figure 1) measured by the
automated vision system, four were used in
combinations to quantify the two most
important behavioral patterns in the
courtship behavior—namely, the posturing
behavior and the sigmoid display. The accu-
racy by which the vision system identified
these two composite behavior patterns was
assessed by replaying the frame sequences.
All situations with posturing behavior were
correctly quantified by the system, and of
464 sigmoid displays identified in the 145
recordings, only 24 cases were considered
questionable by two independent observers
and therefore excluded from further analysis.
The effects of vinclozolin, p,p´-DDE, and
flutamide on each of the seven behavioral 
elements are presented as average values in
Table 1. Considered individually, two
behavioral components of the sexually active
male guppies were particularly affected by
the three compounds. The males from the
treated groups were less oriented toward the
female ( ε in Table 1) and swam less side-
wards, both as regards swimming direction
( ϕ in Table 1) and sideways swimming
velocity (u in Table 1). The male’s efforts to
face the female were most strongly restrained
by vinclozolin at 1.0 µg/mg fodder, whereas
p,p´-DDE most effectively impeded the side-
ways swimming activity. Surprisingly, some
of the behavioral elements displayed a nega-
tive or neutral dose–response relationship. For
instance, the inhibition of male orientation
toward the female and his sideways swim-
ming was more pronounced in the group that
was treated with 1 µg vinclozolin/mg fodder
than in the group treated with the 10 times
higher concentration. The same two behav-
ioral components were affected to the same
degree by the two DDE concentrations. The
remaining elements were less influenced by
the antiandrogenic treatments, including the
male’s position relative to the female ( δ in
Table 1), his body curvature ( ω in Table 1),
and the distance between the two fish (a in
Table 1). It is worth noting that there was no
statistical difference in the general swimming
velocity (v in Table 1) between the males in
the treated groups and the control group.
Signiﬁcant differences in average swimming
velocity could indicate a general toxic effect of
the chemicals.
The two composite patterns in the male
guppy’s courtship behavior, the posturing
behavior and the sigmoid display, were
more strongly affected by the three antian-
drogens than any of the separate constituent
components. In all cases, the chemicals weak-
ened the male’s sexual activity. With the face-
to-face posturing behavior, the male tried to
attract the female’s attention before he per-
formed the sigmoid display. The inﬂuence of
the three antiandrogens on the duration of
posturing behavior within the 10 min of
recording is shown in Figure 3. The males
from the control group spent on average 130
sec in posturing behavior, corresponding to
22% of the observation period. The most
serious inhibition of this behavior was found
in the group fed vinclozolin at 1 µg/mg fod-
der, where the males on average fulﬁlled the
criteria of posturing behavior for only 40 sec,
or 7% of the recording period. In compari-
son, the group treated with ﬂutamide at the
same concentration spent about 15% of the
time on posturing. The composite behaviors
also demonstrated neutral or negative
dose–response relationships. Hence, in the
group treated with vinclozolin concentration
at 10 µg/mg fodder, the posturing behavior
was unaffected, whereas ﬂutamide at this con-
centration inhibited this behavior by 51% rel-
ative to the controls. Correspondingly,
p,p´-DDE restrained the posturing behavior
by 20% and 43% at 0.1 and 1.0 µg/mg,
respectively, when compared with the control
group.
Although the sigmoid display is the most
conspicuous movement pattern in the male
guppy’s courtship behavior, it makes up only
a small part of the courtship temporally. The
total duration of the male’s mating behavior,
including both posturing behavior and sig-
moid displays, is presented in Figure 3. As a
prelude to the copulation attempt itself, the
sigmoid display is the culmination of the
courtship behavior. The number of sigmoid
displays is therefore a suitable measure of the
male’s mating ardor. Figure 2A demonstrates
that males from the control group performed
on average about eight sigmoid displays per
10 min observation period, whereas this
behavior only rarely occurred in the groups
treated with ﬂutamide or the lowest concen-
trations of vinclozolin (1.0 µg/mg) and
p,p´-DDE (0.1 µg/mg). This component in
the courtship behavior also demonstrated a
negative dose–response relationship, with
much less inhibition at the high application
rates of the two pesticides.
Discussion
Oral administration of either vinclozolin, p,p´-
DDE, or ﬂutamide clearly altered the sexual
characteristics of the adult male guppy. After
only 30 days of exposure, the orange display
coloration was reduced in both area and color
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Table 1. The effects of vinclozolin, p,p´-DDE, and ﬂutamide on seven components in the courtship behavior of the male guppy.
Treatment  ε  δ av  ϕ u  ω
(µg/mg fodder) No. (degrees) (degrees) (mm) (mm/sec) (degrees) (mm/sec) (degrees)
Control (19) 44.1 ± 4.3 84.6 ± 5.8 54.9 ± 3.4 17.4 ± 1.5 69.6 ± 2.8 7.4 ± 0.7 9.4 ± 0.4
Vinclozolin, 1.0 (18) 82.5 ± 4.4# 80.2 ± 4.7 75.2 ± 6.8* 20.4 ± 2.5 46.2 ± 3.0# 4.5 ± 0.6** 8.5 ± 0.6
Vinclozolin, 10.0 (18) 60.7 ± 5.5 75.8 ± 3.2 53.9 ± 3.5 18.8 ± 1.8 59.7 ± 5.3 5.2 ± 0.5** 7.5 ± 0.4
DDE 0.1 (17) 69.2 ± 6.6** 81.5 ± 4.1 58.1 ± 6.5 13.2 ± 2.2 59.6 ± 4.8 3.1 ± 0.6# 6.4 ± 0.6#
DDE 1.0 (16) 68.0 ± 5.3** 75.8 ± 3.5 68.4 ± 6.2 15.3 ± 2.1 51.6 ± 6.0* 3.5 ± 0.4# 7.1 ± 0.6
Flutaminde,1.0 (17)  71.1 ± 5.3** 79.8 ± 3.5 67.6 ± 6.5 16.0 ± 1.9 52.4 ± 3.7** 4.6 ± 0.6** 8.5 ± 0.7
Flutaminde, 10.0 (18) 78.7 ± 5.8# 77.3 ± 4.7 91.8 ± 8.7# 19.6 ± 1.8 39.6 ± 3.4# 4.6 ± 0.5# 7.2 ± 0.3#
Differences between treated groups and control group were tested with one-way ANOVA followed by Dunnett’s post-hoc multiple comparisons.
*p < 0.05; **p < 0.001; #p < 0.0001.
Figure 3. The three antiandrogens, vinclozolin,
p,p´-DDE, and ﬂutamide, reduced the time allocated
to courtship behavior in the adult male guppy. Blue
bars indicate the average duration of posturing
behavior during the 10-min recording period. Red
bars show the total time devoted to both posturing
behavior and sigmoid displays. 
*p < 0.05, **p < 0 .001, and #p < 0.0001 as determined by
Dunnett’s post-hoc test. 
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#intensity, the weight of the testis was dimin-
ished, the sperm count had fallen, and the
courtship behavior was almost extinguished.
To our knowledge, the present study provides
the first evidence that these pesticides can
cause severe reproductive abnormalities in ﬁsh.
Two previous studies, involving p,p´-
DDE and vinclozolin concluded that there
was no evidence that these two chemicals act
as endocrine disruptors in ﬁsh. Carlson et al.
(40) microinjected embryos of rainbow trout
(Oncorhynchus mykiss) and chinook salmon
(Oncorhynchus tshawytscha) with a number of
contaminants, including p,p´-DDE. After
rearing for 6 months, no treatment-depen-
dent changes in sex ratio, gonadal histology,
or steroid production were observed.
Similarly, embryonic fathead minnows
(Pimerhales promelas) were exposed to vinclo-
zolin in the water by Makynen et al. (27),
who concluded that vinclozolin had no
adverse effects with respect to sexual differen-
tiation and reproductive success despite the
fact that data showed a 20–60% reduction in
fecundity. In contrast, exposure of adult fat-
head minnows to vinclozolin resulted in
increased plasma 17β-estradiol in males and a
decline in the gonadosomatic index of
females accompanied by a retardation in
oocyte development (27). Accordingly, the
three studies performed till now reached dif-
ferent conclusions regarding the endocrine-
disrupting properties of vinclozolin and
p,p´-DDE. These apparent discrepancies may
be explained by differences in chemical con-
centrations, route of application and time-
window of exposure, but more likely reﬂect
real species differences in the sensitivity of the
reproductive apparatus to antiandrogenic
compounds. Considering that ﬁsh display a
wide range of reproductive strategies and the
growing evidence of interspecies and tissue
differences in AR binding specificity, some
ﬁsh may be more susceptible than others to
endocrine disruption by a particular chemical
(21,25,26).
The three chemicals used in this study
caused impairment of the guppy’s sexual
characteristics in a manner consistent with
the effects of antiandrogens. First, the
affected sex characteristics are known to be
under androgen control in the guppy
(32,41–43). Thus, Pandey (32) blocked the
synthesis of sex steroids in adult male gup-
pies by hypophysectomy, which caused a
marked regression in the testis, inhibition of
spermatogenesis, and a pronounced fading
of the orange display coloration. Subsequent
treatment of these hypophysectomized males
with the androgen methyl testosterone
induced partial restoration of coloration and
testis morphology and function (42).
Similarly, it has been shown that the guppy’s
sexual behavior is under androgen control
(37,41,44), as is the case with other fish
species (33). Accordingly, the changes in the
sexual characteristics induced by vinclozolin
and p,p´-DDE closely parallel those evoked
by androgen deprivation. Second, it has been
thoroughly established that both vinclozolin
and p,p´-DDE are functional antiandrogens
in mammals by blocking the androgen recep-
tor (9,10,12,18) in the same way as the ther-
apeutic drug ﬂutamide, which acts purely as
an antiandrogen (45,46). Collectively, these
considerations strongly suggest that vinclo-
zolin and p,p´-DDE act as endocrine disrup-
tors in the guppy by antagonizing the
androgen receptor. The altered sexual charac-
teristics represent a significant reduction in
the expression of the male phenotype, indi-
cating that the reproductive ﬁtness of antian-
drogen treated ﬁsh was impaired.
An appropriate sexual behavior is prereq-
uisite for mating success in most animals.
Unbiased measures of the guppy courtship
behavior were obtained using the newly
developed vision system, designed to identify
complex behavioral patterns in ﬁsh. The sex-
ual instinct of the male guppy was seriously
compromised by vinclozolin, p,p´-DDE, and
flutamide, which significantly reduced the
time devoted to posturing behavior and
almost eliminated sigmoid displays. It has
been demonstrated that males with a high
sigmoid display frequency are preferred by
females (47,48) and that male mating suc-
cess is positively correlated to the intensity of
sigmoid displays (47,49,50). Also, Matthews
et al. (30) found a strong correlation
between display rate and sperm number,
hence providing further evidence of the link
between sexual behavior and reproductive
capacity in male guppies. 
The male orange coloration is similarly
thought to signal condition and genetic qual-
ity. Several studies have shown that male gup-
pies with the largest and brightest orange spots
are favored by females and that these males
have a higher mating success (48,51,52).
Impairment of the male coloration is there-
fore likely to reduce reproductive ﬁtness. In
addition to antiandrogens, discoloration of
the orange spots has been reported in
response to other chemical and natural stres-
sors, including estrogen (31,53), the xeno-
estrogen octylphenol (31), food quality (50),
and parasites (54).
The relationship between sperm count
and Darwinian ﬁtness is less clear. Kime (55)
noted that it is difﬁcult to relate sperm count
in ﬁsh to population-level effects because the
amount of ejaculate necessary for successful
fertilization is unknown. However, Warner
(56) has argued that most male fish release
only the minimum amount of sperm that is
required for fertilization, so that any decrease
in sperm quantity or quality will result in
reduced fertility. In this study, the number
of sperm cells in the provoked ejaculates of
the treated groups was reduced 20–60%
when compared with the control group.
This reduction in sperm count may be a
simple consequence of the diminished testis
size in the exposed fish and/or caused by a
direct antiandrogenic action of the chemicals
on spermatogenesis. Inhibited spermatogen-
esis in response to antiandrogenic com-
pounds has been reported in a number of
vertebrates, including fish (57), amphibia
(58), hamsters (59), and humans (60). In
particular, signiﬁcant reductions in epididy-
mal sperm counts have been demonstrated
in rats treated with p,p´-DDE (61) and vin-
clozolin (18). In contrast, Moorman et al.
(62) found a surprising increase in sperm
counts in sexually mature rabbits after der-
mal application of vinclozolin during the
peripubertal period. Still, inhibited sper-
matogenesis appears to be the general rule of
antiandrogenic exposure.
The gonopodium was unaffected by
exposure to vinclozolin, p,p´-DDE, or flu-
tamide. This is in agreement with Pandey
(42), who found that the morphology of the
gonopodium in adults was insensitive to
steroid depletion by hypophysectomy and
concluded that once morphogenesis of skeletal
elements is completed, it becomes indepen-
dent of the pituitary hormones and androgens.
The development of the gonopodium is cer-
tainly under androgen control because adult
female guppies fed 17α-methyltestosterone
developed gonopodia (44). Also, a parallel
study in our laboratory has demonstrated
that signiﬁcantly smaller gonopodia evolved
in guppies treated with the three antiandro-
gens during juvenile development (63).
Overall, the three antiandrogens affected
the selected sexual characteristics in the same
direction. Identical amounts of fodder were
added to all aquaria daily, and all fodder was
consumed before feeding the following day.
The ﬁsh appeared eager to feed in all treat-
ments and throughout the experiment, so we
could not detect any possible differences in
palatability between chemicals. Considering
the molar concentrations of the three chemi-
cals in the fodder (vinclozolin: 3.5 and 35
µmol/g fodder; p,p´-DDE: 0.31 and 3.1
µmol/g fodder; ﬂutamide: 3.6 and 36 µmol/g
fodder), it appears that the antiandrogenic
potencies in vivo of vinclozolin and p,p´-
DDE equaled, and in some cases even
exceeded, that of flutamide. However, the
lipophility of p,p´-DDE (log Kow 6.51) is
more than three orders of magnitude greater
than flutamide (log Kow 3.35) and vinclo-
zolin (log Kow 3.10). The strong relationship
between this factor and the uptake constant
(64), depuration rate constant (65), and bio-
concentration factor in fish (66) probably
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p,p´-DDE than vinclozolin or flutamide in
our experiment. Determination of the relative
potencies of these three chemicals will require
investigation of chemical concentrations at
the target tissues. This difference in
lipophility may also explain the noteworthy
effect pattern seen with the lowest dose of
p,p´-DDE. Here, sexual behavior was almost
eliminated, but no effects were seen in sperm
count, GSI, or display coloration. It is reason-
able to expect that p,p´-DDE is rapidly parti-
tioned into tissues with a high lipid content,
such as the brain, thus affecting behavior
before other secondary sex characteristics.
However, the response pattern of p,p´-DDE
is also known to differ from those of vinclo-
zolin and flutamide in the rat (10,12,18).
Finally, it is possible that these differences are
caused by subtle, tissue-dependent differences
in AR afﬁnities for antiandrogens as seen in
other ﬁsh species (24,25). 
Some of the measured parameters exhib-
ited neutral or negative dose responses (i.e.,
the higher dose produced a weaker response
than the low dose). From a traditional toxi-
cologic viewpoint, this type of bell-shaped
dose–response curve is somewhat surprising,
although such responses are common in
physiologic and in certain hormone studies.
A survey of the literature from the last
decade revealed nearly 100 titles reporting
this type of response in hormone research.
Of particular relevance to the present study,
Wong et al. (11) demonstrated that the M2
metabolite of vinclozolin binds the AR, pro-
ducing a ligand that can enter the nucleus.
The presence of even small quantities of the
natural androgen dihydroxytestosterone dis-
torted this ligand, preventing the induction
of DNA transcription, making M2 a func-
tional antiandrogen. However, in the
absence of dihydroxytestosterone, DNA
transcription proceeded and M2 functioned
as an androgen analogue, leading the authors
to suggest that M2 functions as an androgen
at high in vivo concentrations. 
In conclusion, this study demonstrates
that p,p´-DDE, vinclozolin, and flutamide
caused profound demasculinization of fully
matured male guppies, impairing male sex-
ual characteristics from the cellular level to
the organismal level after only 30 days of
exposure. In a parallel study, Bayley et al.
(63) measured the same end points in adult
male guppies after exposure to the same
three chemicals throughout the juvenile
period. Similar results were obtained for
sperm count and courtship behavior, but the
actual size of the testis (GSI) was unaffected
by the treatments. In addition, juvenile
exposure caused delayed sexual maturation
and a skewed sex ratio toward female pre-
dominance at adulthood in treated groups.
The impairments of the guppy’s sexual
characteristics are consistent with an antian-
drogenic action of vinclozolin and p,p´-DDE.
However, it is noteworthy that some of the
measured end points, including body col-
oration and sexual behavior, responded simi-
larly to estrogenic compounds (31,35),
suggesting that demasculinizing and feminiz-
ing endocrine disruptors may have common
molecular targets and/or cellular responses.
Studies of the interactions between these
chemicals and sex steroid receptors are
required in the guppy to provide concrete evi-
dence of the mechanisms underlying these
effects on the sexual phenotype. 
A number of fundamental questions
remain unanswered. First, we need to conﬁrm
or disprove our assumption that the measured
changes in the male sexual characteristics are
actually translated into an impaired reproduc-
tion. Also, the possible effects of vinclozolin
and p,p´-DDE on female fertility should be
investigated, for instance, by mating exposed
males with unexposed females and vice versa.
Finally, long-term exposure to environmen-
tally realistic concentrations, involving several
generations and all life stages, should be car-
ried out. These studies are currently being
performed in our laboratory.
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Some epidemiologic studies suggest an asso-
ciation between pesticide exposure and child-
hood cancer (1,2). Most studies have used
questionnaires to evaluate parental occupa-
tional exposure around the time of the child’s
birth and exposure to the parents or child
from pesticide use in the home and garden.
Such information is potentially limited by
response bias. Childhood cancer has not been
evaluated with respect to potential exposure
to agricultural pesticides because respondents
are unlikely to have speciﬁc knowledge about
pesticide use on nearby ﬁelds.
Few tools exist for identifying regions
with a high density of agricultural pesticide
use. County crop acreage totals are available,
but land use varies tremendously within
California counties because of differences in
topography and urbanization. Some investiga-
tors have used satellite imagery and a geo-
graphic information system (GIS) to identify
the location of agricultural ﬁelds (3,4). These
indices provide information on the popula-
tion living near ﬁelds, but only indirect esti-
mates of pesticide use based on crop type.
The resulting pesticide use estimates are lim-
ited by crop misclassiﬁcation and the assump-
tion that all ﬁelds are treated similarly for a
given crop. Some studies of cancer in adults
have been conducted with pesticide use data
summarized at the county level (5–7).
However, the number of residents living near
agricultural ﬁelds and the amount of speciﬁc
pesticides applied agriculturally in these com-
munities have generally not been available.
In 1992, California accounted for 22% of
all agricultural pesticide use in the United
States (8). There has been some form of pesti-
cide use reporting in California for several
decades, although before 1990 reporting was
limited to applications that were restricted
and required a permit. The California legisla-
ture mandated the Pesticide Use Report
(PUR) system in 1990 (9), legally requiring
growers and applicators to report all commer-
cial agricultural pesticide use. Every month,
written or electronic records of all pesticide
applications are submitted to the county
agricultural commissioners. The California
Department of Pesticide Regulation
(Sacramento) collects the data entered by the
counties and after checking for errors makes
it available to the public annually for a small
fee. Few states have a full pesticide use
reporting system and no other state has been
collecting data since 1990. An important fea-
ture of the PUR data is that they provide the
pounds of active ingredient applied. There
are more than 850 pesticide active ingredi-
ents applied agriculturally in California each
year. Inert ingredients, which might also be
toxic, are not reported. The active ingredi-
ents, which we refer to as pesticides, range
from compounds with no known carcino-
genic potential to substances known to cause
cancer in laboratory animals (10).
The PUR data provide an opportunity
to develop more geographically precise esti-
mates of agricultural pesticide use, which
may be evaluated in conjunction with cancer
incidence rates. California is particularly
suited for such an analysis because it also has
a statewide cancer reporting system. We
focused on potential exposures to children
because the latency period for childhood
cancer is shorter than for adult cancer. For
this statewide analysis, we grouped pesticides
into toxicologic categories and chemical
classes to account for compounds that might
act similarly in the human body or in the
environment. In addition, we prioritized
individual pesticides by weighting the
reported pounds of use by the potential of
the pesticide to cause cancer and the possi-
bility of exposure based on volatilization and
environmental persistence. The geographic
boundaries for which agricultural pesticide
use is reported in California do not match
the census boundaries. We developed GIS
methods to summarize agricultural pesticide
use by census-block group and estimated the
number of children living in the upper 10th
percentile of pesticide use density. Although
we focused on childhood cancer and poten-
tial carcinogens, these methods could be
modified for other health outcomes and
populations.
Methods
PUR data. We used the 1991–1994 PUR
data to coincide with the time period of the
census and cancer incidence data, and because
it represents the ﬁrst few years of full pesticide
use reporting. The PUR database provides the
active ingredient, quantity applied, acres
treated, crop treated, and date and location
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Several studies have suggested an association between childhood cancer and pesticide exposure.
California leads the nation in agricultural pesticide use. A mandatory reporting system for all
agricultural pesticide use in the state provides information on the active ingredient, amount used,
and location. We calculated pesticide use density to quantify agricultural pesticide use in
California block groups for a childhood cancer study. Pesticides with similar toxicologic proper-
ties (probable carcinogens, possible carcinogens, genotoxic compounds, and developmental or
reproductive toxicants) were grouped together for this analysis. To prioritize pesticides, we
weighted pesticide use by the carcinogenic and exposure potential of each compound. The top-
ranking individual pesticides were propargite, methyl bromide, and trifluralin. We used a geo-
graphic information system to calculate pesticide use density in pounds per square mile of total
land area for all United States census-block groups in the state. Most block groups (77%) aver-
aged less than 1 pound per square mile of use for 1991–1994 for pesticides classiﬁed as probable
human carcinogens. However, at the high end of use density (> 90th percentile), there were 493
block groups with more than 569 pounds per square mile. Approximately 170,000 children under
15 years of age were living in these block groups in 1990. The distribution of agricultural pesti-
cide use and number of potentially exposed children suggests that pesticide use density would be
of value for a study of childhood cancer. Key words: agriculture, childhood cancer, ecologic study,
epidemiologic study, exposure assessment, geographic information systems, pesticides, risk assess-
ment. Environ Health Perspect 109:1071–1078 (2001). [Online ________]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1071-1078gunier/abstract.html
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Articlesfor all agricultural pesticide applications. The
locations of pesticide applications are reported
using an identifier that represents a section
within the Public Land Survey System
(PLSS). The PLSS is a nationwide survey that
grids the land in each state into approximately
1-square-mile rectangular units called sec-
tions. Some areas of California were not sur-
veyed when California became a state because
of Spanish land grants. We used a version of
the PLSS with the grid lines extended to cover
any areas that were not surveyed (11). We
checked for and deleted from further analysis
applications with reported section identiﬁers
that did not correspond to a valid section
identiﬁer within the PLSS.
A small percentage of data entry errors
have been reported in the PUR that result in
erroneously large amounts of pounds applied
(12). We developed methods to identify and
correct errors in the quantity of pesticide
applied that could misclassify exposure. We
used the application rate (pounds per acre)
to identify potential reporting errors with
unreasonably high quantities of pesticide
applied. We calculated the mean application
rate for each pesticide using the 1995 PUR
data. We used the 1995 data for quality con-
trol because this was the most recent year
available and had the fewest number of
extremely high application rates. We
assigned each pesticide an estimated maxi-
mum allowable application rate that was at
least 2 standard deviations above its 1995
mean rate. Application rates above the esti-
mated maximum allowable are generally so
large as to be economically unfeasible. An
application in the PUR database was consid-
ered an error if the application rate was
greater than the maximum allowable rate for
that pesticide. We checked these errors in
two counties and found that they were
largely the result of entry errors or illegible
reporting from the growers (13). We recal-
culated the quantity of pesticide applied for
these potentially erroneous applications by
multiplying the acres treated by the maxi-
mum allowable rate.
Pesticide use by groups. We combined
pesticides from the PUR data into four toxi-
cologic groups for our statewide analysis:
probable carcinogens, possible carcinogens,
genotoxic compounds, and reproductive or
developmental toxicants. We identified 73
pesticides for these four groups from all active
ingredients reported to the PUR statewide
from 1991 to 1994 (Table 1). Some individ-
ual pesticides were included in more than one
group. The U.S. Environmental Protection
Agency (EPA) classifies most pesticides
according to their human carcinogenic
potential (10). California banned or severely
restricted the agricultural use of all pesticides
classiﬁed as known human carcinogens (class
A) or probable human carcinogens with lim-
ited human evidence (class B1) before 1991.
For the purposes of this study, we created
one toxicologic group with 19 pesticides
classified as probable human carcinogens
with sufficient evidence in laboratory ani-
mals (class B2). We formed a second group
with 37 compounds categorized as possible
human carcinogens with limited evidence in
animals (class C). 
Some pesticides are not classiﬁed as car-
cinogens but have evidence of other types of
toxicity that may be relevant. Genotoxic
chemicals have demonstrated the ability to
directly damage DNA. Several laboratory tests
are commonly used to assess genetic toxicity,
including gene mutation, chromosome aber-
ration, sister chromatid exchange, and DNA
damage. We chose 27 pesticides with at least
two positive results in genetic toxicity assays
for a third toxicologic group (14,15). Because
many childhood cancer cases occur shortly
after birth and may be related to perinatal
exposures, reproductive and developmental
toxicants were also of interest. We selected 19
pesticides with at least one positive result in
reproductive or developmental studies con-
ducted in laboratory animals to form a ﬁnal
group for analysis (16).
We combined pesticides into four addi-
tional groups based on chemical class
(organochlorides, organophosphates, carba-
mates, and dithiocarbamates). We identiﬁed
chemical classes using a pesticide dictionary
and chemical structure (17). There were 36
pesticides with reported use between 1991 and
1994 in these four classes. Organochloride
insecticides had mostly been replaced by
organophosphates by 1990, so these repre-
sent the smallest and largest groups, respec-
tively. Table 1 provides a list of pesticides in
each chemical class.
Pesticide cancer hazard prioritization.
Although some low-use pesticides may be
highly toxic, for an epidemiologic study a
minimum amount of use is required to pro-
vide enough power to detect a risk.
Therefore, we determined a minimum
annual average use based on the land area of
California, which is approximately 150,000
square miles. We considered average
statewide use greater than one pound per
square mile to be significant, and chose
150,000 pounds as a minimum annual aver-
age statewide use for consideration in this
analysis. Thirty-eight pesticides from the
toxicologic groups met this minimum
annual use.
Children’s Health • Gunier et al.
1072 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health Perspectives
Table 1. Pesticides with reported use in California, 1991–1994, in toxicologic and chemical groups.
Toxicologic and chemical groups Pesticides
Probable carcinogens (class B2)a Alachlor, cacodylic acid, captan, chlordane, chlorothalonil, 
daminozide, 1,3-dichloropropene, iprodione, lindane, mancozeb, 
maneb, metam sodium, orthophenylphenol, oxythioquinox, 
propargite, propoxur, pentachlorophenol, propyzamide, 
vinclozolin
Possible carcinogens (class C)b Acephate, acrolein, amitraz, atrazine, benomyl, bifenthrin, 
bromacil, bromoxynil, carbaryl, chlorthal-dimethyl, cyanazine, 
cypermethrin, dichlobenil, dichlorvos, dicloﬂop-methyl, dicofol, 
dimethoate, ethalﬂuralin, fosetyl-al, hydrogen cyanamide, 
imazalil, linuron, methidathion, metolachlor, molinate, 
norﬂurazon, oryzalin, oxadiazon, oxyﬂuorfen, pendimethalin, 
permethrin, phosmet, phosphamidon, piperonyl butoxide, 
simazine, triadimefon, triﬂuralin
Genotoxic compoundsc 2,4-Diethylamine, acephate, alachlor, aldicarb, atrazine, 
benomyl, captan, carbaryl, carbofuran, chlordane, 
chloropicrin, chlorothalonil, chlorpyrifos, diazinon, 
1,3-dichloropropene, diquat dibromide, malathion, 
metam sodium, methyl bromide, methyl parathion, mevinphos,
orthophenylphenol, oxydemeton, methyl, paraquat dichloride, 
pentachlorophenol, triﬂuralin, ziram
Developmental or reproductive toxicantsd 2,4-Diethylamine, benomyl, bromoxynil, carbofuran, cyanazine, 
diazinon, diquat dibromide, s-ethyl dipropylthiocarbamate 
(EPTC), mancozeb, maneb, metam sodium, methyl bromide, 
methyl parathion, oxyﬂuorfen, propargite, s,s,s-tributyl, 
triadimefon, vinclozolin
Organochloridese Dicofol, endosulfan, lindane
Organophosphatese Acephate, azinphos-methyl, chlorpyrifos, diazinon, dimethoate, 
disulfoton, ethoprop, fonofos, malathion, methamidophos, 
methidathion, methyl parathion, mevinphos, naled, 
oxydemeton-methyl, parathion, phorate, phosmet, profenofos
Carbamatese Aldicarb, benomyl, carbaryl, carbofuran, frometanate, 
methomyl, pebulate, propoxur
Dithiocarbamatese Mancozeb, maneb, metam sodium, thiram, zineb, ziram
aProbable human carcinogens with sufﬁcient evidence in laboratory animals and inadequate or no evidence in humans
(10). bPossible human carcinogens with limited evidence in laboratory animals (10). cPositive in two or more laboratory
assays (14,15). dPositive in one or more developmental or reproductive studies in laboratory animals (16). eChemical
groups were identiﬁed from Meister (17).To prioritize individual pesticides for
analysis, we developed a hazard weighting
system based on two measures of carcino-
genic potential and two measures of expo-
sure potential. We assigned weights for each
of these attributes to the highest-use pesti-
cides from the toxicologic groups. The U.S.
EPA cancer class was used to assign to each
pesticide a weight from 1 through 10 based
on the evidence that it is a carcinogen (10).
Since there were no class A or class B1 car-
cinogens with geographically referenced use
during our study period, the highest score
assigned for cancer class was 7. Cancer slope
factors, which estimate cancer potency from
the dose–response relationship, have been
calculated for all probable (class B2) and
most possible (class C) carcinogens (10). As
a second measure of carcinogenic potential,
we assigned each pesticide a weight from 1
to 10 based on its cancer potency. If data
were not available, a default weight of 1 was
assigned to the pesticide for that attribute.
Table 2 provides a key to the weights for
each attribute.
We used volatilization ﬂux rate and ﬁeld
half-life as measures of physical characteris-
tics that could be associated with exposure
potential. Volatilization flux estimates the
tendency of a pesticide to move into the air
after application and is correlated with the
downwind concentration in air (18). We
estimated the volatilization ﬂux for each pes-
ticide using the vapor pressure, water solu-
bility, and soil absorption coefficient
(19,20). Pesticides were assigned a weight
from 1 through 10 based on the calculated
volatilization ﬂux. We used the ﬁeld dissipa-
tion half-life—a measure of the overall rate
of disappearance of a pesticide from treated
fields—as an indicator of persistence (20).
Pesticides were assigned a weight from 1
through 5 based on persistence. The range
used for persistence weight was half that
used for volatilization flux weight because
the dose received by children from ingestion
of household dust is estimated to be about
half the dose from inhalation for most pesti-
cides (21,22). Moreover, we considered
volatilization and secondary drift a necessary
precursor for most potential exposures to
children in nearby communities. 
We calculated the cancer hazard factor for
each pesticide by multiplying the weights for
each attribute and then normalizing to make
the highest possible score 10. The range of
potential cancer hazard factors covers almost
four orders of magnitude (0.002 to 10):
Cancer Hazard Factor = 
(Class × Potency × Flux × Persistence)/500.
We calculated hazard-adjusted pesticide use
by multiplying the pounds applied by the cor-
responding cancer hazard factor. Individual
pesticides were ranked by hazard adjusted use:
Hazard Adjusted Pesticide Use =
Cancer Hazard Factor × Pounds of Use.
Block-group exposure assessment. We used
the 1991–1994 PUR data to calculate the
annual average pesticide use in pounds for
each square-mile section (23). We used the
annual average because our focus was on can-
cer and chronic exposure. We used a GIS to
determine the spatial relationship between
sections and census-block groups. In 1990,
California block groups had a median land
area of 0.2 square miles and a huge range,
from 0.001 to 3,610 square miles (24).
Pesticide use was allocated from the section to
each corresponding block group on the basis
of percent area of the section in that block
group. We calculated pesticide use density in
pounds per square mile of census-block group
by summing the average pounds applied in all
relevant sections and then dividing by the
block-group area. The median, 90th per-
centile, and maximum block-group pesticide
use density were determined for each pesticide
and pesticide group. We used 1990 census
data to obtain the number of children under
15 years of age by block group. The number
of children living in block groups with pesti-
cide use density above the 90th percentile was
calculated for each pesticide group and the
highest cancer hazard ranking pesticides. 
Results
PUR data. For all pesticides reported in the
PUR, the annual average agricultural pesti-
cide use for 1991–1994 was greater than
169 million pounds. Correcting for applica-
tion rates above the estimated maximum
allowable rate reduced the average by 5% to
160 million pounds. Application rate errors
were often an order of magnitude greater
than the average rate, indicating data entry
errors. Location errors further reduced
statewide annual average pesticide use by
another million pounds or less than 1%.
The most frequent location error involved
sections that were not within the reported
county. Location errors occurred in more
than 1,000 sections (0.5%) and affected a
smaller number of pounds than high appli-
cation rate errors. Given the size of the PUR
database, we considered the observed error
rate of approximately 6% of reported
pounds relatively low.
Pesticide use by groups. The statewide
average annual use for the pesticide groups is
shown in Table 3. The probable and possi-
ble carcinogen groups each had about 10
million pounds per year of reported use, and
the genotoxic and developmental/reproduc-
tive toxicant groups were both greater than
30 million pounds per year. Among the
chemical classes, organochloride insecticides
had the least use with less than 1 million
pounds per year, and the dithiocarbamate
fungicides had the most use with greater
than 10 million pounds per year.
To evaluate changes in pesticide use
from 1991 to 1994, we graphed annual
reported use for probable carcinogens, possi-
ble carcinogens, methyl bromide, and
metam sodium (Figure 1). We chose methyl
bromide and metam sodium because these
were the highest use pesticides from the four
toxicologic groups. The use of probable car-
cinogens (class B) increased from 8 to 16
million pounds from 1991 to 1994. Most of
that increase was caused by metam sodium
use, which grew from approximately 5 mil-
lion to 11 million pounds. The largest
increase occurred between 1991 and 1992,
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Table 2. Pesticide cancer hazard weights by attribute.
Cancer Cancer potencya Volatilization Field half-lifec
Weight classa (mg/kg/day) ﬂuxb,c (days)
10 A > 1 > 10–1 —
8B 1>  0.1–1 >10–3–10–1 —
7B 2 — — —
5C > 0.01–0.1 >10–5–10–3 > 100
4— — —76–100
3G   or D/Rd 0.001–0.01 10–7–10–5 51–75
2— —— 26–50
1N A<  0.001 or NA < 10–7 or NA < 25 or NA
NA, not available. 
aFrom U.S. EPA (10). bFlux rate = vapor pressure/(water solubility × soil absorption coefﬁcient) from Glotfelty et al. (19).
cVapor pressure, water solubility, soil absorption, and ﬁeld half-life from U.S. Department of Agriculture (20). dGenotoxic
or developmental/reproductive toxicant (16). 
Table 3. Average annual pesticide use in
California from 1991 to 1994 for pesticide groups.a
Average
Pesticide group poundsb
Class B carcinogens 12,643,173
Class C carcinogens 9,972,335
Genotoxic compounds 36,445,168
Developmental/reproductive toxicants 31,472,459
Organochlorides 903,550
Organophosphates 6,687,806
Carbamates 2,326,545
Dithiocarbamates 10,884,652
aIndividual pesticides can be in more than one group.
bPUR data corrected for erroneously high application
rates and includes only valid geographic locations.which may reﬂect increased awareness of the
legal mandate of reporting (12). This time
period also coincides with severe restrictions
on the use of 1,3-dichloropropene (Telone),
a fumigant that was largely replaced by
metam sodium. The use of possible carcino-
gens (class C) and methyl bromide remained
relatively constant. 
Pesticide cancer hazard prioritization.
The calculated cancer hazard factors for indi-
vidual pesticides (Table 4) ranged over more
than two orders of magnitude, although
most pesticides had hazard factors between
0.1 and 1.0. For pesticides classiﬁed as prob-
able or possible carcinogens, the cancer haz-
ard weights are greater than the exposure
potential weights because of the lesser
weighting for persistence. The cancer hazard
factors for pesticides from the other toxico-
logic groups were more influenced by their
exposure potential. 
The relative ranking of pesticide use
changed significantly when pounds were
adjusted by the cancer hazard factors. The
top pesticides in the state ranked by hazard-
adjusted use (Table 5) were propargite,
methyl bromide, and trifluralin. The top
pesticides from the toxicologic groups
ranked by pounds alone were methyl bro-
mide, metam sodium, and chlorpyrifos.
Propargite had a larger cancer hazard factor
than some high-use pesticides, such as chlor-
pyrifos, producing a much higher ranking by
hazard-adjusted use.
Block-group exposure assessment. We cal-
culated the statewide distribution of pesticide
use density among block groups with more
than 1 pound per square mile of use for a
given pesticide group or individual pesticide
(Table 6). Very low pesticide use densities
may have been the result of location errors
within counties that could not be eliminated.
Therefore, we considered block groups with
use densities less than 1 pound per square
mile to have little potential exposure. There
were 3,000–9,000 census-block groups in the
state with more than 1 pound per square
mile of pesticide use for each pesticide group.
The median densities were generally greater
than 10 pounds per square mile. The distrib-
utions were not normal with order-of-magni-
tude increases between the median, 90th
percentile, and maximum use densities. The
90th percentile of use density was around
500 pounds per square mile for the two car-
cinogen groups and greater than 1,500
pounds per square mile for the genotoxic and
developmental or reproductive toxicant
groups. Among the chemical classes,
organochlorides had the lowest use density
and dithiocarbamates had the highest, with a
median of 30 pounds per square mile.
For individual pesticides, the number of
block groups with more than 1 pound per
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Figure 1. Annual agricultural pesticide use in California from 1991 to 1994. Metam sodium is included
among Class B carcinogens. PUR data corrected for erroneously high application rates and includes only
valid geographic locations.
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Table 4. Cancer hazard weights and factors for pesticides in toxicologic groups with annual use > 150,000
pounds per year.
Cancer Cancer Volatilization Field Cancer
class potency ﬂux half-life hazard
Pesticide weight weight weight weight factora
Probable carcinogens
Captan 7 3 5 1 0.210
Chlorothalonil 7 3 8 2 0.672
Iprodione 7 5 5 1 0.350
Mancozeb 7 5 1 2 0.140
Maneb 7 5 1 2 0.140
Metam sodium 7 8 1 1 0.112
Propargite 7 5 5 4 1.400
Possible carcinogens
Acephate 5 5 3 1 0.150
Carbaryl 5 5 5 1 0.250
Chlorthal-dimethyl 5 3 8 3 0.720
Cyanazine 5 10 3 2 0.600
Dicofol 5 8 5 3 1.200
Dimethoate 5 1b 51 0.050
Fosetyl-al 5 1b 11 0.010
Methidathion 5 1b 81 0.080
Metolachlor 5 1b 85 0.400
Molinate 5 8 10 1 0.800
Norﬂurazon 5 1b 55 0.250
Oryzalin 5 8 5 1 0.400
Oxyﬂuorfen 5 8 5 2 0.800
Pendimethalin 5 1b 85 0.400
Permethrin 5 5 5 2 0.500
Phosmet 5 1b 51 0.050
Simazine 5 8 5 4 1.600
Triﬂuralin 5 3 10 4 1.200
Genotoxic or developmental/
reproductive toxicants
2,4-Diethylamine 3 1b 52 0.060
Aldicarb 3 1b 52 0.060
Carbofuran 3 1b 52 0.060
Chloropicrin 3 1b 10 1 0.060
Chlorpyrifos 3 1b 82 0.096
Diazinon 3 1b 51 0.030
Ethyl dipropylthiocarbamate 3 1b 10 1 0.060
Malathion 3 1b 51 0.030
Methyl bromide 3 1b 10 2 0.120
Mevinphos 3 1b 51 0.030
Paraquat dichloride 3 1b 15 0.030
S,S,S-tributyl 3 1b 52 0.060
Ziram 3 1b 52 0.060
aCancer hazard factor = (evidence weight × potency weight × ﬂux weight × persistence weight)/500. bNot available. square mile of use varied tremendously from
194 for molinate to > 3,400 for methyl bro-
mide. The 90th percentile of use density was
greater than 100 pounds per square mile for
most individual pesticides. The soil fumigants
methyl bromide and metam sodium had
much higher use densities than the other indi-
vidual pesticides with 90th percentile values
greater than 1,500 pounds per square mile.
To illustrate the methods used to calculate
block-group pesticide use density, an example
is provided from Fresno, California. Figure
2A shows probable carcinogenic pesticide use
in pounds by section and Figure 2B shows the
resulting use density in pounds per square
mile for census-block groups in this area. The
block-group pesticide use density essentially
follows the section-level pesticide use. Figure
2B also illustrates that larger, rural block
groups tend to have the highest pesticide use
density and smaller, urban block groups the
lowest. In high-use rural areas, census-
block–group mapping is less geographically
speciﬁc than mapping by section because of
the large area of these block groups.
We mapped the geographic distribution
of pesticide use density by block group using
the percentiles of the statewide distribution
for all probable carcinogens (Figure 3) and
for propargite, which was the highest-rank-
ing individual compound (Figure 4). For
probable carcinogens, the highest use areas
were in the San Joaquin, Sacramento,
Salinas, and Imperial Valleys. This corre-
sponds well with the heaviest agricultural
counties in the state based on farm revenues
(25). Propargite use was not as geographi-
cally widespread, and the high-use density
area was primarily the San Joaquin Valley.
More than 6.6 million children under 15
years of age lived in California in 1990. The
number of children living in block groups
above the 90th percentile of use density
varied considerably among the pesticide
groups and individual pesticides (Table 6).
Developmental or reproductive toxicants had
the most children with nearly 267,000, and
molinate had the least number of children
with just over 3,300. Organophosphates and
organochlorides had about 200,000 and
60,000 children living in these high-use
block groups, respectively. The variation in
the number of children living in these block
groups demonstrates that different popula-
tions were potentially exposed for each group
and individual pesticide.
Discussion
We developed methods to quantify agricul-
tural pesticide use density for census-block
groups using the PUR data and a GIS. In
California, there was a wide range of pesticide
use density (Table 6). Most block groups in
the state (57–99%) averaged less than 1
pound per square mile of average annual use
(1991–1994) for pesticide groups and indi-
vidual pesticides. However, at the high end of
the distribution (> 90th percentile), pesticide
use density often exceeded 1,000 pounds per
square mile. More than 100,000 children
lived in these high-use density block groups
for most pesticide groups and about 50,000
children for individual pesticides.
The interrelationship of agricultural pes-
ticide use, individual environmental expo-
sure, and health effects has not been well
deﬁned. The limited environmental and bio-
logic monitoring data available suggest that
residents may be exposed to pesticides
applied agriculturally through multiple
routes. Researchers have detected pesticides
in ambient air near agricultural fields in
California and throughout the United States
(26–28). Dermal contact and ingestion of
household dust are important exposure
routes for young children (29–33). Well
monitoring has also identified pesticides in
the groundwater of agricultural communities
in the state (34). Biologic monitoring of pes-
ticide levels in children indicated an inverse
relationship with distance from treated
orchards (35,36).
These ﬁndings suggest that the hundreds
of thousands of children living in areas with
high agricultural pesticide use have a greater
potential for exposure than their more urban
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Table 5. Highest-ranking pesticides based on hazard-adjusted use, 1991–1994.
Cancer Corrected Hazard-
Pesticide hazard factor poundsa adjusted useb
Propargite 1.400 1,600,982 2,241,375
Methyl bromide 0.120 16,901,451 2,028,174
Triﬂuralin 1.200 1,230,218 1,476,262
Simazine 1.600 869,962 1,391,939
Molinate 0.800 1,380,424 1,104,339
Metam sodium 0.112 8,300,569 929,664
Dicofol 1.200 554,077 664,892
Chlorothalonil 0.672 786,572 528,576
Chlorthal-dimethyl 0.720 642,891 462,882
Oxyﬂuorfen 0.800 334,325 267,460
Oryzalin 0.400 667,445 266,978
Cyanazine 0.600 411,331 246,799
Chlorpyrifos 0.096 2,429,610 233,243
Carbaryl 0.250 820,487 205,122
Iprodione 0.350 408,562 142,997
Chloropicrin 0.060 2,364,831 141,890
Pendimethalin 0.400 284,845 113,938
Permethrin 0.500 201,795 100,898
Ziram 0.060 1,590,812 95,449
Captan 0.210 417,612 87,699
aPUR data corrected for erroneously high application rates. bHazard adjusted use = corrected pounds × cancer hazard
factor.
Table 6. Distribution of annual average agricultural pesticide-use density in California census-block
groups for toxicologic groups, chemical groups, and high-hazard individual pesticides.a
90th Children
Block Median percentile Max (< 15 years)
groupsb (lbs/mi2) (lbs/mi2) (lbs/mi2) in 90th percentilec
Toxicologic groups
Class B 4,932 31 569 14,935 169,884
Class C 6,218 23 445 5,043 198,375
Genotoxic 7,505 48 1,844 70,670 261,333
Developmental/reproductive 6,647 45 1,789 48,784 266,960
Chemical groups
Organochlorides 3,881 9 86 589 60,909
Organophosphates 9,268 18 349 7,129 204,144
Carbamates 6,755 14 141 1,706 139,316
Dithiocarbamates 3,216 30 764 14,931 109,474
Individual pesticides
Propargite 2,144 21 172 926 61,892
Methyl bromide 3,431 163 2,668 45,185 127,562
Triﬂuralin 1,287 14 118 784 35,983
Simazine 2,109 15 112 582 64,462
Molinate 194 49 696 1,433 3,334
Metam sodium 1,072 86 1,503 14,480 42,145
Dicofol 1,342 7 72 352 44,902
Chlorothalonil 2,359 13 109 2,537 84,740
aCalculated from census-block groups with use density > 1 lb/mi2 for that pesticide. bNumber of block groups with > 1
lb/mi2 use density for that pesticide; total block groups used in this analysis were 21,443. cNumber of children under 15
years of age living in census-block groups above the 90th percentile of pesticide-use density. counterparts. Population growth in California
has led to the development of suburban areas
adjacent to fields or on former farmland,
increasing the potentially exposed population.
We consider pesticide use density an indicator
for a wide range of potential exposure path-
ways, including inhalation of ambient air, soil
drift and persistence in household dust,
potential groundwater contamination,
parental occupational “take home” exposures,
playing in ﬁelds, and eating produce directly
from treated ﬁelds.
Hazard-weighted pesticide use created
different priorities for assessing individual
compounds (Table 5). Our focus was on
ranking carcinogens for a childhood cancer
study, but these hazard-weighting methods
could be modiﬁed for other health outcomes
of interest (37,38). A hazard scoring system
used by the Department of Pesticide
Regulation to evaluate pesticides as toxic air
contaminants also ranked propargite,
simazine, chlorothalonil, molinate, metam
sodium, cyanazine, and chlorpyrifos among
the top 20 compounds (39). Methyl bro-
mide, trifluralin, carbaryl, and captan are
already classiﬁed as toxic air contaminants in
California pursuant to section 14021(b) of
the Food and Agricultural Code (39).
Nonoccupational exposures to molinate are
suggested to exceed safety margins (40).
Methyl bromide, chlorothalonil, and moli-
nate have been detected in ambient air of
agricultural communities in California (27).
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Figure 2. Annual average class B pesticide use, in pounds per square mile, around Fresno, California, as
reported to (A) a section of the public land survey system, and (B) a census-block group, 1991–1994.
Figure 3. Annual average class B pesticide use density in California census-
block groups, 1991–1994, in pounds per square mile.
Figure 4. Annual average propargite use density in California census-block
groups, 1991–1994, in pounds per square mile.
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0 100    miles 50 50There are some notable limitations to
weighting pesticide use by cancer hazard.
Pesticides that have not been toxicologically
tested for carcinogenicity, genotoxicity, or
developmental/reproductive toxicity were
not included in our prioritization. Eleven
pesticides with more than 1 million pounds
per year of use in California had insuffi-
cient toxicologic and environmental data
for hazard weighting (sulfur, petroleum oil,
sodium chlorate, copper hydroxide, mineral
oil, copper sulfate, chloropicrin, petroleum
distillates, sulfuryl fluoride, calcium
hydroxide, and diuron). Furthermore, the
weighting of each hazard attribute and
exposure relative to carcinogenicity may not
reflect true environmental and biologic
activity. Animal cancer potency may not
accurately reflect the potency for humans,
although the evidence is fairly convincing
that human carcinogens are carcinogenic in
rodents (41). Some pesticides degrade into
compounds that have more or less carcino-
genic or exposure potential than the origi-
nal parent compound. For example, the
actual fumigant action of metam sodium (a
probable carcinogen) comes from a reaction
product called methyl isothiocyanate,
which is not thought to be a carcinogen.
Information on the environmental break-
down products of pesticide active ingredi-
ents was not included in our prioritization
system because data were not available for
most pesticides.
The PUR system has some limitations
that are potentially problematic for epidemi-
ologic studies. Information on residential
pesticide use in the home and garden is not
collected. Agricultural pesticide use is
reported to a square-mile section, but air
monitoring data from application sites
suggest that pesticide concentrations may
decrease significantly within a mile
(18,42–44). Nonagricultural pesticide appli-
cations, including structural fumigations and
landscaping uses on golf courses and along
highways, are reported only at the county
level in the PUR data. Improved spatial
resolution for both agricultural and struc-
tural/landscaping applications would repre-
sent a significant refinement to the PUR
system for use in health studies. The PUR
system is legally mandated, but pesticide use
is self-reported, and underreporting has not
been evaluated. Information on the type and
amount of inert ingredients applied is not
provided. Many of the solvents used in pesti-
cide formulations also have toxicologic
effects of concern (45,46). Despite these
limitations, the PUR system is still probably
the most comprehensive agricultural pesti-
cide use database in the world (12).
We calculated the annual average pesti-
cide use density to examine chronic exposure.
However, pesticide applications are fre-
quently seasonal, and many are applied only
once per year or in response to speciﬁc pest
infestations. If the PUR data are to be used
for studies of other health outcomes, the rele-
vant time period should be considered.
Because of the geographic resolution of the
PUR data, we assumed that pesticide use was
distributed evenly within a square-mile sec-
tion. Pesticide use density represents pesticide
use averaged over the entire land area of the
block group, but all applications could have
occurred in a single section. 
The PUR data represent an extremely
valuable resource for conducting health stud-
ies. Residents are unlikely to have knowledge
about pesticide use on nearby fields, unlike
home and garden use. The measures pre-
sented here are based on independent report-
ing and do not rely on recall by study
participants. The PUR data also allowed for
evaluation of speciﬁc pesticide active ingredi-
ents and the combination of pesticides with
similar chemical or toxicologic properties.
For other health studies, pesticide groups
should be tailored to the health outcomes or
exposure pathways of interest. A GIS was
essential in conducting this analysis because
it allowed for the spatial overlay of agricul-
tural pesticide use and census-block groups. 
The heavy use of potentially toxic agri-
cultural pesticides in some areas of California
warrants further exposure and epidemiologic
investigation. Environmental and biologic
monitoring is needed to determine the rela-
tionship between agricultural pesticide use
and individual exposure. Additional toxico-
logic data are also desirable for many high-
use pesticides. The range of values reported
here for census-block group pesticide use
density are suitable for a statewide epidemio-
logic study of childhood cancer. The number
of children living in both high and low pesti-
cide-use density areas is sufﬁcient to allow for
statistical testing between these groups (47).
The pesticide-use density methods presented
here can be used, with some minor modiﬁca-
tions, in other health studies conducted at
the block-group level in California or in
other states if pesticide use reporting systems
are developed. 
REFERENCES AND NOTES
1.  Daniels JL, Olshan AF, Savitz DA. Pesticides and child-
hood cancers. Environ Health Perspect 105:1068–1077
(1997).
2.  Zahm SH, Ward MH. Pesticides and childhood cancer.
Environ Health Perspect 106(suppl 3):893–908 (1998).
3.  Ward MH, Nuckols JR, Weigel SJ, Maxwell SK, Cantor
KP, Miller RS. Identifying populations potentially
exposed to agricultural pesticides using remote sensing
and a geographic information system. Environ Health
Perspect 108:5–12 (2000).
4.  Xiang H, Nuckols JR, Stallones L. A geographic information
assessment of birth weight and crop production patterns
around mother’s residence. Environ Res 82:160–167 (2000).
5.  Kettles MA, Browning SR, Prince TS, Horstman SW.
Triazine herbicide exposure and breast cancer inci-
dence: an ecologic study of Kentucky counties. Environ
Health Perspect 105:1222–1227 (1997).
6.  Mills PK. Correlation analysis of pesticide use data and
cancer incidence rates in California counties. Arch
Environ Health 53(6):410–413 (1998).
7.  Schreinemachers DM, Creason JP, Garry VF. Cancer
mortality in agricultural regions of Minnesota. Environ
Health Perspect 107:205–211 (1999).
8.  Aspelin AL. Pesticides industry sales and usage: 1992
and 1993 market estimates. 733-K-94-001. Washington,
DC:U. S. Environmental Protection Agency, 1994.
9. California Department of Pesticide Regulation.
Pesticide Use Reporting: An Overview of California’s
Unique Full Reporting System. Sacramento: California
Department of Pesticide Regulation, 2000. Available:
http://www.cdpr.ca.gov/docs/pur/purmain.htm [cited 22
August 2001].
10. U.S.  Environmental Protection Agency. Reference Dose
Tracking Report. Available: http://nptn.orst.edu/track-
ing.htm [cited 8 March 2001].
11.  California Department of Pesticide Regulation. Public
Land Survey System. Data File. Sacramento,
CA:California Department of Pesticide Regulation, 1995.
12. Wilhoit L, Supkoff D, Steggall J, Braun A, Goodman C,
Hobza B, Todd B, Lee M. An Analysis of Pesticide Use in
California, 1991–1995. PM 98–01. Sacramento, CA:
California Department of Pesticide Regulation, 1998.
13.  English PB, Harnly M, Scalf R, Seidel S, Sullivan M, Wolff
C. Analytical Procedures, Methodologies, and Field
Protocols to Monitor and Determine Environmental
Contaminants: Pesticide Use in California, U.S./Mexico
Border Region. Oakland, CA:Impact Assessment, Inc.
and California Department of Health Services, 1998.
14.  Gold, Lois S, Zeiger E. Handbook of Carcinogenic Potency
and Genotoxicity Databases. New York:CRC Press, 1997.
15.  Genetic Activity Proﬁle [Computer Program]. Version 4.08.
Washington, DC:U.S.Environmental Protection Agency,
1997.
16.  California Department of Pesticide Regulation, Medical
Toxicology Branch. Summaries of Toxicology Data.
Sacramento, CA:California Department of Pesticide
Regulation, 1997.
17.  Meister RT. Farm Chemicals Handbook. Willoughby,
OH:Meister Publishing Company, 1992.
18.  Woodrow JE, Seiber JN, Baker LW. Correlation tech-
niques for estimating pesticide volatilization flux and
downwind concentrations. Environ Sci Technol
31(2):523–529 (1997).
19.  Glotfelty DE, Leech MM, Jersey J, Taylor AW.
Volatilization and Wind Erosion of Soil Surface Applied
Atrazine, Simazine, Alachlor and Toxaphene. J Agric
Food Chem 37:546–551 (1989).
20. U.  S.  Department of Agriculture. Pesticide Properties
Database. Available: http://wizard.arsusda.gov/
acsl/ppdb3.html [cited 9 March 2001].
21.  Lewis RG, Fortmann RC, Camann DE. Evaluation of meth-
ods for monitoring the potential exposure of small chil-
dren to pesticides in the residential environment. Arch
Environ Contam Toxicol 26:37–46 (1994).
22. Whitmore RW, Immerman FW, Camann DE, Bond AE,
Lewis RG, Schaum JL. Non-occupational exposures to
pesticides for residents of two U.S. Cities. Arch Environ
Contam Toxicol 26:47–59 (1994).
23.  California Department of Pesticide Regulation,
Environmental Monitoring and Pest Management
Branch. Pesticide Use Reporting Data 1991–1994. Data
File. Sacramento, CA:California Department of Pesticide
Regulation, 1996.
24.  U.S. Bureau of the Census. TIGER Line Files. Data File.
Washington, DC:U. S. Bureau of the Census, 1995.
25.  U.S. Department of Agriculture. Census of Agriculture.
Available: http://www.nass.usda.gov/census/census92
[cited 31 May 1999].
26. Majewski  MS, Capel PD. Pesticides in the Atmosphere.
94-506. Sacramento, CA:U.S. Geological Survey, 1995.
27.  Baker LW, Fitzell DL, Seiber JN, Parker TR, Shibamoto T,
Poore MW, Longley KE, Tomlin RP, Propper R, Duncan
DW. Ambient concentrations of pesticides in California.
Environ Sci Technol 30:1365–1368 (1996).
278. Hawthorne SB, Miller DJ, Louie PK, Butler RD, Mayer
GG. Atmospheric pollutants and prace gases. J Environ
Qual 25:594–600 (1996).
Children’s Health • Agricultural pesticide use in California
Environmental Health Perspectives • VOLUME 109 | NUMBER 10 | October 2001 107729.  Cohen Hubal EA, Sheldon LS, Burke JM, McCurdy TR,
Berry MR. Children’s exposure assessment: a review of
factors influencing children’s exposure, and the data
available to characterize that exposure. Environ Health
Perspect 108:475–486 (2000).
30.  Zartarian VG, Özkaynak H, Burke JM, Zufall MJ, Rigas
ML, Furtaw EJ Jr. A modeling framework for estimating
children’s residential exposure and dose to chlorpyrifos
via dermal residue contact and nondietary ingestion.
Environ Health Perspect 108:505–514 (2000).
31.  Quakenboss JJ, Pellizzari ED, Shubat P, Whitmore RW,
Adgate JL, Thomas KW. Design strategy for assessing
multi-pathway exposure for children: the Minnesota
Children’s Pesticide Exposure Study. J Expo Anal Environ
Epidemiol 10:145–158 (2000).
32.  Simcox NJ, Fenske RA, Wolz SA, Lee I-C, Kalman DA.
Pesticides in household dust and soil: exposure path-
ways for children of agricultural families. Environ Health
Perspect 103:1126–1134 (1995).
33.  Bradman MA, Harnly ME, Draper W, Seidel S, Teran S,
Wakeham D, Neutra R. Pesticide exposures to children
from California’s Central Valley: results of a pilot study. J
Expo Anal Environ Epidemiol 7(2):217–234 (1997).
34.  Spurlock F, Burrow K, Dubrovsky N. Chloroﬂuorocarbon
dating of herbicide-containing well waters in Fresno and
Tulare Counties, California. J Environ Qual 29:474–483
(2000).
35.  Loewenherz C, Fenske RA, Simcox NJ, Bellamy G,
Kalman D. Biological monitoring of organophosphorus
pesticide exposure among children of agricultural work-
ers in central Washington State. Environ Health
Perspect 105:1344–1353 (1997).
36.  Fenske RA, Kissel JC, Lu C, Kalman DA, Simcox NJ.
Biologically based pesticide dose estimates for children
in an agricultural community. Environ Health Perspect
108:515–520 (2000).
37.  Barnard C, Daberkow S, Padgitt M, Smith ME, Uri ND.
Alternative measures of pesticide use. Sci Total Environ
203:229–244 (1997).
38.  Pease WS, Liebman J, Landy D, Albright D. Pesticide Use
in California: Strategies for Reducing Environmental Health
Impacts. Berkeley, CA:California Policy Seminar, 1996.
39.  Kelley K, Reed N. Pesticides for Evaluation as Candidate
Toxic Air Contaminants. Sacramento, CA:California
Department of Pesticide Regulation, 1996.
40.  Cochran R, Formoli T, Pfeifer K, Aldous C. Characterization
of risks associated with the use of molinate. Regul Toxicol
Pharmacol 25(2):146–157 (1997).
41.  Rall DP. Can laboratory animal carcinogenicity studies
predict cancer in exposed children? Environ Health
Perspect 103(suppl 6):173–175 (1995).
42.  Chester G, Ward RJ. Occupational exposure and drift
hazard during aerial application of paraquat to cotton.
Arch Environ Contam Toxicol 13:551–563 (1984).
43.  Seiber J, McChesney M, Woodrow J. Airborne residues
resulting from use of methyl parathion, molinate and
thiobencarb on rice in the Sacramento Valley, California.
Environ Toxicol Chem 8:577–588 (1989).
44.  van den Berg F. Measured and computed concentra-
tions of methyl isothiocyanate in the air around fumi-
gated ﬁelds. Atmos Environ 27A(1):63–71 (1993).
45.  Axelson O, Hogsed C. The health effects of solvents. In:
Occupational Medicine (Zenz C, Dickerson OB, Horvath
EP, eds). 3rd ed. New York:Mosby, 1994;764–775.
46.  Kukull WA, Larson EB, Bowen JD, McCormick WC, Teri
L, Pfanschmidt ML, Thompson JD, O'Meara ES, Brenner
DE, van Belle G. Solvent exposure as a risk factor for
Alzheimer’s disease: a case-control study. Am J
Epidemiol 141:1059–1071 (1995). 
47.  Reynolds P, Von Behren J, Gunier R, Hertz A, Harnly M.
Childhood cancer and agricultural pesticide use: an ecolog-
ical study in California. Am J Epidemiol 151(11):S–80 (2000).
Children’s Health • Gunier et al.
1078 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health PerspectivesEnvironmental Health Perspectives • VOLUME 109 | NUMBER 10 | October 2001 1079
Iron Deﬁciency Associated with Higher Blood Lead in Children Living in
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Childhood lead exposure is one of the most
signiﬁcant environmental health threats that
affect children(1–3). Adverse effects of lead
include cognitive deficits, neurotoxicity,
behavior disorders, slowed growth, reduced
heme synthesis, and impaired hearing
(1,3–9). Although health and regulatory pro-
grams designed to reduce lead exposure are
proving successful (10), many young children
in the United States still have blood lead lev-
els > 10 µg/dL, the Centers for Disease
Control and Prevention (CDC) level of con-
cern (1,10–12). The prevalence of elevated
blood lead levels among minority, low-
income inner-city children remains several
times the national average (10–12). These
same children are also more likely than others
to be iron deﬁcient, a condition that affects
up to 6% of young children nationally
(13–16), with insufﬁcient iron intake in up to
one-third of children in some communities
(17).
It is biologically plausible that iron deﬁ-
ciency could lead to higher lead levels in
children. Controlled animal studies consis-
tently demonstrate higher lead levels in
iron-deficient animals than in iron-replete
controls (18–23). The mechanism for
enhanced absorption is likely to be substitu-
tion of Fe+2 with Pb+2 and increased active
transport into the body (19,22,24,25).
Similarly, it is possible that Pb+2 may occupy
vacant Fe+2 sites in the hematopoeitic system,
thereby reducing lead excretion. Clinical
studies of chelation therapy suggest that iron-
deficient children may retain more lead in
their bodies (26,27). It is also possible that
iron deﬁciency modiﬁes behavior, increasing
pica or hand-to-mouth behavior in children
and thereby increasing ingestion exposures to
lead in their environment (28,29).
Despite the consistency of results in ani-
mal studies, the findings in human studies
are less definitive. Experimental studies of
iron deficiency and lead uptake in human
adults are not consistent (19,30–33). Several
epidemiologic studies in children support a
correlation between iron deficiency and
higher blood lead (15,34–36). Other studies
have found no relationship between iron
intake or low iron stores and blood lead in
children (37,38); however, these studies
either used diet to measure iron status (38) or
studied older children (10–18 years) and did
not control for age (37), which is an impor-
tant factor affecting lead absorption (39).
To date, no studies examining iron status
and blood lead in children account for envi-
ronmental lead contamination, and thus the
source of a child’s exposure. Iron deﬁciency
may be directly associated with lead uptake
and systemic retention, or lead and iron deﬁ-
ciency may be independent factors, both of
which may be related to another factor, such
as poverty. Because the sociodemographic
characteristics of children who are likely to be
iron deﬁcient also puts them at higher risk of
lead exposure (10), it is not certain to what
extent iron deficiency directly affects blood
lead levels. Nor have any studies attempted to
quantify the level of protection that sufﬁcient
iron status may confer on a child. In this
study we evaluate whether iron deﬁciency is
related to increased blood lead in children liv-
ing in contaminated environments; we also
account for major covariates, including
socioeconomic status and child age.
Methods
Selection of households and participants.
Participants in the study were part of an epi-
demiologic study of childhood lead exposure
in Sacramento, California, one of three
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The evidence that iron deﬁciency increases lead child exposure is based primarily on animal data
and limited human studies, and some of this evidence is contradictory. No studies of iron status
and blood lead levels in children have accounted for environmental lead contamination and,
therefore, the source of their exposure. Thus, no studies have directly determined whether iron
deﬁciency modiﬁes the relationship of environmental lead and blood lead. In this study, we com-
pared blood lead levels of iron-deficient and iron-replete children living in low, medium, or
highly contaminated environments. Measurements of lead in paint, soil, dust, and blood, age of
housing, and iron status were collected from 319 children ages 1–5. We developed two lead expo-
sure factors to summarize the correlated exposure variables: Factor 1 summarized all environmen-
tal measures, and Factor 2 was weighted for lead loading of house dust. The geometric mean
blood lead level was 4.9 µg/dL; 14% exceeded 10 µg/dL. Many of the children were iron deﬁcient
(24% with ferritin < 12 ng/dL). Seventeen percent of soil leads exceeded 500 µg/g, and 23% and
63% of interior and exterior paint samples exceeded 5,000 µg/g. The unadjusted geometric mean
blood lead level for iron-deﬁcient children was higher by 1 µg/dL; this difference was greater (1.8
µg/dL) after excluding Asians. Blood lead levels were higher for iron-deﬁcient children for each
tertile of exposure as estimated by Factors 1 and 2 for non-Asian children. Elevated blood lead
among iron-deﬁcient children persisted after adjusting for potential confounders by multivariate
regression; the largest difference in blood lead levels between iron-deﬁcient and -replete children,
approximately 3 µg/dL, was among those living in the most contaminated environments. Asian
children had a paradoxical association of sufﬁcient iron status and higher blood lead level, which
warrants further investigation. Improving iron status, along with reducing exposures, may help
reduce blood lead levels among most children, especially those living in the most contaminated
environments. Key words: children, environmental exposure, epidemiology, iron deﬁciency, lead
poisoning. Environ Health Perspect 109:1079–1084 (2001). [Online ________]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1079-1084bradman/abstract.html
Children’s Health ArticlesCalifornia sites studied by the California
Department of Health Services (CDHS)
from 1988 to 1990. We used information
from the 1980 census to identify speciﬁc cen-
sus tracts with many children between ages 1
and 6 years and a high prevalence of lead risk
factors, including a high proportion of older
housing, low income, and minority ethnicity.
We selected speciﬁc census tracts after discus-
sions with local health ofﬁcials and ﬁrsthand
observation. Eligible households were enu-
merated by door-to-door survey. Any house-
hold with a child between 1 and 6 years of
age was considered eligible. Seventy-nine per-
cent of 2,220 households in the study area
were enumerated; 483 were eligible, and 232
households participated with a total of 382
children. Of the 382 children, 28 were miss-
ing information on environmental exposure
and 35 were missing measurements of fer-
ritin, a measure of iron status, for a total of
319 children for this analysis.
Environmental measurements of lead
contamination. We collected up to three
interior and three exterior paint samples
from different areas of peeling and/or chip-
ping paint. We collected paint samples from
intact surfaces if there was no peeling or
chipping paint available. Interior and exte-
rior trim and porches were sampled in pref-
erence to walls and siding. We used the
maximum interior and exterior paint lead
level to characterize the dwelling. We col-
lected front, side, and rear-yard soil samples
from the top 2.5 cm or less of soil, and used
the geometric mean of these soil lead levels
for the data analysis. We collected house
dust samples with a vacuum cleaner with an
in-line ﬁlter trapping particles > 0.3 mm at
98% efficiency. Each sample was collected
from the center of a room, with preference
given to areas where children were reported
to spend time. Values for both concentration
of lead in house dust (micrograms per gram)
and loading (amount of lead per unit area,
micrograms per square meter) were reported.
Environmental samples were digested in
nitric acid and analyzed by atomic absorption
spectroscopy. Additional information is pre-
sented in Sutton et al. (40). 
Environmental data, particularly dust
measurements, were missing from several
homes. Dust, paint, and soil lead measures
were highly correlated (40). For homes with
only one absent medium (i.e., dust, paint, or
soil) (n = 69 children), we estimated the level
of lead in the missing medium from multi-
variate regression equations derived from the
other complete measurements. Housing age
was ascertained from county tax assessor data.
Questionnaire. Interviews were adminis-
tered in English, Spanish, Vietnamese,
Cambodian, or Tagalog to the primary care-
giver of each child. Questions addressed the
child’s risk factors for lead exposure, ethnic-
ity, income, education, access to medical
care, previous screening for lead poisoning,
participation in day care or school, use of
vitamins with iron, dwelling renovation,
general health status, and a variety of other
demographic and health information.
Blood lead and iron status measures. We
measured lead levels and iron status in blood
samples obtained by venipuncture. Lead and
iron status measurements were conducted at
the Metabolic Nutrition Laboratory (MNL)
at Children’s Hospital Oakland. We per-
formed laboratory analysis for blood lead
using graphite furnace atomic absorption
spectroscopy with a detection limit of 1
µg/dL. MNL participates in the California
Department of Health Services Lead
Proﬁciency Testing Program, which, in turn,
participates in national proficiency testing
programs (41). The average percentage dif-
ferences between measured and true concen-
trations for 46 external proficiency samples
during batch runs was 9.2% for samples <
40 µg/dL. Lead concentrations in the quality
control samples were established from the
mean of values obtained by five nationally
recognized reference laboratories. The coefﬁ-
cient of variation for internal quality control
measurements was < 10%. Iron related mea-
sures included ferritin, hematocrit (Hct),
hemoglobin (Hgb), and mean corpuscular
volume (MCV). 
Ferritin is an iron-storage protein that
maintains sufﬁcient blood iron when dietary
intake is inadequate. Ferritin levels may
decrease, indicating low iron intake, while
other measures of iron status remain normal.
Therefore, low ferritin is a highly sensitive
and speciﬁc indicator of iron deﬁciency with
or without anemia. If ferritin levels are
depleted, later signs of iron deficiency may
develop, including low hematocrit, hemo-
globin, and mean corpuscular volume
(42–44). Using ferritin as the primary mea-
sure of iron status reduces the potential to
misclassify low iron status. We chose ferritin
levels, a priori, as the primary determinant of
low iron status. For deﬁning iron deﬁciency,
we used a ferritin cutoff value of ≤ 12 ng/mL
(3,44,45,46). A secondary analysis used
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Table 1. Loadings and eigenvalues for two envi-
ronmental lead factors derived from principal
components analysis of environmental exposure
measures.a
Factor pattern
Components Factor 1 Factor 2
Ln – Soil lead (µg/g) 0.75 –0.10
Ln – Indoor paint lead (µg/g) 0.58 –0.32
Ln – Outdoor paint lead (µg/g) 0.72 –0.08
Ln – Dust lead level (µg/g) 0.63 –0.49
Ln – Dust lead loadingb (µg/m2) 0.30 0.83
House age (years) 0.79 –0.31
Eigenvalues 2.52 1.14
Ln, natural logarithm.
aCalculated with SAS Proc Factor, minimum eigenvalue =
1, no rotation (49,50). bLead loading = mass of lead per
area of floor sampled for house dust, micrograms per
square meter. 
Table 2. Distribution of demographic characteristics and geometric mean blood lead and ferritin levels by
demographic strata.
Distribution of  Blood lead Ferritin GMa
total sample GM (µg/dL) (ng/mL)
Covariate n = 382 (%) (± 1 SD) (± 1 SD)
Overall 381 (100)b 4.9 (2.5–9.5) 19.1 (8.1–45.1)
Age (years)
1 59 (15) 5.4 (2.6–11.2) 13.3 (5.3–33.4)
2 82 (22) 4.8 (2.6–9.0) 17.6 (7.5–41.7)
3 102 (27) 5.0 (2.5–9.9) 19.7 (8.2–47.0)
4 74 (19) 4.5 (2.5–7.9) 24.2 (11.8–49.9)
5 64 (17) 4.8 (2.3–20.0) 19.9 (8.4-47.0)
Ethnicity
Black 95 (25) 5.8 (3.3–10.0) 20.9 (9.2–47.5)
Hispanic 152 (40) 4.4 (2.2–8.6) 16.8 (6.6–42.5)
Asian 68 (18) 5.8 (2.9–11.6) 20.3 (8.4–48.9)
Otherc 64 (17) 4.1 (2.0–8.4) 22.2 (11.8–41.7)
Sex
Female 194 (51) 5.1 (2.5–10.3) 16.9 (7.3–39.3)
Male 187 (49) 4.6 (2.5–8.7) 21.5 (9.1–50.9)
SES
Low 202 (53) 5.4 (2.9–10.1) 18.5 (7.5–46.1)
Medium 116 (30) 4.7 (2.3–9.6) 18.2 (8.1–40.9)
High 63 (17) 3.8 (2.1–7.1) 22.9 (10.8–46.1)
Reported use of vitamins with iron
Yes 65 (17) 3.8 (2.0–7.2) 17.6 (7.8–39.6)
No 316 (83) 5.1 (2.6–9.9) 19.5 (8.2–46.5)
Time spent in school/day care
Yes 105 (28) 4.3 (2.3–8.2) 20.7 (9.5–45.2)
No 276 (72) 5.1 (2.9–9.9) 18.5 (7.7–44.7)
GM, geometric mean.
aThirty-ﬁve missing ferritin measurements; distribution of reduced samples is very similar to total distribution. bOne miss-
ing blood lead measurement. cPredominantly white.other measures of iron status—Hct, Hgb,
and MCV. The age-speciﬁc cutoff values to
define low iron status were < 33–34% for
Hct, < 11–11.2 g/dL for Hgb (47), and
< 67–73 fL for MCV (15,48).
Statistical analyses. We performed all sta-
tistical analyses using SAS PC software
(49,50). Measures of blood and environmen-
tal lead and ferritin were log-transformed (40).
Initial analyses used simple linear regres-
sion and scatter plots to investigate the asso-
ciations among ferritin, blood lead, and
covariates. We then developed multiple lin-
ear regression models to assess associations
between ferritin and the dependent variable,
blood lead, while accounting for potential
confounders that affect blood lead and/or
iron status measures [age, sex, ethnicity,
socioeconomic status (SES), and reported
use of vitamins with iron] (1,14, 15,45) or
were signiﬁcant in the bivariate analysis. For
example, bivariate analyses suggested that
attendance in day care or school protected
against lead exposure, perhaps because chil-
dren who spent more time away from their
homes may receive less exposure from home
contamination. Thus, we controlled for this
variable in the regression model.
We performed the above analyses using
both a continuous measure of ferritin and a
dichotomous measure (≤ 12 or >12 ng/mL).
We also examined other measures of iron
status (Hgb, Hct, MCV), both individually
and as a composite measure, where iron deﬁ-
ciency was assigned if ferritin, Hgb, Hct, or
MCV was low (as deﬁned above). Hgb, Hct,
and MCV, all later signs of iron deficiency
(13,44), were not consistently related to
blood lead. The results for ferritin and the
composite measure of iron status were con-
sistently related to blood lead; of these, fer-
ritin was the best predictor of blood lead.
Therefore we report results only for ferritin. 
The next steps involved determining
whether ferritin status modiﬁed the relation-
ship between environmental lead and blood
lead. We assigned each child to a high,
medium, or low contaminated environment
based on a composite measure of contami-
nation. This measure was derived from a
principal components analysis (minimum
eigenvalue criteria = 1.0) that reduced the six
correlated environmental variables (r =
0.15–0.65, p-value = 0.01 or less) (soil,
indoor or outdoor paint, dust lead, lead
loading, and housing age) to two indepen-
dent environmental factors. 
Table 1 presents the loadings for the vari-
ables in each factor. The first factor,
Environmental Lead Factor 1, summarizes
the largest share of the environmental data
(eigenvalue = 2.52) and is primarily a general
summary of the environmental lead variables.
The second, Environmental Lead Factor 2,
(eigenvalue = 1.4) is weighted most heavily by
lead loading (the mass of lead per area of ﬂoor
sample for house dust, micrograms per square
meter) and reﬂects an effect of house dust lead
loading that is independent from the overall
household lead levels. We calculated contami-
nation scores for each child by multiplying
the loadings for each factor by the values of
the associated variables and summing. We
then assigned tertiles of these scores to high,
medium, and low environmental contamina-
tion categories for each child.
Next, we conducted simple bivariate
analyses to examine trends in blood lead lev-
els between children with low ferritin and
normal ferritin levels overall and within each
level of environmental lead contamination.
Results are presented for individual ethnic
groups, all ethnic groups combined, and
non-Asians combined. The bivariate analysis
conﬁrmed that Asians had a distinctly differ-
ent relationship between blood lead levels
and iron status at each level of environmen-
tal contamination. Our ﬁnal model was run
with and without Asians. Final results are
presented for non-Asians only.
Finally, we developed a multivariate
regression model with the dependent vari-
able blood lead; the independent variables
consisted of the covariates, main effects of
iron status and environmental category, and
an interaction term of these last two vari-
ables. We used this model to compute
adjusted (least squares) mean blood lead lev-
els for children with low and normal ferritin
levels. This strategy allowed us to compare
mean blood lead levels within and between
environmental lead categories while adjust-
ing for covariates, including age, sex, ethnic-
ity, SES, reported use of vitamins with iron,
and whether or not a child spent time in
school or day care.
Results
Table 2 presents the study population distri-
bution and blood lead and ferritin levels
stratified by major covariates considered in
the analysis. Overall, blood lead levels were
similar to levels in the U.S. population as a
whole at that time (geometric mean = 4.9
µg/dL; maximum = 23 µg/dL). However,
14% of the children exceeded 10 µg/dL, the
CDC level of concern. No trends with age
were apparent. Blacks and Asians had higher
lead levels than Hispanics and whites. Female
children also had slightly higher blood lead.
Higher SES, reported use of vitamins with
iron, and time spent in school or day care
were associated with lower lead levels.
The average ferritin level was 19.1
ng/mL (Table 2), with 24% of children
having ferritin levels < 12 ng/mL. As
expected, ferritin tended to increase with
age. Ferritin level was somewhat lower
among Hispanics, female children, those
with low SES, and those who did not attend
school or day care. Paradoxically, ferritin
was slightly higher among children with no
reported use of vitamins.
Environmental measurements demon-
strate significant lead hazards in the homes
of many participating children (Table 3).
Seventeen percent of soil lead levels were
> 500 µg/g, a level associated with signiﬁcant
childhood exposure (1,2,51). Exterior paint
lead levels were several times higher than
interior paint, with 23% and 63% of
interior and exterior paint samples, respec-
tively, exceeding 5,000 µg/g, the current
Department of Housing and Urban
Development action level for abatement
(52). Seventy-six percent of homes were
built before 1950, after which paint lead lev-
els started to decline (53,54). The six envi-
ronmental variables were significantly
correlated (r = 0.15–0.65; p-value = 0.01).
Table 4 presents unadjusted geometric
mean blood lead levels for children with low
ferritin and normal ferritin levels in all eth-
nic groups. For the population as a whole,
the mean blood lead level is slightly higher
(by 1 µg/dL) for children with low ferritin
levels. This pattern persists within all ethnic
groups, except for Asians, where children
with normal ferritin levels appear to have
higher blood lead levels. Excluding Asian
children from the total population increases
the difference in blood lead levels between
children with low ferritin and those with
normal ferritin levels to 1.8 µg/dL.
After adjusting for the potential covari-
ates (ethnicity, sex, age, SES, use of vitamins,
and whether or not the child has spent time
in school or day care), the geometric mean
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Table 3. Descriptive statistics for environmental measurements of lead and housing age.a
No. No. of children
of homes in homes
Medium sampledb with samples Mean ± 1 SD Maximum
Soil 227 375 234c µg/g 104–529 2,664
Indoor paint 222 367 1,412c µg/g 207–9,611 201,014
Outdoor paint  219 360 8,430c µg/g 949–74,892 320,834
Dust concentration  188 312 180c µg/g 79–411 3,105
Lead loading  188 312 24c µg/g 5–105 886
Housing age  232 361 52d (years) 31–73 100
aData from Sutton et al. (40). bTotal number of homes in study: 232. cGeometric mean +1 SD. dArithmetic mean ±1 SD.blood lead levels for non-Asian children with
low ferritin and those with normal ferritin
were 5.7 and 4.0 µg/dL, respectively (t = 4.0,
p-value < 0.01). Including Asian children in
the model reduced the magnitude of the dif-
ference to 1.0 µg/dL (t = 2.4, p-value = 0.02).
Figure 1 presents the adjusted geometric
mean blood lead levels by ferritin status
within low, medium, and high lead contami-
nation categories for Environmental Lead
Factors (ELF) 1 and 2. We have not included
Asian children in these adjusted analyses.
Lead levels in children increase with the envi-
ronmental measures of contamination, as
shown in Figure 1. Children with low ferritin
levels, regardless of the level of environmental
contamination, have higher lead levels than
do those with normal ferritin levels. The dif-
ference in blood lead levels between those
with low and normal ferritin increases as the
level of environmental contamination
increases. (The mean difference in blood lead
levels within each low, medium, and high
contamination category for ELF1 = 0.7, 1.9,
3.2 µg/dL, and for ELF2 = 1.7, 0.8, and 2.9
µg/dL, respectively.) The results for both
environmental factors are similar. The high-
est blood lead levels and the largest difference
in mean blood lead levels between children
with normal and low ferritin are seen in the
highest contamination category (3 µg/dL). 
Including Asian children in the model
tended to reduce the signiﬁcance and magni-
tude of the difference in means within each
environmental category (about 1 µg/dL) but
did not alter the overall pattern. For example,
the difference in mean blood lead between
low and normal iron-status children in highly
contaminated environments was 2.8 µg/dL
for ELF1 when Asians were included (p-value
= 0.02), but 3.2 µg/dL when Asians were
excluded (p-value = 0.01). Excluding the
children with estimated environmental data
also did not change the results. Finally,
because more than one child may have come
from the same household, we randomly
selected one child from each household to
assess possible bias introduced by the lack of
independence. Although the statistical signif-
icance of some comparisons was reduced
because of the smaller sample size, the overall
results were not changed (data not shown).
Discussion
Overall, we found that children with iron
deﬁciency, as measured by low ferritin level,
had higher blood lead levels than children
with normal iron levels. This relationship
persisted after we stratified by the level of
environmental contamination measured in
their homes, with the largest difference in
blood lead between iron-deficient and
iron-replete children living in the most cont-
aminated environments. These results sug-
gest that inadequate iron status may amplify
the effect of lead contamination in the envi-
ronment by increasing absorption and possi-
bly retention of lead in the body and/or
increasing hand-to-mouth or pica behavior
and thus lead ingestion (28,29). 
Our finding is consistent with several
studies that have reported higher propor-
tions of children with elevated blood lead
among those with low iron levels (15,16,
34–36). Yip and Dallman (15) found that
the correlation of iron deﬁciency and blood
lead was strongest among the youngest chil-
dren (1–2 years), weaker in older children,
and not significant in adults. This lack of
correlation between iron and blood lead in
older children (10–18 years) was also
reported by Hershko et al. (37). The age dis-
tribution in our study is limited to young
children, who are at highest risk for lead
exposure, so our results cannot be general-
ized to ﬁndings for older children. 
The relationship of iron status and blood
lead varied within ethnic groups in this pop-
ulation, with Asian children having an
apparently paradoxical association of suffi-
cient iron status and higher blood lead. We
have no clear explanation for this unex-
pected finding. We have speculated about
the possibility of lead-contaminated foods or
cooking utensils linking both iron and lead
ingestion, but no data are available. The
Asian participants in our study were primar-
ily of Southeast Asian origin. It is possible
that genetic polymorphisms for δ-aminole-
vulinic acid dehydratase (ALAD) alleles
(55–58), or other differences in lead binding
proteins could affect blood lead indepen-
dently of iron status. It is also possible that
this finding was caused by chance alone.
Additional research is needed to explain
intraethnic patterns of lead exposure and
iron status.
Our results may be affected by misclassi-
ﬁcation of iron status or environmental lead
exposure. Although low ferritin status is suf-
ﬁcient evidence of iron deﬁciency (44), nor-
mal ferritin status does not necessarily
indicate iron sufficiency because ferritin is
an acute-phase reactant and may be elevated
by infection or inflammatory disease (44).
Thus, some iron deficient children may
have been misclassified as iron-replete on
the basis of ferritin level, which would bias
our results toward the null hypothesis.
Similarly, the characterization of environ-
mental lead exposure may have been mis-
classified because we could not consider a
child’s behavioral interaction with his or her
environment within a given environmental
contamination category. The presence of a
lead hazard in the home is a necessary but
not a sufﬁcient prerequisite for exposure to
lead. Children’s exposures may vary widely
depending on behavior. We also did not
consider dietary sources of lead exposure
other than possible use of imported pottery
and home remedies.
Several factors limit the generalizability of
our ﬁndings. As a cross-sectional study, it is
impossible to determine the temporal pattern
of exposure, iron deﬁciency, and blood lead,
so we cannot infer causal relationships
between these factors. Additionally, it is possi-
ble that iron deﬁciency is correlated with cal-
cium deﬁciency, which may also enhance lead
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Table 4. Unadjusted blood lead levels by ethnicity and ferritin status.a
Geometric mean blood lead (µg/dL)
Ferritin Total without
status Black Hispanic Asian Otherb Total Asians
Low ferritin 6.6 5.5 4.6 7.7 5.6 6.0
±1   SD 4.1–10.6 2.9–10.4 1.9–10.8 3.8–15.5 2.8–11.0 3.3–11.0
n 15 38 17 8 78 61
Normal ferritin 5.3 3.8 6.7 3.8 4.6 4.2
±1   SD 3.1–9.2 2.0–7.2 3.6–12.3 1.9–7.5 2.4–8.8 2.2–8.0
n 63 93 41 44 241 200
aNormal ferritin status: ferritin > 12 ng/mL; low ferritin status: ferritin ≤ 12 ng/mL. bPredominantly white.
Figure 1. Adjusted geometric mean blood lead levels by ferritin status and environmental lead category:
(A) Environmental Factor 1; (B) Environmental Factor 2. R2 for full model = 0.23; n = 261 (excludes Asians);
p-values for difference of means; ferritin low ≤ 12 ng/mL; ferritin normal > 12 ng/mL. Values adjusted for
ethnicity, sex, age, SES, reported use of vitamins with iron, and whether or not the child spent time in
school or day care.
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)absorption (59–61). However, the evidence
for an inverse relationship between blood lead
and calcium intake in the normal physiologic
range is uncertain (62). Several studies suggest
that ingestion of calcium inhibits lead uptake
(35,38,39,59–64), but the role of chronic cal-
cium deﬁciency has not been fully elucidated
(62). Studies of calcium intake and blood lead
themselves may be confounded by sociode-
mographic factors and failure to account for
proximate exposure sources.
In summary, we found that iron-deﬁcient
children averaged 1–2 µg/dL higher blood
lead than children with adequate iron status,
with as high as a 3 µg/dL difference for chil-
dren in the most contaminated environments.
By directly controlling for environmental
contamination we avoided confounding by
the simultaneous presence of sociodemo-
graphic lead exposure-risk factors. Because
population blood lead levels are log-normally
distributed (10), small average reductions in
lead levels would signiﬁcantly reduce the pro-
portion of children exceeding 10 µg/dL, the
CDC level of concern. Thus, improving iron
status in children could, if confirmed, help
achieve important public health objectives of
reducing blood lead levels below this thresh-
old, particularly for children living in diffi-
cult-to-reach contaminated environments.
Both iron deﬁciency and lead exposure dis-
proportionately affect minority, poor, and
urban children (10). Because iron deﬁciency
has independent effects on cognitive func-
tioning in children that are similar to those of
lead poisoning (1,8,27,65,66), there should
be important prophylactic benefits for chil-
dren’s health and development if organized
intensive iron deﬁciency screening, nutritional
counseling, and supplementation were imple-
mented in areas where children are at high
risk of both conditions (67). Because the rela-
tionship between nutritional factors and
blood lead is likely to be a complex interac-
tion of nutritional status, individual diurnal
and secular nutrient intake patterns, meal fre-
quency, behavior, caregiver ability, and envi-
ronmental contamination, additional research
is urgently needed to validate current
hypotheses and quantify the speciﬁc beneﬁts
of sufﬁcient iron status while accounting for
calcium and other major nutrient cations.
Because of uncertainties about the beneﬁts of
nutritional factors in reducing blood lead
(62), improved nutritional status must be
complemented with removal of lead from
children’s environments. 
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Case Presentation
We present three cases encountered in the
Boston City Hospital Pediatric Allergy–
Immunology–Respiratory Clinic and a fourth
case seen as an inpatient at Boston City
Hospital in which exposure to violence
seemed to be the asthma symptom precipitant.
Case 1. Case 1 is a 12-year-old African-
American girl with lifelong asthma who has
numerous recognized triggers that include
pollen, cold air, and exercise. She had pre-
sented several times each year to her neigh-
borhood clinic with acute wheezing that
responded to nebulized bronchodilator treat-
ment. On initial evaluation in July 1994, her
physical exam was notable for allergic rhini-
tis. Pulmonary function testing showed a
mild obstructive defect primarily affecting
the small airways: forced vital capacity
(FVC), 94%; forced expiratory volume in 1
sec (FEV1), 79%; and forced expiratory ﬂow
rate over the middle 50% of the FVC vol-
ume (FEF25%–75%), 51%. Oral antihista-
mines, nasal cromolyn, and inhaled steroids
were added to her inhaled bronchodilator
therapy. In the subsequent month, amoxi-
cillin was begun for sinusitis, and nasal
steroids were added to her treatment regi-
men. After a period of symptom stability she
developed increased wheezing in October
1994. Oral prednisone was begun, resulting
in rapid improvement to her baseline by the
fifth day which was Halloween. On
Halloween night, the patient heard gunshots
outside of her home in a housing project and
shortly thereafter became aware that one of
her peers had been fatally shot. She quickly
developed recurrent wheezing, slept poorly
that night due to respiratory symptoms, and
required an extended course of prednisone to
control the recurrent asthma exacerbation.
Following recovery from this episode, her
asthma stabilized. 
Case 2. Case 2 is a 15-year-old Hispanic
girl who has had severe asthma since infancy
and is now enrolled in a college preparatory
course in an urban high school. Her history
was remarkable because of her need for
assisted ventilation with status asthmaticus at
the age of 2 years and subsequent every-
other-day prednisone therapy up to the age
of 5 years. Her currently recognized asthma
triggers include exercise, upper respiratory
tract infections, and exposure to dust and
pets. Allergy skin testing demonstrated sensi-
tivities to several environmental allergens.
She was controlled on theophylline, inhaled
serevent, flunisolide, nedocromil, oral anti-
histamines, and regular peak ﬂow monitor-
ing. Typical pulmonary function test results
before and after bronchodilator therapy,
respectively, in the Pediatric Allergy–
Immunology–Respiratory clinic for this
patient were FVC, 68% and 100%, FEV1,
43% and 69%, and FEF25%–75%, 17% and
31%. During the fall of 1994 she developed
increased wheezing on three occasions,
which required pulse doses of prednisone.
Each episode began on a Sunday evening
before the start of a new school week.
Inquiry revealed that, at the end of the previ-
ous school year, the girl had been attacked
on a subway platform by a group of girls.
She was physically attacked and her jewelry
and book bag, containing her asthma med-
ications, were stolen. In retrospect, Case 2
reported an acute asthma episode immedi-
ately after the assault. The patient later iden-
tiﬁed the assailants to the police and pressed
charges against them. Through the fall, the
patient encountered her assailants periodi-
cally on the subway. She subsequently expe-
rienced an asthma flare after a court
appearance where she testified against her
attackers; during this court appearance, they
verbally threatened her. After the sentencing
of the assailants, the patient had no further
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In the United States, rising trends in asthma prevalence and severity, which disproportionately
impact minorities and the urban poor, have not been fully explained by traditional physical envi-
ronmental risk factors. Exigencies of inner-city living can increase psychosocial risk factors (e.g.,
stress) that confer increased asthma morbidity. In the United States, chronic exposure to violence
is a unique stressor existing in many high-risk urban neighborhoods. In this paper, we describe a
series of cases that exemplify a temporal association between exposure to violence and the precipi-
tation of asthma exacerbations in four urban pediatric patients. In the ﬁrst three cases, the nature
of the exposure is characterized by the proximity to violence, which ranged from direct victimiza-
tion (through either the threat of physical assault or actual assault) to learning of the death of a
peer. The fourth case characterizes a scenario in which a child was exposed to severe parental con-
ﬂict (i.e., domestic violence) in the hospital setting. Increasingly, studies have begun to explore
the effect of living in a violent environment, with a chronic pervasive atmosphere of fear and the
perceived or real threat of violence, on health outcomes in population-based studies. Violence
exposure may contribute to environmental demands that tax both the individual and the commu-
nities in which they live to impact the inner-city asthma burden. At the individual level, interven-
tion strategies aimed to reduce violence exposure, to reduce stress, or to council victims or
witnesses to violence may be complementary to more traditional asthma treatment in these popu-
lations. Change in policies that address the social, economic, and political factors that contribute
to crime and violence in urban America may have broader impact. Key words: asthma, case series,
inner-city, stress, violence. Environ Health Perspect 109:1085–1089 (2001). [Online ________]
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Center, Boston, Massachusetts, USAdocumented acute asthma exacerbations for
15 months corresponding to the period of
incarceration of her assailants. Over this time
course she stopped taking her medications
except for an albuterol inhaler as needed and
she did not receive follow-up in the Pediatric
Allergy-Immunology-Respiratory Clinic.
Following the release of the assailants, she
again developed severe symptoms requiring
two hospitalizations in a 2-month period. 
Case 3. Case 3 is a 9-year-old Caucasian
girl with asthma since early infancy. The
known triggers include exercise, emotional
upsets, and upper respiratory tract infections.
Allergy skin testing demonstrated sensitivity
to many environmental allergens including
Aspergillus. Sputum cultures have been
repeatedly negative for Aspergillus, and mea-
sured immunoglobulin E (IgE) is 154. Her
asthma was managed on inhaled ﬂunisolide,
cromolyn, an albuterol inhaler as needed,
nasal cromolyn, and diphenhydramine.
During the spring of 1994, frequent asthma
exacerbations led to a 3-month course of
prednisone. Typical pulmonary function test
results were as follows: FVC, 90%; FEV1,
69%; and FEF25%–75%, 41%. Intensive aller-
gen control measures in the home, including
replacing carpeting with linoleum, installing
a dehumidifier, restoring crumbling walls,
and fumigation, were associated with success
in weaning the patient off prednisone and
normalization of her spirometry. In October
1994 her daily wheezing returned. It was
subsequently revealed that Case 3 had been
assaulted on the school bus by an older boy
and had reported the incident to teachers.
Thereafter the perpetrator’s female cousin
began to threaten to stab the patient with
sharp scissors while they were riding the
school bus. The patient finally refused to
board the school bus one day for the ride
home and subsequently developed wheezing
and respiratory distress requiring emergency
treatment. 
Case 4. Case 4 is a 3-year-old girl admit-
ted to the pediatric intensive care unit (ICU)
with an asthma exacerbation in the setting of
a viral illness and an exposure to sprayed pes-
ticide 10 days before the onset of symptoms.
The patient’s initial oxygen saturation was
77% on room air and 89–95% on a 100%
non-rebreather face mask. She did not
require intubation. Three days into her hos-
pital course, the patient began to show slow
clinical improvement on a medical regimen
that included continuous nebulized ventolin
treatments, intravenous solumedrol, ipratro-
prium bromide nebulized treatments, and a
continuous terbutaline infusion, which was
started on the second hospital day.
Case 4’s mother stayed with her around
the clock. Visits by the patient’s father were
associated with loud arguments between the
parents, which were overheard by the medical
staff caring for the patient. On one occasion,
a nurse observed the patient’s mother slap-
ping the father and then the patient’s father
pushing and shoving the mother. The health
care staff noted that the patient’s respiratory
rate had increased from 50–60 breaths/min to
80–90 breaths/min during her exposure to
these parental encounters. One event docu-
mented in the medical record describes the
father hitting the mother, causing her to crash
into the glass doors of the patient’s ICU
room. The patient became visibly upset and
began screaming. Vital signs documented
before the event charted a respiratory rate of
30–34 breaths/min, a heart rate of 145
beats/min, a temperature of 99.4°F, and oxy-
gen saturation of 92% on a 40% face mask.
Vital signs documented in the 3–4 hr after
the episode showed a clinical decompensation
with a respiratory rate of 42–50 breaths/min,
a heart rate of 155–180 beats/min, and an
initial oxygen saturation of 91% on a 70%
face mask. A clinical exam documented
decreased air movement and recurrent wheez-
ing associated with the persistent tachypnea
and tachycardia.
Discussion
These cases exemplify a temporal association
between exposure to violence and the precip-
itation of asthma exacerbations in four
inner-city pediatric patients. Although each
patient is vulnerable to a variety of asthma
triggers, exposure to violent events seemed to
be a common precipitant of asthma symp-
toms. Notably, Case 2 experienced improve-
ment in her chronic asthma symptoms once
the perceived threat of violence was no
longer present and deterioration in her respi-
ratory status when that threat reemerged. In
Case 4, there was a clear temporal associa-
tion between witnessing parental conflict
and deterioration in the patient’s clinical
course and vital signs. Because of a raised
awareness, we are now inquiring about expo-
sure to violence as an apparent asthma symp-
tom precipitant. Although these cases
support a role of exposure to violence and
acute exacerbations of established asthma,
we should also consider plausible pathways
through which living in a violent environ-
ment may inﬂuence the genesis of asthma.
Asthma is the most common chronic
disease of childhood and a leading cause of
morbidity in children. In the United States,
recent trends of increasing childhood asthma
prevalence and morbidity disproportionately
affect nonwhite children living in urban
areas and children living in poverty (1–3). It
is not clear that differences in generally
known asthma risk factors such as chemical
and particulate air pollutants (4), environ-
mental and in utero tobacco smoke exposure
(5), viral respiratory infections (6), and
home allergen exposure (7) fully explain
these trends. As yet unidentiﬁed unique fac-
tors may contribute to the higher asthma
morbidity and mortality rates seen in inner-
city poor minority populations (8). 
Connections between the health and
economic well-being of populations are
increasingly seen to be embedded within the
larger context of people’s lives. It has been
proposed that differential exposure to and
perception of stress may, in part, explain
socioeconomic disparities in health (9).
Various sociodemographic characteristics
(e.g., lower social class, ethnic minority sta-
tus) may predispose individuals to particular
pervasive forms of life stress (10,11), and the
degree of chronic stress can be significantly
inﬂuenced by the characteristics of the com-
munities in which people live (12). Chronic
stress in U.S. urban populations has been
conceptualized as neighborhood disadvan-
tage, characterized by the presence of a num-
ber of community-level stressors including
poverty, unemployment, substandard hous-
ing, and high crime/violence rates (13). Such
physical and social factors can be a source of
environmental demands that contribute to
stress experienced by populations living in a
particular area (14). 
Studies in minority and lower income
populations have shown a high prevalence of
children who encounter violence in the inner
city. A prevalence study at Boston City
Hospital found that 10% of children had
witnessed a knifing or shooting before the
age of 6 years; 18% had witnessed shoving,
kicking, or punching; and 47% had heard
gunshots (15). In an inner-city cohort in
Chicago, Illinois, investigators found that of
children between the ages of 7–13, 42% had
seen someone shot and 37% had seen some-
one stabbed (16). A survey of urban elemen-
tary school children in New Orleans,
Louisiana, found that more than 90% had
witnessed violent episodes, 70% involving
use of weapons (17). Although stress is decid-
edly common and has many causes in our
society, the increased prevalence of chronic
community violence is a speciﬁc and extreme
stressor confronting the urban poor. 
Violence can be conceptualized as a
source of psychological and environmental
stress that taxes both the individual and the
communities in which they live. Community
violence can be considered a pervasive stressor
that adds to environmental demands imposed
on an already vulnerable population of chil-
dren and families (18). Inner-city populations
that experience high rates of exposure to vio-
lence are also characterized by high levels of
poverty, hopelessness, lack of opportunity,
and unemployment (i.e., chronic ongoing
stressors). Living in a violent environment is
Grounds Rounds in Environmental Medicine • Wright and Steinbach
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phere of fear and the perceived threat of vio-
lence (19,20). Children and families living
with community violence are likely to view
their world and their lives as being out of
their control. Facing daily life experiences in
an unpredictable or uncontrollable environ-
ment predisposes these populations to greater
deleterious effects of stress (21). Moreover,
both the duration and the frequency of expe-
rienced stress are important determinants of
its impact on health and illness. Variable
response to acute challenges (e.g., high fre-
quency of exposure to violence) superimposed
on chronic stressors (e.g., other components
of neighborhood disadvantage) may have dif-
ferent implications on disease expression (22).
Events that last a very short time can also have
more long-term stress effects through lasting
physiologic responses thought to be main-
tained by recurrent unwanted or “intrusive”
thoughts about past events (23). Symptoms of
post-traumatic stress disorder (PTSD),
including ﬂashbacks or recurrent memories of
traumatic events, are highly associated with
exposure to violence (24). 
Psychological stress has been associated
with the activation of the hypothalamic–pitu-
itary–adrenal (HPA) axis and disturbed regu-
lation of the HPA system.This may best be
understood within McEwen el al.’s concept of
allostasis, which refers to the ability of the
body to achieve stability through change, such
that “the autonomic nervous system, the
HPA axis, and cardiovascular, metabolic, and
immune systems protect the body by
responding to internal and external stress”
(25). The potential cost of such accommoda-
tion is conceptualized as allostatic load, which
is the wear and tear from chronic overactivity
(or underactivity) of the HPA system. With
regard to immune function, during a period
of acute stress, increased cortisol and cate-
cholamines promote allostasis by inﬂuencing
cell trafﬁcking and by modulating cytokines,
which fight infection (26). In contrast,
chronic overactivity (or underactivity) of these
same mediators may result in allostatic load
(i.e., potential immunosuppressive effects
when the mediators are chronically secreted
or not turned off). Some optimal level of
mediators is needed to maintain a functional
balance, and the absence of appropriate levels
of gluccocorticoids and catecholamines may
allow other immune mediators to overreact
and increase the risk of inﬂammatory disor-
ders (27). In this framework, violence can be
conceptualized as a psychosocial environmen-
tal exposure that can “get into the body” and
result in biological changes that may con-
tribute to asthma morbidity.
There is a renewed interest in the links
between psychological stimuli and asthma
(28,29). Exposure to violence as a major life
stressor may impact on the pathogenesis of
asthma and/or contribute to the morbidity of
disease by triggering exacerbations through
neuroimmunologic mechanisms. Augmented
parasympathetic response has been docu-
mented after intense or prolonged stress
experiences (30,31). Increased parasympa-
thetic tone produces increased smooth mus-
cle tone in the lung and thus may mediate
emotionally induced bronchoconstriction in
asthma (32). Cytokines known to be impor-
tant in inflammatory diseases like asthma
may also serve a role in mediating the acute
response to physical and emotional stress.
Psychosocial stressors can moderate both
humoral and cellular immune function
(33,34). Stressor-linked alterations in the
immune system may predispose to respira-
tory tract infections (35,36), which may trig-
ger acute asthma exacerbations. Stress
hormones influence immunoglobulin and
cytokine expression and thus may increase a
genetically predisposed individual’s risk of
developing asthma. Current knowledge sup-
ports the notion that expression of the asth-
matic phenotype, as related to the immune
response, is modulated by environmental fac-
tors that include viral infection, air pollu-
tants, maternal smoking, breast-feeding, and
allergen exposure (37). Stress may potentiate
the allergic response to allergens by increasing
the release of inflammatory mediators and
the subsequent cascade of inflammatory
events characteristic of chronic asthma. That
is, violence as a psychosocial stressor may be
an “adjuvant” to the asthmatic inﬂammatory
response. Thus, while stress and emotional
distress are generally recognized as factors
aggravating asthma symptoms in those with
existing disease, they may play a role in the
genesis of the disease as well (29). 
Preliminary empirical evidence suggests
that exposure to violence may contribute to
the burden of asthma morbidity on the
inner-city poor. In a cohort study in Boston,
Wright et al. (38) retrospectively ascertained
lifetime exposure to violence through a
parental-report interview questionnaire
administered to 416 caregivers and their
children who are being followed longitudi-
nally for respiratory health outcomes,
including asthma. Preliminary analyses sug-
gest a link between higher lifetime exposure
to community violence and an increased risk
of asthma and wheeze syndromes and pre-
scription bronchodilator use. 
Violence exposure may ameliorate
resources needed to manage and cope with
chronic asthma. Exposure to community vio-
lence (and other determinants of neighbor-
hood disadvantage) may operate through
effects on impulse control, risk-taking behav-
ior, and the adoption of coping behaviors
such as smoking, thus leading to increased
exposure to a known environmental asthma
trigger (39). Smoking can be conceptualized,
at the individual level, as a strategy to cope
with negative affect or stress (40,41).
Neighborhood effects on health behaviors
such as smoking have also been demonstrated
(42,43). For example, evidence from the
1987 General Social Survey (44) suggests
that stress may be one factor promoting
increased prevalence of smoking in African-
American communities. Romano et al. (45)
surveyed 1,137 African-American households
and found that the strongest predictor of
smoking was a report of high-level stress, rep-
resented by a “hassles” index. The “hassles”
index was an abbreviated 10-item scale based
on items chosen to represent a dimension
that community residents involved in the
project perceived to be especially relevant.
Notably, among the items were neighbor-
hood level factors including being concerned
about violence or living in an unsafe area.
Community-level characteristics such as
increased prevalence of violence may influ-
ence an individual’s behavior, resulting in
increased exposure to other known environ-
mental risk factors for asthma. Parents in
high-violence communities may restrict their
children’s outdoor activities. In the same
Boston pediatric cohort discussed above,
parental reports of keeping children indoors
primarily because of fear of neighborhood
violence was related to increased risk of
wheeze and physician’s’s diagnosis of asthma
prior to the age of 2 years (46). Reasonable
hypotheses as to why this association was
seen may include the following. The child
who is kept indoors may become decondi-
tioned, experiencing shortness of breath with
decreasing levels of exertion. An increased
sedentary lifestyle may be linked to obesity in
children. Recent studies have linked obesity
to asthma (47,48), and studies suggest that
obesity has increased among families living in
poverty in the United States (49). Also, chil-
dren who are kept indoors may be exposed
for longer periods to indoor aeroallergens and
have an increased likelihood of sensitization
and allergic symptoms in response to dust
mite, pet, roach, and rodent allergens.
Parents who are worried about their chil-
dren’s safety in their neighborhood because
of crime may keep their children indoors and
otherwise restrict their social behavior; thus
each child’s ability to develop support net-
works may be compromised (i.e., exposure to
violence may lead to diminished stress-
buffering factors such as social networks)
(50). Psychopathology (e.g., PTSD, depres-
sion) influenced by life stress and chronic
exposure to violence may also prevent the
child from forming relationships that are nec-
essary to promote normal social develop-
ment. Fear of crime fosters a distrust of
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(51). It is clear that violence is related to fac-
tors that limit formation of social networks.
These additional supports may be especially
important to health and well-being in high-
risk urban populations faced with cumulative
effects of many other ecologic stressors (i.e.,
poverty, low education, poor housing). 
Coping with a violent environment may
affect compliance with therapy and medical
follow-up for asthma. Fong (52) discussed
the impact of violence on the management of
hypertensive urban African Americans,
underscoring violence as a perceived barrier
to keeping appointments and following pre-
scribed exercise programs. Fear of making a
trip across town to a pharmacy or medical
facility or adhering to a prescribed walking
program as a result of prior victimization or a
perceived threat of violence may be a barrier
to compliance. This may lead to lapses in use
of prophylactic medication, delayed interven-
tion, and consequently greater morbidity.
Adolescents who witness violence are more
likely to develop a foreshortened sense of the
future (53) and thus a fatalistic outlook that
may undermine their ability to invest in the
future by complying with a chronic asthma
treatment regimen. Other barriers to adher-
ence to a prescribed asthma regimen may
include the lack of a community pharmacy
open 24 hr/day. Pharmacies may be reluctant
to remain open 24 hr/day in poor communi-
ties, especially when violence is a concern.
Violence can indirectly affect access to med-
ical care by diverting limited funds away
from primary care and specialty clinics,
including those caring for asthmatics (54,55). 
Exposure to violence may affect asthma
management when increased family dysfunc-
tion impedes development of appropriate
coping strategies necessary to facilitate
improved quality of care for the asthmatic
child. Dysfunctional patterns are common
in homes of children with asthma and may
be precipitated by anxiety experienced
around asthmatic attacks (56). Family dys-
function has been related to increased
asthma morbidity and mortality (57,58).
The level of stress in the home of an asth-
matic child is likely to increase as parents
attempt to balance the child’s need for activ-
ity and independence with their concerns
about avoiding allergen- or exercise-induced
symptoms and maintaining adherence to a
pharmacologic regimen. Likewise, stress and
anxiety may be compounded in families who
are also faced with the real or perceived
threat of violence or injury in the child’s
home, neighborhood, or school, which leads
to greater dysfunction. Parents who have
experienced violence, or whose children have
had such experiences, may develop depres-
sion or PTSD, which impairs their ability to
supervise and respond to their children. This
reduction in parenting capacity may under-
mine an adult’s ability to coordinate a child’s
ongoing asthma care. 
Conclusions
Exigencies of inner-city living, such as coping
with the high prevalence of exposure to vio-
lence, may increase psychosocial risk factors,
which in turn may confer increased asthma
morbidity on high-risk urban populations.
High crime rates, and thus the real or per-
ceived threat of violence, are speciﬁc aspects
of the inner-city environment that may
impact psychologic functioning as well as
health-promoting and health care-seeking
behaviors of the inhabitants (59). More
research is needed to examine the public
health impact of children and their families
living with violence. Systematic exploration of
an association between violence (an urban
stressor) and asthma throughout childhood
may help us to understand the rise in asthma
prevalence, severity, and medical care use as
well as to further our understanding of its dis-
proportionate occurrence in poor urban chil-
dren in this country. We present these cases
to alert clinicians and researchers to a poten-
tial risk factor for increased asthma morbidity
that has not previously been recognized. 
Increasingly, pediatricians are being
asked to manage chronic childhood illness in
the context of complicated family and com-
munity environments that clearly impact
disease management. Pediatricians have long
recognized the impact of violence on the
health and well-being of children and have
been expanding efforts to increase response
to exposure to violence as a health care issue
in the clinical setting (60). The identiﬁcation
of exposure to violence as a trigger of asthma
exacerbations may alert health professionals
caring for asthmatics in the inner-city setting
to inquire about patient’s exposure among
other known triggers. Secondary interven-
tion strategies designed to reduce exposure
to violence or to facilitate positive coping
mechanisms for individual patients may
obviate the need for more aggressive and
costly pharmacologic therapies for asthma
with potential side effects. For example,
referral to a stress reduction program or to
programs that provide counseling for chil-
dren who have witnessed or experienced vio-
lence (61) may be helpful. In our experience,
it is unlikely that the child’s asthma control
can be improved unless such psychosocial
issues are also addressed. 
Primary prevention at the population or
neighborhood level should also be consid-
ered. Social cohesion and social capital are
strongly correlated with rates of violent crime
within neighborhoods (62). Research sug-
gests that crime is most prevalent in societies
that permit large disparities in the material
standards of living of its citizens, which in
turn are created by broad-scale societal and
political factors (63,64). Emerging evidence
underscores the need for policy makers to pay
increased attention to political and economic
forces that result in further marginalization of
minority populations in the inner city and
contribute to the growing income gap
between the rich and the poor in this country
(65). Policies aimed at improvements in life
opportunities and living conditions may
increase social cohesion and decrease violence
in the inner cities. Social cohesion may inﬂu-
ence the health behaviors of neighborhood
residents by promoting diffusion of health
information or increasing the adoption of
healthy behaviors through exerting social con-
trol over smoking. Improved neighborhood
social capital may impact health through
increased access to local services and amenities
(e.g., safe transportation, pharmacy availabil-
ity). It is unlikely that the health problems of
disadvantaged populations can be solved
unless we try to understand the potential role
of unique environmental stressors such as
violence exposure. 
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